Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 179324-69-7 Chemical Structure| 179324-69-7

Structure of Bortezomib
CAS No.: 179324-69-7

Chemical Structure| 179324-69-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Bortezomib is a reversible and selective proteasome inhibitor that effectively inhibits the 20S proteasome by targeting threonine residues (Ki = 0.6 nM). Bortezomib is mainly used in the treatment research of multiple myeloma and other hematologic cancers.

Synonyms: PS-341; LDP-341; MLN341

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Brett H. Pogostin ; Samuel X. Wu ; Michael J. Swierczynski ; Christopher Pennington ; Si-Yang Li ; Dilrasbonu Vohidova , et al.

Abstract: Maintaining safe and potent pharmaceutical drug levels is often challenging. Multidomain peptides (MDPs) assemble into supramolecular hydrogels with a well-defined, highly porous nanostructure that makes them attractive for drug delivery, yet their ability to extend release is typically limited by rapid drug diffusion. To overcome this challenge, we developed self-assembling boronate ester release (SABER) MDPs capable of engaging in dynamic covalent bonding with payloads containing boronic acids (BAs). As examples, we demonstrate that SABER hydrogels can prolong the release of five BA-containing small-molecule drugs as well as BA-modified insulin and antibodies. Pharmacokinetic studies revealed that SABER hydrogels extended the therapeutic effect of ganfeborole from days to weeks, preventing Mycobacterium tuberculosis growth better than repeated oral administration in an infection model. Similarly, SABER hydrogels extended insulin activity, maintaining normoglycemia for six days in diabetic mice after a single injection. These results suggest that SABER hydrogels present broad potential for clinical translation.

Purchased from AmBeed: ; ; ;

Alternative Products

Product Details of Bortezomib

CAS No. :179324-69-7
Formula : C19H25BN4O4
M.W : 384.24
SMILES Code : CC(C)C[C@@H](B(O)O)NC([C@@H](NC(C1=NC=CN=C1)=O)CC2=CC=CC=C2)=O
Synonyms :
PS-341; LDP-341; MLN341
MDL No. :MFCD09056737
InChI Key :GXJABQQUPOEUTA-RDJZCZTQSA-N
Pubchem ID :387447

Safety of Bortezomib

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H300-H310-H330-H372
Precautionary Statements:P260-P301+P310-P304+P340-P320-P330-P361-P405-P501
Class:6.1
UN#:3249
Packing Group:

Isoform Comparison

Biological Activity

Target
  • 20S proteasome

    20S proteasome, Ki:0.6 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
LP-1 cells 10 nM 24 h Evaluate the effect of HDAC1 inhibitor Rom combined with Bortezomib, significantly increased apoptosis rate PMC9998874
MM.1 S cells 0.5 nM 6 months Induce Bortezomib resistance, IC50 value increased more than 10 times PMC9998874
GBC-SD cells 0.01 μM 48 h To evaluate the antiproliferative effect of ES-NP(BTZ;Ce6) +NIR on GBC-SD cells, the results showed an IC50 value significantly lower than that of BTZ alone. PMC8895115
NOZ cells 0.0048 μM 48 h To evaluate the antiproliferative effect of ES-NP(BTZ;Ce6) +NIR on NOZ cells, the results showed an IC50 value of 4.8 × 10^-9 M, significantly lower than 11.4 × 10^-9 M for BTZ alone. PMC8895115
L1210 cells 10 nM 24 h To evaluate the cytotoxic effects of Bortezomib on L1210 cells under starvation conditions, results showed that Bortezomib significantly enhanced the proapoptotic effects of starvation. PMC10982641
MEC2 cells 10 nM 24 h To evaluate the cytotoxic effects of Bortezomib on MEC2 cells under starvation conditions, results showed that Bortezomib significantly enhanced the proapoptotic effects of starvation. PMC10982641
MEC1 cells 10 nM 24 h To evaluate the cytotoxic effects of Bortezomib on MEC1 cells under starvation conditions, results showed that Bortezomib significantly enhanced the proapoptotic effects of starvation. PMC10982641
UMSCC-17A cells 0.01 –10000 nM 24 h To study the sensitivity of different HNSCC cell lines to Bortezomib, it was found that UMSCC-17A cells had a lower IC50 value for Bortezomib, indicating relative sensitivity. PMC8994767
UMSCC-11 cells 0.01 –10000 nM 24 h To study the sensitivity of different HNSCC cell lines to Bortezomib, it was found that UMSCC-11 cells had a higher IC50 value for Bortezomib, indicating relative resistance. PMC8994767
UMSCC-17B cells 0.01 –10000 nM 24 h To study the sensitivity of different HNSCC cell lines to Bortezomib, it was found that UMSCC-17B cells had a lower IC50 value for Bortezomib, indicating relative sensitivity. PMC8994767
HN31 cells 0.01 –10000 nM 24 h To study the sensitivity of different HNSCC cell lines to Bortezomib, it was found that HN31 cells had a higher IC50 value for Bortezomib, indicating relative resistance. PMC8994767
U266 cells 9.21 nM 12 h and 24 h To evaluate the inhibitory effect of anti-BCMA-Exo-Btz on myeloma cell proliferation, results showed that anti-BCMA-Exo-Btz was more effective than free Btz in suppressing myeloma cell proliferation. PMC11421322
LP-1 cells 9.21 nM 12 h and 24 h To evaluate the inhibitory effect of anti-BCMA-Exo-Btz on myeloma cell proliferation, results showed that anti-BCMA-Exo-Btz was more effective than free Btz in suppressing myeloma cell proliferation. PMC11421322
AMO1 cells 5 nM 24 h To evaluate the effect of ISG20L2 overexpression on BTZ sensitivity, results showed that ISG-OE AMO1 cells were less sensitive to BTZ. PMC9675441
ARD cells 3.125 to 50 nM 24 h To evaluate the effect of ISG20L2 knockdown on BTZ sensitivity, results showed that ISG-KD ARD cells were more sensitive to BTZ. PMC9675441
Mouse dorsal root ganglion (DRG) neurons 3 nM - 10 µM 24 h Bortezomib caused neurite retraction and neuronal death PMC10698173
Mouse dorsal root ganglion (DRG) neurons 100 nM 24 h Bortezomib induced long-term sensitization of TRPV1, increasing the response to capsaicin PMC10698173

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NSG mice Xenograft model Subcutaneous injection 0.5 mg/kg Bortezomib every 3 days, Rom every 2 days, for 24 days Evaluate the effect of HDAC1 inhibitor Rom combined with Bortezomib, significantly suppressed tumor growth and prolonged survival PMC9998874
Mice GBC cell-derived xenograft (CDX) and patient-derived xenograft (PDX) animal models Intravenous injection 0.25 mg/kg Every 3 days for a total of 6 times To evaluate the antitumor efficacy of ES-NP(BTZ;Ce6) +NIR in CDX and PDX models, the results showed significant inhibition of tumor growth, with a reduction of 96.8 ± 1.5% in tumor volume. PMC8895115
Mice Chronic Lymphocytic Leukemia (CLL) model Intraperitoneal injection 0.35 mg/kg Once per week for 3 weeks To evaluate the anti-CLL effects of Bortezomib in combination with Rituximab under fasting-mimicking conditions, results showed that the combination treatment significantly delayed CLL progression and prolonged mouse survival. PMC10982641
Nude mice Subcutaneous HNSCC tumor model Tail vein injection 0.3 mg/kg Every three days for 6 weeks To study the effect of ΔNp63 α on Bortezomib resistance in vivo, it was found that silencing ΔNp63 α inhibited the growth of HN-31 cells, while forced expression of ΔNp63 α significantly promoted the growth of UMSCC-17B cells. PMC8994767
NSG mice Orthotopic MM xenograft model Lateral tail vein injection 0.29 mg/kg 3 times a week for 2 weeks To evaluate the antitumor effect of anti-BCMA-Exo-Btz in vivo, results showed that anti-BCMA-Exo-Btz significantly inhibited tumor growth and prolonged the overall survival of the animals. PMC11421322
Mice Human MM xenograft model Intraperitoneal injection 0.75 mg/kg Twice a week for 4 weeks To evaluate the effect of ISG20L2 knockdown on BTZ treatment efficacy, results showed that ISG-KD MM was more sensitive to BTZ treatment, and mice survived longer. PMC9675441
Mice Wild-type and TRPV1 knockout mice Intraperitoneal injection 1 mg/kg Injected on days 1, 3, and 5, lasting for 2 weeks Bortezomib caused a reduction in intraepidermal nerve fiber density and loss of sensory function, and TRPV1 knockout mice were protected from these effects PMC10698173

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00571493 Non-hodgkin's Lymphoma ... More >> Mantle Cell Lymphoma Less << Phase 1 Phase 2 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center, Section of Oncology/Hematology Omaha, Nebraska, United States, 68198-7680 Less <<
NCT00580320 Melanoma Soft... More >> Tissue Sarcoma Parathyroid Carcinoma Small Cell Carcinoma of the Lung Carcinoid Tumors Less << Phase 1 Completed - United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, Virginia Massey Cancer Center/Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT02808091 Extranodal NK-T-CELL LYMPHOMA Phase 2 Terminated(Slow recruitment) - Singapore ... More >> National Cancer Centre Singapore, Singapore, 169610 Less <<
NCT00777738 Waldenstrom Macroglobulinemia Phase 2 Completed - France ... More >> Hopital La Pitie Salpetriere Paris, France, 75013 Less <<
NCT00288028 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00483262 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University in Saint Louis St. Louis, Missouri, United States, 63110 Less <<
NCT00483262 - Completed - -
NCT01046006 Waldenstrom's Macroglobulinemi... More >>a Less << Phase 2 Unknown - Greece ... More >> Alexandra Hospital , Department of Clinical Therapeutics Athens, Attica, Greece, 115 28 Laikon Hospital Athens, Attica, Greece, 11528 Netherlands Erasmus Medical Center Rotterdam, Netherlands, 3015 CE Spain Hospital Universitario de Salamanca Salamanca, Spain, 37007 Less <<
NCT01462773 Melanoma Phase 1 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00417911 Multiple Myeloma Phase 3 Completed - Denmark ... More >> Hæmatologisk afdeling L Amtssygehuset i Herlev Herlev, Denmark, DK-2730 Medicinsk Hæmatologisk afd L4042, Rigshospitalet København Ø, Denmark, DK-2100 Hæmatologisk afd X, Odense Universitetshospital Odense C, Denmark, DK-5000 Hæmatologisk afdeling B, Aalborg Sygehus Syd Ålborg, Denmark, DK-9000 Hæmatologisk afd. B, Århus Universitetshospital, Amtssygehuset Århus C, Denmark, DK-8000 Finland Tampere University Hospital, Dep 10a Tampere, Finland, SF-33 521 Turku University Hospital, Dept. of Medicine, PL 52, Turku, Finland, SF-20521 Iceland Hemathology department, University State Hospital, Landspitali Reykjavik, Iceland, 101 Norway Hematologisk seksjon, med avd, Haukeland Universitetssykehus Bergen, Norway, N-5021 Seksjon for blodsykdommer, Med. avd.,Rikshospitalet Oslo, Norway, N - 0027 Hematologisk avdeling Ullevål Sykehus Oslo, Norway, N - 0407 Med avd B, Hematologisk seksjon, Universitetssykehuset Nord Norge Tromsø, Norway, N-9038 Hematologisk seksjon Regionssykehuset Trondheim, Norway, N - 7006 Sweden Hematologiska klin, Huddinge sjukhus Huddinge, Sweden, SE-141 86 Hematologkliniken, Universitetssjukhuset Linköping, Sweden, SE-581 85 University Hospital Lund Lund, Sweden, SE-221 85 Medicinklin, Universitetssjukhuset MAS, Malmö, Sweden, SE-205 02 Medicinklin, sekt för hematologi, Norrlands Universitetssjukhus Umeå, Sweden, SE-901 85 Medicinklin, Akademiska sjukhuset Uppsala, Sweden, SE-751 85 Medicinkliniken, Universitetssjukhuset Örebro, Sweden, SE-70185 Less <<
NCT01873157 Late Rejection of Renal Transp... More >>lant Antibody-mediated Rejection Less << Phase 2 Completed - Austria ... More >> Medical University of Vienna, Department of Nephrology and Dialysis Vienna, Austria, 1090 Less <<
NCT01462773 - Completed - -
NCT00093704 Lymphoma Lymp... More >>hoproliferative Disorder Less << Phase 1 Terminated(study could not rec... More >>ruit any more patients) Less << - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT01058239 Post-transplant Lymphoprolifer... More >>ative Disease Solid Organ Transplant Stem Cell Transplant (Bone Marrow Transplant) Epstein Barr Virus Infections Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00571493 - Completed - -
NCT01058239 - Completed - -
NCT00722722 Kidney Transplantation PHASE2 COMPLETED 2025-04-14 Mayo Clinic, Rochester, Minnes... More >>ota, 55905, United States Less <<
NCT00422799 Waldenstrom's Macroglobulinemi... More >>a Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00722722 Kidney Transplantation PHASE2 COMPLETED 2025-04-14 Mayo Clinic, Rochester, Minnes... More >>ota, 55905, United States Less <<
NCT00422799 - Completed - -
NCT00153920 Multiple Myeloma Phase 2 Completed - United States, Georgia ... More >> Emory Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 04263 Memorial Sloan-Kettering Cancer Center New York City, New York, United States, 10021 Less <<
NCT00901147 Peripheral T-cell Lymphoma (No... More >>t Otherwise Specified) Angioimmunoblastic T-cell Lymphoma Extranodal NK/T-cell Lymphoma Nasal Type Enteropathy- Type T-cell Lymphoma Hepatosplenic T-cell Lymphoma Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative) Relapsed ALCL (ALK-1 Positive) Post Autologous Transplant Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Centre Seoul, Korea, Republic of, 135-710 Malaysia Subang Jaya Medical Centre Subang Jaya, Selangor, Malaysia, 47500 Hospital Universiti Kebangsaan Malaysia ( HUKM ) Kuala Lumpur, Malaysia, 56000 Singapore National Cancer Center Singapore, Singapore, 169608 Singapore General Hospital Singapore, Singapore, 169608 Less <<
NCT00153920 - Completed - -
NCT00990652 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT01397591 - Terminated(Study closed by PI ... More >>due to lower than expected accrual.) Less << - -
NCT00990652 - Completed - -
NCT00765102 Multiple Myeloma Phase 2 Terminated(There was a change ... More >>in the Sponsor's research strategy; safety concerns were not a factor.) Less << - United States, California ... More >> Loma Linda University Cancer Center Loma Linda, California, United States, 92354 Desert Cancer Care, Inc Rancho Mirage, California, United States, 92270 Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara, California, United States, 93105 James R Berenson, MD, Inc. West Hollywood, California, United States, 90069 United States, Georgia Georgia Cancer Specialists I, PC Atlanta, Georgia, United States, 30341 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, North Carolina Mecklenburg Medical Group Charlotte, North Carolina, United States, 28204 United States, Texas Baylor Sammons Cancer Center Dallas, Texas, United States, 75246 Dallas Oncology Consultants, P.A. Duncanville, Texas, United States, 75137 Oncology Consultants, P.A Houston, Texas, United States, 77024 United States, Utah Central Utah Clinic, PC Provo, Utah, United States, 84604 United States, Washington Virginia Mason Medical Centre Seattle, Washington, United States, 98101 Less <<
NCT01472627 - Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00153933 Refractory Multiple Myeloma ... More >> Relapsed Multiple Myeloma Multiple Myeloma Less << Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Winship Cancer Center Atlanta, Georgia, United States, 30322 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Center Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, New York St. Vincent's Comprehensive Cancer Center New York City, New York, United States, 10011 Less <<
NCT01397591 Recurrent Adult Diffuse Large ... More >>Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Less << Phase 2 Terminated(Study closed by PI ... More >>due to lower than expected accrual.) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT02497378 Multiple Myeloma Phase 1 Completed - Japan ... More >> Hiroshima, Japan Hitachi, Japan Nagoya, Japan Shibuya, Japan Tachikawa, Japan Less <<
NCT00642395 Multiple Myeloma PHASE2 COMPLETED 2025-07-11 Service of Blood Deseases - So... More >>uth Hospital, Amiens, 80054, France|Service of Clinical Hematology - Bocage Hospital, Angers, 49033, France|Service of Clinical Hematology - Cote Basque Hospital, Bayonne, 64109, France|Service of Clinical Hematology - Minjoz Hospital, Besan?on, 25030, France|Service of Clinical Hematology - Avicenne Hospital, Bobigny, 93009, France|Service of Clinical Hematology - A. Morvan Hospital, Brest, 29609, France|Service of Clinical Hematology - F. Baclesse Center, Caen, 14076, France|Service of Clinical Hematology - Army Instruction Hospital of Percy, Clamart, 92141, France|Service of Clinical Hematology - UH of Clermont-Ferrand, Clermont-Ferrand, 63003, France|Service of Oncohematology - Louis Pasteur Hospital, Colmar, 68024, France|Service of Hematology - Bocage Hospital, Dijon, 21034, France|Service of Hematology - General Hospital, Dunkerque, 59385, France|Service of Hematology - A. Michallon Hospital, Grenoble, 38043, France|Service of Hematology - Claude Hurriez Hospital, Lille, 59037, France|Service of Hematology - Léon Bérard Center, Lyon, 69008, France|Service of Hematology - Edouard Herriot Hospital, Lyon, 69437, France|Service of Hematology - Lyon Sud Hospital, Lyon, 69495, France|Service of Hematology - Paoli Calmette Institute, Marseille, 13273, France|Service of Hematology - Notre Dame du Bon Secours Hospital, Metz, 57038, France|Service of Blood Deseases - UH of Nantes, Nantes, 44035, France|Service of Clinical Hematology - Archet 1 Hospital, Nice, 06202, France|Service of Oncology - Archet 1 Hospital, Nice, 06202, France|Service of Hematology - Hotel Dieu, Paris, 75004, France|Service of Hematology - Cochin Hospital, Paris, 75014, France|Service of Blood Deseases - Saint Antoine Hospital, Paris, 75571, France|Service of Hematology - Jean Bernard Hospital, Poitiers, 86021, France|Service of Hematology - R.Debré Hospital, Reims, 51032, France|Service of Hematology - Pontchaillou Hospital, Rennes, 35033, France|Service of Hematology -Henri Becquerel Center, Rouen, 76038, France|Service of Hematology - Hautepierre Hospital, Strasbourg, 67098, France|Service of Clinical Hematology - Purpan hospital TSA 40031, Toulouse, 31059, France|Service of Onco-Hematology - Bretonneau Hospital, Tours, 37044, France|Service of Hematology - Brabois Hospital, Vandoeuvre, 54511, France|Service of Hematology -Gustave Roussy Institute, Villejuif, 94805, France Less <<
NCT03700229 Acquired Hemophilia A Phase 2 Recruiting April 15, 2020 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Huacong Cai    01069158271    caihc@pumch.cn    Contact: Tienan Zhu, MD    01069158271    zhutn@pumch.cn    Principal Investigator: Tienan Zhu, MD Less <<
NCT01226849 Diffuse Large B-Cell Lymphoma Phase 1 Completed - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 169608 Less <<
NCT00671112 714leukemia L... More >>ymphoma Less << Phase 1 Terminated(Treatment ineffecti... More >>ve) Less << - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00624936 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00983346 Cancer|Myeloma|Multiple Myelom... More >>a Less << PHASE2 TERMINATED 2025-09-14 Huntsman Cancer Institute, Sal... More >>t Lake City, Utah, 84112, United States Less <<
NCT00765102 - Terminated(There was a change ... More >>in the Sponsor's research strategy; safety concerns were not a factor.) Less << - -
NCT00983346 Cancer|Myeloma|Multiple Myelom... More >>a Less << PHASE2 TERMINATED 2025-09-14 Huntsman Cancer Institute, Sal... More >>t Lake City, Utah, 84112, United States Less <<
NCT00581360 - Completed - -
NCT03110562 Multiple Myeloma Phase 3 Recruiting June 2020 -
NCT00714246 Non Small Cell Lung Cancer Phase 1 Phase 2 Active, not recruiting August 2017 United States, Pennsylvania ... More >> Penn State College of Medicine, Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00784823 Multiple Myeloma Phase 1 Phase 2 Completed - United States, New Jersey ... More >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00431769 Multiple Myeloma PHASE2 COMPLETED 2025-01-10 Graz, Austria|Oberpullendorf, ... More >>Austria|Wien, Austria|Antwerpen, Belgium|Brussels, Belgium|Brussel, Belgium|Gent, Belgium|Roeselare, Belgium|Dijon, France|Limousis, France|Marseille, France|Nantes, France|Paris, France|Pessac, France|Bad Soden, Germany|Berlin, Germany|Erlangen, Germany|Hamburg, Germany|Hamm, Germany|Hannover, Germany|Kiel, Germany|K?ln, Germany|Mainz, Germany|Würselen, Germany|Athens, Greece|Patra, Greece|Thessalonikis, Greece|Luxembourg, Luxembourg|Almada N/A, Portugal|Coimbra, Portugal|Lisboa, Portugal|Barcelona, Spain|Cadiz N/A, Spain|Málaga, Spain|Salamanca, Spain|Santiago De Compostela, Spain|Sevilla, Spain|Toledo, Spain|Zaragoza, Spain Less <<
NCT00581360 Adenoid Cystic Carcinoma Phase 2 Completed - United States, Ohio ... More >> UPMC Cancer Center - Teramana Cancer Center - Steubenville Steubenville, Ohio, United States, 43952 United States, Pennsylvania UPMC Cancer Center - Beaver Beaver, Pennsylvania, United States, 15009 UPMC Cancer Center - Clairton Clairton, Pennsylvania, United States, 15025 UPMC Cancer Center - Arnold Palmer Pavilion - Greensburg Greensburg, Pennsylvania, United States, 15601 UPMC Cancer Center - Oakbrook Commons - Greensburg Greensburg, Pennsylvania, United States, 15601 UPMC Cancer Center - Indiana Indiana, Pennsylvania, United States, 15701 UPMC Cancer Center - John P. Murtha Pavilion - Johnstown Johnstown, Pennsylvania, United States, 15901 UPMC Cancer Center - McKeesport McKeesport, Pennsylvania, United States, 15132 UPMC Cancer Center -Haymaker Rd. Monroeville, Pennsylvania, United States, 15146 UPMC Cancer Center -Mosside Blvd. Monroeville, Pennsylvania, United States, 15146 UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group Moon Township, Pennsylvania, United States, 15108 UPMC Cancer Center -Mt. Pleasant Mt. Pleasant, Pennsylvania, United States, 15666 UPMC Cancer Center -New Castle New Castle, Pennsylvania, United States, 16105 UPMC Cancer Center -Delafield Rd. Pittsburgh, Pennsylvania, United States, 15215 UPMC Cancer Center - Mercy Pittsburgh, Pennsylvania, United States, 15219 University of Pittsburgh Cancer Institute-Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 UPMC Cancer Center - Passavant Pittsburgh, Pennsylvania, United States, 15237 UPMC Cancer Center -Drake Pittsburgh, Pennsylvania, United States, 15241 UPMC Cancer Center - Uniontown Uniontown, Pennsylvania, United States, 15401 UPMC Cancer Center - Washington Washington, Pennsylvania, United States, 15301 UPMC Cancer Center -Wexford Wexford, Pennsylvania, United States, 15090 Less <<
NCT00620295 Breast Cancer ... More >> Colorectal Cancer Head and Neck Cancer Kidney Cancer Lung Cancer Ovarian Cancer Pancreatic Cancer Prostate Cancer Sarcoma Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02811978 Multiple Myeloma Phase 3 Completed - China ... More >> Beijing, China Chengdu, China Chongqing, China Fuzhou, China Guangzhou, China Nanjing, China Shanghai, China Suzhou, China Tianjin, China Wuhan, China Less <<
NCT01183949 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Massachusetts General Hospital Boston, Massachusetts, United States, MA02115 Dana Faber Cancer Institute Boston, Massachusetts, United States United States, New York Memorial Sloan-Kettering Cancer Centre New York, New York, United States, 10065 United States, Wisconsin MCW and Froedtert Clinical Cancer Center, Division of Neoplastic Diseases & Related Disorders Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01860170 - Active, not recruiting - -
NCT01860170 Hematological Malignancy Phase 1 Phase 2 Active, not recruiting March 2018 United States, Michigan ... More >> Spectrum Health Grand Rapids, Michigan, United States, 49503 Less <<
NCT01524445 - Completed - Greece ... More >> Alexandroupoli, Greece Athens Attica, Greece Athens, Greece Patra, Greece Less <<
NCT02976272 - Recruiting January 2019 France ... More >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr    Principal Investigator: Carine CHALETEIX Less <<
NCT03016988 Mantle Cell Lymphoma Phase 2 Not yet recruiting December 2020 -
NCT02703779 Multiple Myeloma Phase 2 Recruiting January 2019 United States, Kansas ... More >> The University of Kansas Medical Center Recruiting Westwood, Kansas, United States, 66205 Contact: Kerry Hepler, PhD       ctnursenav@kumc.edu    Principal Investigator: Siddhartha Ganguly, MD          Sub-Investigator: Joseph McGuirck, DO          Sub-Investigator: Anurag Singh, MD          Sub-Investigator: Leyla Shune, MD          Sub-Investigator: Tara Lin, MD Less <<
NCT02902965 Multiple Myeloma Phase 2 Completed - Czechia ... More >> Fakultní nemocnice Brno Brno, Czechia Fakultní nemocnice Hradec Králové Nový Hradec Králové, Czechia Fakultní nemocnice Ostrava Ostrava-Poruba, Czechia Všeobecná fakultní nemocnice v Praha Praha 2, Czechia Germany Helios-Kliniken Berlin-Buch Berlin, Germany Vivantes Klinikum Spandau Berlin, Germany Universitätsklinikum Jena Jena, Germany Klinikum der Universität München Campus Grosshadern München, Germany Greece 251 General Air Force Hospital Athens, Greece General Hospital of Athens "Alexandra" Athens, Greece General Hospital of Athens "Evangelismos" Athens, Greece General Hospital of Athens "LAIKO" Athens, Greece University General Hospital of Patra Patras, Greece General Hospital of Thessaloniki "G. Papanikolau" Thessaloniki, Greece Italy IRCCS Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi Bologna, Italy Istituto Scientifico Romagnolo Per lo Studio e la Cura dei Tumori Meldola (FC), Italy Ospedale Santa Maria delle Croci Ravenna, Italy Ospedale degli Infermi Rimini, Italy Azienda Ospedaliera S. Maria di Terni Terni, Italy Spain Hospital Universitario Rey Juan Carlos Mostoles, Madrid, Spain Complejo Hospitalario Universitario A Coruña A Coruna, Spain ICO Badalona-Hospital Germans Trias i Pujol Badalona, Spain Hospital Clínic i Provincial de Barcelona Barcelona, Spain Hospital Universitario Madrid Sanchinarro Madrid, Spain Clinica Universidad de Navarra Pamplona, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital Universitario Virgen del Rocio Sevilla, Spain Hospital Universitario Dr. Peset Valencia, Spain Turkey Ankara University Medical Faculty Ankara, Turkey Dokuz Eylul University Medicine Faculty Izmir, Turkey Erciyes University Medical Faculty Kayseri, Turkey Ondokuz Mayis Univ. Med. Fac. Samsun, Turkey Less <<
NCT03617484 Mantle Cell Lymphoma Phase 2 Not yet recruiting September 2021 United States, Michigan ... More >> University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States, 48187 Less <<
NCT00372905 Lymphoma Phase 1 Phase 2 Terminated(Study was closed pe... More >>rmanently before the accrual goal was met due to slow accrual) Less << - United States, Georgia ... More >> Emory University School of Medicine Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00372905 - Terminated(Study was closed pe... More >>rmanently before the accrual goal was met due to slow accrual) Less << - -
NCT00923247 Medullary Thyroid Carcinoma Phase 1 Phase 2 Terminated(Terminated due to s... More >>low accrual,primary endpoint reached & investigator left NIH.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01315873 Multiple Myeloma Phase 2 Terminated(PI left the institu... More >>tion before all data analysis was completed) Less << - United States, New York ... More >> New York University Langone Medical Center New York, New York, United States, 10016 Less <<
NCT00923247 - Terminated(Terminated due to s... More >>low accrual,primary endpoint reached & investigator left NIH.) Less << - -
NCT01315873 - Terminated(PI left the institu... More >>tion before all data analysis was completed) Less << - -
NCT02467010 Multiple Myeloma Phase 2 Completed - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands, 9713 GZ Less <<
NCT01273844 Amyloidosis COMPLETED 2016-05-12 Soochow University, Suzhou, Ji... More >>angsu, 215325, China Less <<
NCT02201576 Chronic Antibody-mediated Tran... More >>splant Rejection Less << Phase 2 Recruiting February 2020 France ... More >> CHRU Lille Not yet recruiting Lille, France, 59000 Contact: Marc HAZZAN    +33 3 20 44 67 70    marc.hazzan@unviv-lille2.fr    Hopital Necker Enfants-malades Recruiting Paris, France, 75015 Contact: Rebecca SBERRO-SOUSSAN    +33 1 44 49 42 51    rebecca.sberro@aphp.fr    CHU Rouen Not yet recruiting Rouen, France, 76230 Contact: Dominique BERTRAND    +33 2 32 88 90 09    dominique.bertrand@chu-rouen.fr    CHU Bretonneau Not yet recruiting Tours, France, 37044 Contact: Matthias BUCHLER    +33 2 47 47 82 29 Less <<
NCT02336386 Extramedullary Plasmacytoma Phase 3 Unknown December 2016 China, Beijing ... More >> Yuping ZHONG Recruiting Beijing, Beijing, China, 100043 Contact: Yuping ZHONG, Doctor    860105171-8999    zhongyp3352@126.com    Principal Investigator: Yuping ZHONG, Doctor          Principal Investigator: Jin LU, Doctor Less <<
NCT01891968 Leukemia PHASE2 COMPLETED 2017-01-18 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT01497626 Advanced Solid Tumors Phase 1 Terminated(Drug support withdr... More >>awn) Less << - United States, District of Col... More >>umbia Georgetown Lombardi Comprehensive Cancer Center Washington, District of Columbia, United States, 20007 Less <<
NCT02139397 Neuroblastoma Recurrent Phase 1 Phase 2 Recruiting July 2019 United States, Arkansas ... More >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Janet Storment, RN    501-364-2760    StormentJanetS@uams.edu    Principal Investigator: Kathleen Neville, MD          United States, Connecticut Connecticut Children's Hospital Recruiting Hartford, Connecticut, United States, 06106 Contact: Sharon Huie-White    860-545-9337    shuie@connecticutchildrens.org    Principal Investigator: Michael Isakoff, MD          United States, Florida Arnold Palmer Hospital for Children- MD Anderson Recruiting Orlando, Florida, United States, 32806 Contact: Michelle Pope, RN    321-841-8588       Principal Investigator: Don Eslin, MD          United States, Michigan Helen DeVos Children's Hospital Recruiting Grand Rapids, Michigan, United States, 49503 Contact: Shannon MacKeigan    616-267-1162    shannon.mackeigan@helendevoschildrens.org    Principal Investigator: Deanna Mitchell, MD          Principal Investigator: Giselle Sholler, MD          United States, Missouri Children's Mercy Hospitals and Clinics Recruiting Kansas City, Missouri, United States, 64108 Contact: Michelle Dinkins    816-302-6893    MDinkins@cmh.edu    Principal Investigator: Keith August, MD          United States, South Carolina Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Liz Shewfelt    843-792-2957    shewfelt@musc.edu    Principal Investigator: Jaqueline Kraveka, MD Less <<
NCT02351427 Kidney Transplantation Phase 3 Unknown December 2015 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Su-Kil Park, M.D., PhD    82-2-3010-3263    skpark@amc.seoul.kr    Contact: Chung Hee Baek, M.D.    82-2-3010-1481    bch393@naver.com Less <<
NCT00622674 Breast Cancer ... More >> Colorectal Cancer Head and Neck Cancer Kidney Cancer Lung Cancer Pancreatic Cancer Sarcoma Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00789256 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndromes Less << Not Applicable Completed - United States, Florida ... More >> Integrated Community Oncology Network Jacksonville, Florida, United States, 32256 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT01485835 Multiple Myeloma Phase 1 Completed - United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Georgia Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Siteman Cancer Center at Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Texas The Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 United States, Virginia Virginia Cancer Specialists Fairfax, Virginia, United States, 22031 Less <<
NCT01891968 Leukemia PHASE2 COMPLETED 2017-01-18 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT00657553 Multiple Myeloma PHASE3 TERMINATED 2025-01-09 University of Arkansas for Med... More >>ical Sciences, Myeloma Institute for Research and Therapy, Little Rock, Arkansas, 72205, United States Less <<
NCT00789256 - Completed - -
NCT01453088 Multiple Myeloma Phase 2 Recruiting March 2020 United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Recruiting Washington, District of Columbia, United States, 20057 Contact: Kristen Gunn, RN, BSN    202-687-4773    keg91@georgetown.edu    Contact: Julia Varga, RN, MSN    202-687-7354    jmv78@georgetown.edu    Principal Investigator: Pashna Munshi, MD          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Mariefel Vendivil    551-996-5828    Mariefel.Vendivil@HackensackMeridian.org    Contact: Andrea Ortega    551-996-3923    Andrea.Orgeta@HackensackMeridian.org    Principal Investigator: Michele Donato, MD          Sub-Investigator: David Vesole, MD, PhD          Sub-Investigator: Scott D Rowley, MD          Sub-Investigator: Melissa Baker, APN          Sub-Investigator: Michele Boonstra, APN          Sub-Investigator: Noa Biran, MD          Sub-Investigator: David S Siegel, MD, PhD          Sub-Investigator: Joshua Richter, MD          Sub-Investigator: Phyllis McKiernan, APN          Sub-Investigator: Alan Skarbnik, MD          Sub-Investigator: Mary DiLorenzo, APN Less <<
NCT00657553 Multiple Myeloma PHASE3 TERMINATED 2025-01-09 University of Arkansas for Med... More >>ical Sciences, Myeloma Institute for Research and Therapy, Little Rock, Arkansas, 72205, United States Less <<
NCT00815919 - Completed - -
NCT01812096 Multiple Myeloma Proved by Lab... More >>oratory Tests Less << Phase 1 Phase 2 Unknown June 2017 China, Jiangsu ... More >> The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China, 215006 Less <<
NCT00815919 Chronic Graft Versus Host Dise... More >>ase Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01833143 Non-Small Cell Lung Cancer Phase 2 Active, not recruiting April 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Less <<
NCT03509246 Ovarian Neoplasm Epithelial ... More >> High Grade Serous Carcinoma Less << Phase 2 Not yet recruiting March 2022 Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam Si, Gyenggi DO, Korea, Republic of, 463707 Less <<
NCT01736943 Acute Myelogenous Leukemia Phase 2 Active, not recruiting December 2019 United States, California ... More >> University of California Comprehensive Cancer Center Sacramento, California, United States, 95817 Less <<
NCT01504477 Colorectal Cancer Phase 1 Phase 2 Terminated(Low accrual--unable... More >> to meet accrual goals) Less << - United States, District of Col... More >>umbia Georgetown Lombardi Comprehensive Cancer Center Washington, D.C., District of Columbia, United States, 20007 Less <<
NCT00644696 Neuroblastoma Phase 1 Completed - United States, Michigan ... More >> The University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT01158105 Chronic Graft-versus-host Dise... More >>ase Less << PHASE2 UNKNOWN 2025-01-17 Charles A. Cancer Center, Bayl... More >>or University Medical Center, Dallas, Texas, 75246, United States Less <<
NCT01672736 Multiple Myeloma Phase 1 Phase 2 Terminated(The Sponsor decided... More >> to stop further manufacture the study drug 'Linsitinib' in Nov 2015.) Less << - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Illinois University Of Chicago Medical Center Chicago, Illinois, United States, 60637 Canada, Nova Scotia Queen Elizabeth II Health Sciences Center Halifax, Nova Scotia, Canada, B3H2Y9 Canada, Ontario University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada, H1T 2M4 Sir Mortimer B. Davis-Jewish General Hospital Montreal, Quebec, Canada, H3T 1E3 Less <<
NCT01672736 - Terminated(The Sponsor decided... More >> to stop further manufacture the study drug 'Linsitinib' in Nov 2015.) Less << - -
NCT01328236 Plasma Cell Leukemia ... More >> Multiple Myeloma Less << Phase 2 Unknown September 2015 China, Beijing ... More >> Beijing Clinical Service Center Recruiting Beijing, Beijing, China Contact: zhao wang, M.D    861063138303 ext 861063138303    zhaowww263@yahoo.com Less <<
NCT01171092 Malignant Lymphoma, Stem Cell ... More >>Type Autologous Transplant Less << Early Phase 1 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 University of Kansas Medical Center, Westwood Campus Westwood, Kansas, United States, 66205 Less <<
NCT01241708 Multiple Myeloma|Auto Stem Cel... More >>l Transplant Less << PHASE3 COMPLETED 2023-07-15 John Theurer Cancer Center @ H... More >>ackensack University Medical Center, Hackensack, New Jersey, 07601, United States Less <<
NCT02613598 Hodgkin's Lymphoma ... More >> Lymphoma, Non-Hodgkin Less << Phase 1 Recruiting October 2021 United States, Michigan ... More >> University of Michgan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48187 Contact: Tycel Phillips, M.D.    734-232-2883    tycelp@umich.edu    Principal Investigator: Tycel Phillips, M.D. Less <<
NCT01696474 Refractory Cold Agglutinin Dis... More >>ease Less << PHASE2 COMPLETED 2017-03-27 Struttura Complessa di Ematolo... More >>gia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria, Foggia, Italy|Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico, Milano, Italy|Cattedra di Ematologia CTMO Università degli Studi di Parma, Parma, Italy|U.O. Ematologia Clinica - Azienda USL di Pescara, Pescara, Italy|Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, 89100, Italy|Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia, Roma, Italy|Clinica Ematologica - Policlinico Universitario, Udine, Italy|Ospedale San Bortolo, Vicenza, 36100, Italy Less <<
NCT01930253 Refractory Autoimmune Cytopeni... More >>a(s) Less << Phase 1 Unknown January 2014 United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Angela D Poston    513-636-8815    angela.poston@cchmc.org    Contact: Pooja Khandelwal, MD    513-303-1779    pooja.khandelwal@cchmc.org    Principal Investigator: Alexandra Filipovich, MD          Sub-Investigator: Pooja Khandelwal, MD Less <<
NCT01720875 Multiple Myeloma Phase 2 Unknown August 2017 United Kingdom ... More >> Nottingham University Hospital Nottingham, Nottinghamshire, United Kingdom, NG5 1PB University Hospital Southampton Southampton, United Kingdom, SO16 6YD Less <<
NCT03737136 Antibody-mediated Rejection RECRUITING 2025-10-01 SBMU, Tehran, Iran, Islamic Re... More >>public of Less <<
NCT03643549 Glioblastoma Phase 1 Phase 2 Recruiting August 31, 2023 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Dorota Goplen, MD, PhD    +4755974019    dgop@helse-bergen.no    Contact: Jorunn Brekke, MD    +4755970986    joub@helse-bergen.no Less <<
NCT02356458 Mantle Cell Lymphoma Phase 1 Phase 2 Recruiting March 2021 Germany ... More >> Universitätsmedizin Mainz Recruiting Mainz, Germany, 55131 Contact: Georg Hess, Prof    +49 6131 17 50 40    georg.hess@unimedizin-mainz.de    Principal Investigator: Georg Hess, Prof          Klinikum der Universität München Recruiting München, Germany, 81377 Contact: Martin Dreyling, Prof    +49 (089) 4400 72202    martin.dreyling@med.uni-muenchen.de    Principal Investigator: Martin Dreyling, Prof          Universitätsmedizin Rostock Recruiting Rostock, Germany, 18057 Contact: Sebastian Böttcher, MD    +49 381 494 7405    sebastian.boettcher@med.uni-rostock.de    Principal Investigator: Sebastian Böttcher, MD          Italy Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, Italy, 15100 Contact: Marco Ladetto, MD    +39 131206 262    marco.ladetto@ospedale.al.it    Principal Investigator: Marco Ladetto, MD          European Institute of Oncology Recruiting Milano, Italy, 20141 Contact: Corrado Tarella, Prof    +39 02-57489.538    corrado.tarella@unito.it    Principal Investigator: Corrado Tarella, Prof          Università di Torino Recruiting Torino, Italy, 10126 Contact: Simone Ferrero, MD    +39 011 633 4220    simone.ferrero@unito.it    Principal Investigator: Simone Ferrero, MD          Switzerland Kantonsspital Aarau Recruiting Aarau, Switzerland, CH-5001 Contact: Mario Bargetzi, Prof    41-62-838-6053    mario.bargetzi@ksa.ch    Principal Investigator: Mario Bargetzi, Prof          Kantonsspital Baden Recruiting Baden, Switzerland, 5404 Contact: Clemens Caspar, MD    +41 56 486 27 62    clemens.caspar@ksb.ch    Principal Investigator: Clemens Caspar, MD          Inselspital, Bern Recruiting Bern, Switzerland, CH-3010 Contact: Urban Novak, MD    +41 31 632 41 14    urban.novak@insel.ch    Principal Investigator: Urban Novak, MD          Kantonsspital Graubünden Recruiting Chur, Switzerland, 7000 Contact: Ulrich Mey, MD    +41 81 256 71 70    ulrich.mey@ksgr.ch    Principal Investigator: Ulrich Mey, MD          Hopitaux Universitaires de Geneve Recruiting Genève 14, Switzerland, 1211 Contact: Noémie Lang, MD    +41 79 55 32 398    noemie.lang@hcuge.ch    Principal Investigator: Noémie Lang, MD          Centre Pluridisciplinaire d`Oncologie CHUV Recruiting Lausanne, Switzerland, 1011 Contact: Anne Cairoli, MD    +41 (0)21 314 41 82    anne.cairoli@chuv.ch    Principal Investigator: Anne Cairoli, MD          Kantonsspital Baselland Recruiting Liestal, Switzerland, 4410 Contact: Michèle Voegeli, MD    +41 61 925 27 10    michele.voegeli@ksbl.ch    Principal Investigator: Michèle Voegeli, MD          Istituto Oncologico della Svizzera Italiana Recruiting Lugano, Switzerland, CH-6900 Contact: Emanuele Zucca, Prof    +41 91 811 91 47    emanuele.zucca@eoc.ch    Principal Investigator: Emanuele Zucca, Prof          Kantonsspital Luzern Recruiting Luzerne, Switzerland, CH-6000 Contact: Thilo Zander, MD    +41 41 205 11 11    thilo.zander@luks.ch    Principal Investigator: Thilo Zander, MD          Kantonsspital - St. Gallen Recruiting St. Gallen, Switzerland, CH-9007 Contact: Martin Fehr, MD    +41 71 494 11 11    martin.fehr@kssg.ch    Principal Investigator: martin fehr, MD          Klinik Hirslanden Recruiting Zurich, Switzerland, CH-8032 Contact: Christoph Renner, Prof    +41 43 344 33 44    christoph.renner@hirslanden.ch    Principal Investigator: Christoph Hirslanden, Prof          Onkozentrum - Klinik Im Park Recruiting Zürich, Switzerland, 8038 Contact: Christoph Renner, Prof    +41 43 344 33 33    christoph.renner@hirslanden.ch    Principal Investigator: Christoph Renner, Prof          UniversitätsSpital Zürich Recruiting Zürich, Switzerland, 8091 Contact: Thorsten Zenz, Prof    +41 44 255 94 96    thorsten.zenz@usz.ch    Principal Investigator: Thorsten Zenz, Prof Less <<
NCT01965977 Diffuse Large B Cell Lymphoma PHASE2 UNKNOWN 2021-10-30 Samsung Medical Center, Seoul,... More >> 135-710, Korea, Republic of Less <<
NCT01090921 Multiple Myeloma PHASE2 COMPLETED 2025-03-15 Little Rock VA Medical Center,... More >> Little Rock, Arkansas, 72205, United States|West Los Angeles VA Medical Center, Los Angeles, California, 90073, United States|San Francisco VA Medical Center, San Francisco, California, 94121, United States|Eastern Colorado Health Care System, Denver, Colorado, 80220, United States|West Haven VA Medical Center, West Haven, Connecticut, 06516, United States|Tampa VA Medical Center, Tampa, Florida, 33612, United States|Atlanta VA Medical Center, Atlanta, Georgia, 30033, United States|VA Boston Healthcare System, Jamaica Plain, Massachusetts, 02130, United States|Kansas City VA Medical Center, Kansas City, Missouri, 64128, United States|Pittsburgh VA Medical Center, Pittsburgh, Pennsylvania, 15240, United States|Michael E. DeBakey VA Medical Center, Houston, Texas, 77030, United States Less <<
NCT01902862 Lymphoma, Follicular Phase 2 Terminated(Recruitment too slo... More >>w) Less << - Germany ... More >> Kiel, Germany Regensburg, Germany Stuttgart, Germany Less <<
NCT00408928 Graft-versus-Host Disease PHASE2 COMPLETED 2025-09-09 Thomas Jefferson University, P... More >>hiladelphia, Pennsylvania, 19107, United States Less <<
NCT02220608 Multiple Myeloma Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00408928 Graft-versus-Host Disease PHASE2 COMPLETED 2025-09-09 Thomas Jefferson University, P... More >>hiladelphia, Pennsylvania, 19107, United States Less <<
NCT01672229 Graft Versus Host Disease PHASE1 COMPLETED 2018-04-09 University of California Compr... More >>ehensive Cancer Center, Sacramento, California, 95817, United States Less <<
NCT02308280 Multiple Myeloma ... More >> High-Risk Cancer Less << Phase 2 Active, not recruiting November 2022 Canada, Quebec ... More >> Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada, H1T 2M4 Less <<
NCT01695330 Multiple Myeloma Phase 2 Terminated(Terminated by Spons... More >>or of this study.) Less << - United States, California ... More >> James R. berenson, M.D., Inc. West Hollywood, California, United States, 90069 Less <<
NCT01842074 Patients Awaiting a Living Kid... More >>ney Donation Less << PHASE4 UNKNOWN 2025-03-18 Assistance Publique - H?pitaux... More >> de Paris, Bicêtre Hospital, Le KREMLIN-BICETRE, 94 275, France Less <<
NCT01163786 Bronchiolitis Obliterans PHASE2 TERMINATED 2015-09-09 Northwestern University, Chica... More >>go, Illinois, 60611, United States Less <<
NCT03129828 Diffuse Large B Cell Lymphoma Phase 1 Phase 2 Recruiting March 31, 2022 Germany ... More >> Charité - Universitätsmedizin Berlin, Hematology, Oncology and Tumor Immunology, Campus Virchow Klinikum Recruiting Berlin, Germany, 13353 Contact: Clemens Schmitt, Prof. Dr.    +49-30-450 553 896    clemens.schmitt@charite.de    Contact: Sophy Denker, Dr.    +49-30-450 653 569    sophy.denker@charite.de    Principal Investigator: Clemens Schmitt, Prof. Dr. Less <<
NCT01801436 Multiple Myeloma PHASE3 COMPLETED 2025-04-08 -
NCT01695330 - Terminated(Terminated by Spons... More >>or of this study.) Less << - -
NCT01517724 Multiple Myeloma PHASE2 COMPLETED 2019-01-24 University College London, Lon... More >>don, United Kingdom Less <<
NCT02254551 Multiple Myeloma Phase 2 Terminated(Safety lead-in data... More >> did not support continuation of study.) Less << - United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45236 United States, Tennessee Tennessee Oncology Chattanooga, Tennessee, United States, 37404 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 United States, Texas Texas Transplant Institute/Methodist Healthcare San Antonio, Texas, United States, 78229 Less <<
NCT01801436 Multiple Myeloma PHASE3 COMPLETED 2025-04-08 -
NCT02268890 Multiple Myeloma PHASE4 COMPLETED 2025-07-15 Changhua, Taiwan|Kaohsiung, Ta... More >>iwan|Taichung City, Taiwan|Tainan, Taiwan|Taipei, Taiwan|Taoyuan, Taiwan Less <<
NCT02102594 Myasthenia Gravis|Systemic Lup... More >>us Erythematosus|Rheumatoid Arthritis Less << PHASE2 TERMINATED 2019-08-30 Charite - Universit?tsmedizin ... More >>Berlin, NeuroCure Clinical Research Center, Berlin, 10117, Germany|Charité - Universit?tsmedizin Berlin, Internal Medicine / Rheumathology, Berlin, 10117, Germany Less <<
NCT03013114 Immune Thrombocytopenia PHASE2 UNKNOWN 2025-12-17 Shandong University Qilu hospi... More >>tal, Jinan, Shandong, 250012, China Less <<
NCT02370693 Interstitial Lung Disease ... More >> ILD Systemic Sclerosis Scleroderma Less << Phase 2 Recruiting November 2017 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Margaret Travis, RN, BSN    312-695-2269    margaret.travis@northwestern.edu    Principal Investigator: Manu Jain, MD          Sub-Investigator: Jane Dematte-D'Amico, MD          Sub-Investigator: John Varga, MD          Sub-Investigator: Rishi Raj, MD Less <<
NCT02254551 - Terminated(Safety lead-in data... More >> did not support continuation of study.) Less << - -
NCT02893111 Neuromyelitis Optica Spectrum ... More >>Disorder Less << PHASE2 COMPLETED 2017-01-31 Tianjin Medical University Gen... More >>eral Hospital, Tianjin, Tianjin, 300052, China Less <<
NCT03103555 Adult-onset Immunodeficiency Phase 2 Recruiting November 1, 2019 Thailand ... More >> Faculty of Medicine Siriraj Hospital, Mahidol University Recruiting Bangkok, Thailand, 10700 Contact: Nasikarn Angkasekwinai, MD    66818708766    nasikarn@gmail.com    Sub-Investigator: Yupin =Suputtamongkol, MD. Less <<
NCT01929980 Allogeneic Stem Cell Transplan... More >>tation|Refractory Autoimmune Cytopenia(s) Less << PHASE2 COMPLETED 2025-05-14 Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States Less <<
NCT03345303 Intrahepatic Cholangiocarcinom... More >>a Less << PHASE3 UNKNOWN 2025-12-22 Easter hepatobiliary surgery h... More >>ospital, Shanghai, Shanghai, 200438, China Less <<
NCT01929980 Allogeneic Stem Cell Transplan... More >>tation|Refractory Autoimmune Cytopenia(s) Less << PHASE2 COMPLETED 2025-05-14 Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States Less <<
NCT00724568 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Massachusetts Dana Farber Cancer Institute (and Massachusetts General) Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Ohio The Ohio State University Medical Center Columbus, Ohio, United States, 43210 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01212952 Refractory Multiple Myeloma Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00719901 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Phase 2 Terminated(This trial was term... More >>inated due to slow accrual and the drug supply of Obatoclax during the phase I; therefore, the phase II portion will never open.) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00724568 - Completed - -
NCT00903968 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Cape Cod Hospital Hyannis, Massachusetts, United States, 02601 Milford Hospital Milford, Massachusetts, United States, 01757 Newton-Wellesley Hospital Newton, Massachusetts, United States, 02462 United States, Pennsylvania Cancer Treatment Centers of America (Eastern Regional Medical Center) Philadelphia, Pennsylvania, United States, 19124 Less <<
NCT00719901 - Terminated(This trial was term... More >>inated due to slow accrual and the drug supply of Obatoclax during the phase I; therefore, the phase II portion will never open.) Less << - -
NCT01074411 Fallopian Tube Clear Cell Aden... More >>ocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube Mucinous Adenocarcinoma Fallopian Tube Serous Adenocarcinoma Fallopian Tube Transitional Cell Carcinoma Ovarian Brenner Tumor Ovarian Clear Cell Adenocarcinoma Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Adenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Seromucinous Carcinoma Ovarian Serous Adenocarcinoma Ovarian Serous Cystadenocarcinoma Ovarian Transitional Cell Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Undifferentiated Fallopian Tube Carcinoma Undifferentiated Ovarian Carcinoma Less << Phase 1 Completed - United States, Connecticut ... More >> Hartford Hospital Hartford, Connecticut, United States, 06102 The Hospital of Central Connecticut New Britain, Connecticut, United States, 06050 United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Cooper Hospital University Medical Center Camden, New Jersey, United States, 08103 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Cancer Center/Fairview Hospital Cleveland, Ohio, United States, 44111 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Hillcrest Hospital Cancer Center Mayfield Heights, Ohio, United States, 44124 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Oklahoma Cancer Specialists and Research Institute-Tulsa Tulsa, Oklahoma, United States, 74146 United States, Rhode Island Women and Infants Hospital Providence, Rhode Island, United States, 02905 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00310037 Mantle Cell Lymphoma Phase 2 Active, not recruiting - -
NCT00093028 Multiple Myeloma Phase 3 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00903968 - Completed - -
NCT00237627 Breast Cancer ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Ovarian Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00479167 Follicular Lymphoma Phase 2 Completed - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT02109861 Multiple Myeloma Early Phase 1 Unknown December 2015 Denmark ... More >> Department of Haematology, Aalborg University Hospital Aalborg, Denmark, 9000 Less <<
NCT02535806 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 2 Terminated(Funding source disc... More >>ontinued) Less << - United States, Missouri ... More >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less <<
NCT03117361 Multiple Myeloma Phase 2 Terminated(PharmaMar has decid... More >>ed to end this study due to the slow recruitment rate of the trial) Less << - France ... More >> CHRU de Lille - Hôpital Claude Huriez Lille, France, 59037 Institut Gustave Roussy Villejuif, France, 94800 Italy Policlinico Vittorio Emanuele Hospital Catania, Italy, 95123 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Meldola, Italy, 47014 Azienda Ospedaliera Città della Salute e della Scienza di Torino Torino, Italy, 00126 Spain Hospital Universitario Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 Institut Català d´Oncologia Girona Girona, Spain, 17007 Institut Català d´Oncologia L´Hospitalet Hospitalet de Llobregat, Spain, 08908 Hospital General Universitario J.M. Morales Meseguer Murcia, Spain, 30008 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Complexo Hospitalario Universitario de Santiago Santiago De Compostela, Spain, 15706 Complejo Hospitalario Regional Virgen Del Rocio Sevilla, Spain, 41013 Less <<
NCT00310037 - Active, not recruiting - -
NCT00670423 Graft vs Host Disease ... More >> Peripheral Blood Stem Cell Transplantation Transplantation, Homologous Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00869323 Lymphoproliferative Disorder Phase 2 Terminated(Funding unavailable... More >>) Less << - United States, Minnesota ... More >> University of Minnesota Medical Center - Fairview Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University School of Medicine - Oncology Division Saint Louis, Missouri, United States, 63110 Less <<
NCT00369226 Hematologic Malignancies Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00103376 Prostate Cancer Phase 2 Terminated(Low Accrual) - United States, California ... More >> Loma Linda University Cancer Institute at Loma Linda University Medical Center Loma Linda, California, United States, 92354 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 Less <<
NCT01063179 Multiple Myeloma Phase 3 Completed - Italy ... More >> A.O.U. S. Giovanni Battista Torino, Italy, 10126 Less <<
NCT01114282 Multiple Myeloma Phase 1 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00103376 - Terminated(Low Accrual) - -
NCT00651781 Acute Myeloid Leukemia PHASE1|PHASE2 COMPLETED 2025-02-13 Hospital Germans Trias I Pujol... More >>, Badalona, Spain|Hospital Clinic y Provincial de Barcelona, Barcelona, Spain|Hospital Santa Creu y Sant Pau.Barcelona, Barcelona, Spain|Hospital Vall d′hebron, Barcelona, Spain|Hospital Juan Canalejo, La Coru?a, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Clínico San Carlos., Madrid, Spain|Hospital Ramón y Cajal. Madrid, Madrid, Spain|Hospital Morales Messeguer, Murcia, Spain|Hospital Central de Asturias, Oviedo, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital La Fe de Valencia, Valencia, Spain|Hospital Lozano Blesa, Zaragoza, Spain Less <<
NCT00742625 Acute Myeloid Leukemia ... More >> Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, District of Col... More >>umbia Washington Hospital Center Washington, District of Columbia, United States, 20010 Lombardi Comprehensive Cancer Center at Georgetown University Washington, District of Columbia, United States, 20057 United States, Florida Florida Hospital Orlando, Florida, United States, 32803 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maine Eastern Maine Medical Center Bangor, Maine, United States, 04401 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Missouri University of Missouri - Ellis Fischel Columbia, Missouri, United States, 65212 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 North Shore University Hospital Manhasset, New York, United States, 11030 North Shore-LIJ Health System CCOP Manhasset, New York, United States, 11030 Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 North Shore-LIJ Health System/Center for Advanced Medicine New Hyde Park, New York, United States, 11040 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 Kinston Medical Specialists PA Kinston, North Carolina, United States, 28501 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT00818649 Leukemia Myel... More >>odysplastic Syndrome Less << Phase 2 Terminated(Met protocol stop r... More >>ule [i.e., extreme toxicity]) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00869323 - Terminated(Funding unavailable... More >>) Less << - -
NCT01060202 - Completed - -
NCT02474563 - Completed - Korea, Republic of ... More >> Anyang, Korea, Republic of Busan, Korea, Republic of Cheonan City, Korea, Republic of Cheonan, Korea, Republic of Chungcheongbuk-Do, Korea, Republic of Dae-Gu, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Daejon, Korea, Republic of Gyeonggi-Do, Korea, Republic of Hwasun Gun, Korea, Republic of Iksan, Korea, Republic of Incheon, Korea, Republic of Jeonju-Si, Korea, Republic of Jinju-Si, Korea, Republic of Pucheon, Korea, Republic of Pusan, Korea, Republic of Seongnam, Korea, Republic of Seoul, Korea, Republic of Suwon, Korea, Republic of Ulsan, Korea, Republic of Less <<
NCT00818649 - Terminated(Met protocol stop r... More >>ule [i.e., extreme toxicity]) Less << - -
NCT00276614 Kidney Cancer Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00569868 - Completed - -
NCT00369226 - Completed - -
NCT00569868 MULTIPLE MYELOMA Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00276614 - Completed - -
NCT01026701 - Completed - -
NCT03620903 Waldenstrom Macroglobulinemia Phase 2 Not yet recruiting November 2024 -
NCT01675245 - Completed - -
NCT00742625 - Completed - -
NCT01075425 Acute Lymphocytic Leukemia ... More >> Acute Myeloid Leukemia Myelodysplastic Syndrome Chronic Myelogenous Leukemia Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT01063907 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Arizona ... More >> Arizona Clinical Research Center, Inc. / Arizona Oncology Associates, 1825 N Kolb, Tucson, Arizona, United States, 85715 United States, California Pacific Shores Medical Group 1043 Elm Ave, Suite 104 Long Beach, California, United States, 90813 UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, Los Angeles, California, United States, 90095-7059 United States, Florida Collaborative Research Group 2320 S Seacrest Blvd, Suite 202 Boynton Beach, Florida, United States, 33435 United States, Illinois Rush University Medical Center / Division of Hematology/Oncology Research 1725 W Harrison Street, Suite 834 Chicago, Illinois, United States, 60612 United States, New Jersey Cancer Institute of New Jersey 195 Little Albany Street New Brunswick, New Jersey, United States, 08903-2681 United States, Tennessee The Jones Clinic 7710 Wolf River Circle Germantown, Tennessee, United States, 38138 United States, Texas UT MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, United States, 77030 United States, Wisconsin Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001, La Crosse, Wisconsin, United States, 54601 Philippines National Kidney and Transplant Institute, Rm 3215 Doctors Clinic, East Avenue Diliman, Quezon City, Philippines Makati Medical Center, New Wing Hall C372, #2 Amorsolo Street, Legaspi Village, Makati City, Philippines The Medical City, 1609 MATI Building, The Medical City, Ortigas Avenue, Pasig City, Metro Manila, Philippines Saint Lukes Medical Center, Rm 222 MAB Saint Lukes Medical Center, E. Rodriguez Quezon City, Philippines United Kingdom Darent Valley Hospital Dept of Haematology, Acorn House, Darenth Wood Road Dartford, Kent, United Kingdom, DA2 8DA St Bartholomew's Hospital Haematology Department, 1st Floor, Pathology Dominion House, 59 Bartholomew Close, London, United Kingdom, EC1 7ED Christie Hospital - Department Haematology, 550 Wilmslow Road Withington, Manchester, Greater Manchester, United Kingdom, M20 4BX Hillingdon Hospital Dept of Haematology, Pield Health Road Uxbridge, Middlesex, United Kingdom, UB8 3NN Nottingham University Hospitals NHS Trust, Centre for Clinical Haemotology Hucknall Road, Nottingham, United Kingdom, NG5 1PB Royal Marsden Hospital, Orchard House Downs Road, Sutton, Surrey, United Kingdom, SM2 5PT Royal Bournemouth Hospital, Dept. of Haematolgy, Castle Lane East, Bournemouth, United Kingdom, BH7 7DW Royal Devon & Exeter Hospital Haematology Centre, Barrack Road Exeter, United Kingdom, EX2 5DW Northwick Park Hospital Dept of Haematology, Watford Road Harrow, United Kingdom, HA1 3UJ St James Hospital, St James' Institute of Oncology, Department of Haematology, Level 03, Bexley Wing, Leeds, United Kingdom, LS9 7TF UCL Cancer Institute, Paul O'Gorman Building, University College London,72 Huntley Street London, United Kingdom, WC1E 6DD Manchester Royal Infirmary Dept of Haematology, Oxford Road Manchester, United Kingdom, M13 9WL Royal Cornwall Hospital Haematology Clinic Truro, United Kingdom, TR1 3LS Less <<
NCT00664898 Multiple Myeloma Phase 1 Completed - -
NCT00077441 Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00837174 Non-Hodgkin Lymphoma Phase 2 Withdrawn(Study never activate... More >>d/opened as funding source and other support not available.) Less << - -
NCT01329289 Multiple Myeloma in Relapse ... More >> Multiple Myeloma Less << Phase 2 Withdrawn(Clinical trial being... More >> transferred to Columbia University with the Investigator.) Less << - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00791011 Hodgkin's Lymphoma ... More >> Low Grade Lymphoma Lymphoma Mantle Cell Lymphoma Non-Hodgkin's Lymphoma Diffuse Large Cell Lymphoma Less << Phase 1 Completed - -
NCT01063907 - Completed - -
NCT00075881 - Completed - -
NCT00111813 Multiple Myeloma Phase 1 Completed - -
NCT01594242 Multiple Myeloma EARLY_PHASE1 COMPLETED 2015-03-02 Abramson Cancer Center of the ... More >>University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT02514382 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Active, not recruiting February 21, 2020 United States, California ... More >> USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00075881 Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00111813 - Completed - -
NCT03652064 Multiple Myeloma Phase 3 Not yet recruiting April 30, 2025 -
NCT00093769 Lymphoma Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095 Less <<
NCT01818752 Multiple Myeloma Phase 3 Completed - -
NCT00059618 Ovarian Cancer ... More >> Primary Peritoneal Cancer Fallopian Tube Cancer Less << Phase 1 Completed - United States, Texas ... More >> University of Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02877082 Acute Leukemia ... More >> Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Diffuse Large B-Cell Lymphoma Follicular Lymphoma Graft Versus Host Disease Mantle Cell Lymphoma Marginal Zone Lymphoma Myelodysplastic Syndrome Myelofibrosis Myeloproliferative Neoplasm Small Lymphocytic Lymphoma Less << Phase 2 Terminated - United States, Georgia ... More >> Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01633645 Non Small Cell Lung Cancer ... More >> Metastatic Less << Phase 2 Completed - Greece ... More >> Air Forces Military Hospital of Athens Athens, Greece Athens, Greece METAXA Hospital, B' Pathology Department Athens, Greece SOTIRIA Hospital, Medical Oncology Department Athens, Greece University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece Heraklion, Greece "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology Thessaloniki, Greece Less <<
NCT02877082 - Terminated - -
NCT01021592 - Completed - -
NCT01818752 - Completed - -
NCT01383759 Light Chain Deposition Disease... More >> (LCDD or MIDD) Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) Monoclonal Immunoglobulin Deposition Disease (MIDD) Amyloidosis Less << Not Applicable Active, not recruiting June 2019 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01169857 Lupus Nephritis ... More >> Proteinuria Hematuria Less << Phase 4 Withdrawn(No participants were... More >> enrolled.) Less << December 2012 United States, New York ... More >> The Rogosin Institute New York, New York, United States, 10021 Less <<
NCT02441686 Multiple Myeloma Phase 2 Active, not recruiting August 2022 United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Maine Eastern Maine Medical Center Brewer, Maine, United States, 04412 United States, Massachusetts Massachusetts General Hosptial Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Minnesota Virginia Piper Cancer Institute Coon Rapids, Minnesota, United States, 55433 Virgina Piper Cancer Institute Minneapolis, Minnesota, United States, 55407 United States, New Jersey Hematology Oncology of Northern New Jersey Morristown, New Jersey, United States, 07962 Less <<
NCT00334438 Lymphoma Phase 1 Completed - United States, New Jersey ... More >> Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States, 07601 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00574236 Metastatic Breast Cancer Phase 2 Terminated(no additional fundi... More >>ng) Less << - United States, Wisconsin ... More >> University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00574236 - Terminated(no additional fundi... More >>ng) Less << - -
NCT00770731 Advanced Cancer Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00560352 Multiple Myeloma Phase 1 Terminated - United States, Florida ... More >> Orlando Health, Inc. M.D. Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, Georgia Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 France Local Institution Nantes, Cedex 1, France, 44093 Local Institution Lille Cedex, France, 59037 Italy Local Institution Bari, Italy, 70124 Local Institution Bologna, Italy, 40138 Spain Local Institution Salamanca, Spain, 37007 Less <<
NCT01965353 Multiple Myeloma in Relapse Phase 1 Active, not recruiting December 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01440582 Myeloma Phase 1 Active, not recruiting February 1, 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01919086 Multiple Myeloma (MM) Phase 2 Active, not recruiting August 2019 United States, Connecticut ... More >> Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States, 06102 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Less <<
NCT01056601 - Terminated(Funding not availab... More >>le) Less << - -
NCT01056601 Pancreatic Cancer Phase 2 Terminated(Funding not availab... More >>le) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00703664 Recurrent Mantle Cell Lymphoma... More >> Recurrent Non-Hodgkin Lymphoma Less << Phase 2 Completed - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Montefiore Medical Center-Weiler Hospital Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00560352 - Terminated - -
NCT00054483 Adult Grade III Lymphomatoid G... More >>ranulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Multiple Myeloma Splenic Marginal Zone Lymphoma Stage III Multiple Myeloma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Waldenstr?m Macroglobulinemia Less << Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT01038388 Multiple Myeloma Phase 1 Active, not recruiting January 2019 United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT02026505 Multiple Myeloma|Heart Failure... More >>, Systolic|Cardiotoxins Less << COMPLETED 2019-03-01 -
NCT01009840 Multiple Myeloma Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, Georgia Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland University of Maryland School of Medicine - Marlene & Stewart Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Pennsylvania University of Pennsylvania -Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 The Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, Texas South Texas Veterans Health Care System San Antonio, Texas, United States, 78229 Texas Transplant Physician Group, PLLC San Antonio, Texas, United States, 78229 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01009840 - Completed - -
NCT00720148 Solid Tumors Phase 1 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT02027220 Myeloma Borte... More >>zomib Cyclophosphamide Dexamethasone Granulocyte Colony-Stimulating Factor Less << Phase 2 Unknown December 2015 China, Jiangsu ... More >> The Second Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215004 Contact: jinxiang fu, doctor    86-512-67784066    lbzwz0907@hotmail.com    Principal Investigator: jinxiang fu, doctor Less <<
NCT01078961 Melanoma Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02290431 Relapse/Refractory Multiple My... More >>eloma Less << Phase 2 Recruiting July 8, 2019 Japan ... More >> Nagoya City University Hospital Recruiting Nagoya City, Aichi, Japan, 467-8602 Novartis Investigative Site Completed Kashiwa-city, Chiba, Japan, 277-8567 Matsuyama Red Cross Hospital Recruiting Matsuyama-City, Ehime, Japan, 790-8524 Novartis Investigative Site Terminated Fukuoka city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Recruiting Ogaki-city, Gifu, Japan, 503-8502 Gunma University Hospital Recruiting Maebashi-city, Gunma, Japan, 371-8511 Principal Investigator: Hiroshi Handa, M.D.          Novartis Investigative Site Recruiting Shibukawa-city, Gunma, Japan, 377-0280 Novartis Investigative Site Completed Kure-city, Hiroshima, Japan, 737-0023 Kobe City Medical Center General Hospital Recruiting Kobe, Hyogo, Japan, 650-0047 Mito Medical Center Recruiting Higashiibaraki-gun, Ibaraki, Japan, 311-3193 University Hospital, Kyoto Prefectural, University of Medicine Recruiting Kamigyo-ku, Kyoto, Japan, 602-8566 Novartis Investigative Site Recruiting Sendai-shi, Miyagi, Japan, 983 8520 Niigatq Cancer Ce3nter Hospital Recruiting Kawagishi-cho, Chuo-ku, Niigata, Japan, 951-8566 Novartis Investigative Site Completed Okayama-city, Okayama, Japan, 701-1192 Osaka University Hospital Recruiting Yamadaoka, Suita-City, Osaka, Japan, 565-0871 Novartis Investigative Site Completed Utsunomiya-shi, Tochigi, Japan, 320-0834 Tokushima University Hospital Recruiting Tokushima-City, Tokushima, Japan, 770-8503 Novartis Investigative Site Completed Koto-ku, Tokyo, Japan, 135 8550 Japanese Red Cross Medical Center Recruiting Shibuya-Ku, Tokyo, Japan, 150-8935 Center Hospital of the National Center for Global Health and Medicine Recruiting Shinjuku-ku, Tokyo, Japan, 162-8655 Principal Investigator: Akiyoshi Miwa, M.D.          Novartis Investigative Site Recruiting Tachikawa, Tokyo, Japan, 190-0014 Novartis Investigative Site Recruiting Aomori, Japan, 030 8553 Less <<
NCT02718833 Multiple Myeloma Phase 2 Recruiting September 2023 United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Andrew J Yee, MD    617-724-4000    ayee1@mgh.harvard.edu    Principal Investigator: Andrew J Yee, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Jacob Laubach, MD    617-632-4218       Principal Investigator: Jacob Laubach, MD          Mass General/North Shore Cancer Center Recruiting Danvers, Massachusetts, United States, 01923 Contact: Andrew Yee, MD    617-724-4000    ayee1@mgh.harvard.edu    Newton-Wellesley Hospital Recruiting Newton, Massachusetts, United States, 02462 Contact: Omar Nadeem, MD    617-219-1230    onadeem@partners.org    United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Erica Campagnaro, MD    734-936-5310    ericacam@med.umich.edu    United States, New York University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Brea C. Lipe, MD    585-275-5823       Principal Investigator: Brea C. Lipe, MD Less <<
NCT01083602 Relapsed and Bortezomib Refrac... More >>tory Multiple Myeloma Refractory Multiple Myeloma Multiple Myeloma in Relapse Less << Phase 2 Completed - United States, California ... More >> University of California at Los Angeles Los Angeles, California, United States, 90095 Stanford University Medical Center Division of Hematology Stanford, California, United States, 94305-5826 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Dept. of Winship Cancer Inst. Atlanta, Georgia, United States, 30322 Georgia Regents University MedCollege of GA Cancer Ctr 2 Augusta, Georgia, United States, 30912 United States, Illinois Hematology/Oncology of the North Shore Orchard Healthcare Res. Inc. Skokie, Illinois, United States, 60076 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Jersey Somerset Hematology Oncology Associates Somerset Hema Oncol Assoc (2) Somerset, New Jersey, United States, 08873 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 United States, North Carolina Duke University Medical Center Dept. of DUMC (4) Durham, North Carolina, United States, 27710 United States, Tennessee Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt UMC Nashville, Tennessee, United States, 37212 United States, Texas MD Anderson Cancer Center/University of Texas MD Anderson CC Houston, Texas, United States, 77030 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02371148 Waldenstrom's Macroglobulinemi... More >>a Less << Phase 2 Active, not recruiting June 2020 Italy ... More >> AO Riuniti Papardo Piemonte Messina, ME, Italy, 98158 Centro di Riferimento Oncologico della Basilicata Rionero in Vulture, PZ, Italy, 85028 AUSL di Ravenna Ravenna, RA, Italy, 48100 A.O. Bianchi - Melacrino - Morelli Reggio Calabria, RC, Italy, 89125 Nuovo Regina Margherita Roma, RM, Italy, 00153 Uo Oncoematologia, Po "A.Tortora" Pagani, Salerno, Italy, 84016 Ospedale S. Giacomo di Castelfranco Veneto Castelfranco Veneto, Treviso, Italy, 31033 A.O. SS. Antonio e Biagio e C. Arrigo Alessandria, Italy, 15121 A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona Ancona, Italy, 60126 Centro di riferimento Oncologico - Oncologia Medica A Aviano (PN), Italy A.O. Ospedale Degli Infermi Biella, Italy, 13900 Ospedale Businco, Divisione di Ematologia Cagliari, Italy Area Vasta Romagna e IRST Meldola (FC), Italy Irccs Ospedale Maggiore Policlinico Di Milano Milano, Italy, 20122 A.O. Universitaria Policlinico Di Modena Modena, Italy, 41124 Ospedale Maggiore Della Carita' - Scdu Ematologia Novara, Italy, 28100 Ospedale San Martino, Asl Oristano- Ematologia Oristano, Italy, 09170 Ematologia Policlinico San Matteo Pavia, Italy, 27100 Ausl Di Piacenza Piacenza, Italy, 29121 Ausl Di Rimini Rimini, Italy, 47924 Ematologia 1 - A.O. Citta' Della Salute E Della Scienza Di Torino Torino, Italy, 10126 Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI Varese, Italy, 21100 Less <<
NCT00703664 - Completed - -
NCT01083602 - Completed - -
NCT00416208 Multiple Myeloma PHASE3 COMPLETED 2025-05-13 Bamberg, Germany|Berg, Germany... More >>|Berlin, Germany|Bremen, Germany|Dortmund, Germany|Dresden, Germany|Duisburg, Germany|Erlangen, Germany|Eschweiler, Germany|Frankfurt / Main, Germany|Freiburg, Germany|Goch, Germany|Greifswald, Germany|G?ttingen, Germany|Halle, Germany|Hamburg, Germany|Hamm, Germany|Jena, Germany|Karlsruhe, Germany|Kempten, Germany|Kiel, Germany|K?ln N/A, Germany|Lübeck, Germany|Magdeburg, Germany|Mutlangen, Germany|München, Germany|Münster, Germany|Nürnberg, Germany|Oldenburg, Germany|Regensburg, Germany|Rostock, Germany|Stuttgart, Germany|Trier, Germany|Ulm, Germany|Villingen-Schwenningen, Germany|Wiesbaden, Germany|Würzburg, Germany Less <<
NCT00310024 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Completed - United States, Maryland ... More >> University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 Less <<
NCT01100242 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(Low accrual) - United States, New Mexico ... More >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 The Cancer Center at Presbyterian Albuquerque, New Mexico, United States, 87110 Memorial Medical Center- Cancer Center Las Cruces, New Mexico, United States, 88011 Less <<
NCT00920556 Multiple Myeloma Phase 2 Terminated(Study terminated.24... More >> subjects enrolled;provided adequate data for decision making.) Less << - Denmark ... More >> GSK Investigational Site Vejle, Denmark, 7100 United Kingdom GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5NG GSK Investigational Site Birmingham, United Kingdom, B15 2TH GSK Investigational Site Leeds, United Kingdom, LS9 7TF GSK Investigational Site London, United Kingdom, EC1A 7BE Less <<
NCT01100242 - Terminated(Low accrual) - -
NCT00439361 Hodgkin Lymphoma ... More >> Lymphoma Less << Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01286077 Multiple Myeloma Phase 2 Completed - Austria ... More >> Feldkirch N/A, Austria Graz, Austria Wien, Austria Czech Republic Brno, Czech Republic Denmark Vejle, Denmark Germany Hamburg, Germany Kiel, Germany Mÿnchen, Germany Greece Athens, Greece Sweden Huddinge, Sweden Stockholm, Sweden Turkey Adana, Turkey Ankara, Turkey Antalya, Turkey Eskisehir, Turkey Gebse, Turkey Istanbul, Turkey Izmir, Turkey United Kingdom Edinburgh, United Kingdom Sheffield Yorks, United Kingdom Wakefield, United Kingdom Less <<
NCT00083226 Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00580242 Myelodysplasia Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01530594 Multiple Myeloma Phase 3 Completed - Saudi Arabia ... More >> King Faisal Specialist Hospital &Reseach Center Riyadh, Saudi Arabia, 11211 Less <<
NCT00083226 - Completed - -
NCT01695941 Recurrent B-Cell Non-Hodgkin L... More >>ymphoma Recurrent Mantle Cell Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Mantle Cell Lymphoma Less << Phase 1 Active, not recruiting - United States, New York ... More >> Montefiore Medical Center-Einstein Campus Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York, United States, 10016 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00984828 Multiple Myeloma Phase 2 Phase 3 Terminated(Very slow recruitme... More >>nt) Less << December 2016 China ... More >> Rui Jin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, China, 200025 Less <<
NCT01016730 AIDS-Related Kaposi Sarcoma ... More >> HIV Infection Recurrent Kaposi Sarcoma Less << Phase 1 Completed - United States, California ... More >> UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States, 90035 UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 University of California San Diego San Diego, California, United States, 92103 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston Medical Center Boston, Massachusetts, United States, 02118 United States, New York Memorial Sloan Kettering-Rockefeller Outpatient Pavilion New York, New York, United States, 10022 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT01286077 - Completed - -
NCT00426855 Lymphoma, Non-Hodgkin Phase 1 Phase 2 Completed - -
NCT00426855 - Completed - -
NCT00872521 - Completed - -
NCT00734149 - Completed - -
NCT00992446 Adult Diffuse Large B-Cell Lym... More >>phoma B-Cell Non-Hodgkin Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Non-Hodgkin Lymphoma T-Cell Non-Hodgkin Lymphoma Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00872521 Multiple Myeloma Phase 2 Completed - Australia ... More >> Adelaide, Australia Box Hill, Australia Brisbane, Australia Camperdown, Australia Geelong, Australia Gosford, Australia Greenslopes, Australia Malvern, Australia Melbourne, Australia Parkville, Australia Perth, Australia Sydney, Australia Westmead, Australia Woden, Australia Wollongong, Australia Woolloongabba N/A, Australia Less <<
NCT00895687 Advanced Cancer Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00992446 - Completed - -
NCT00608907 Multiple Myeloma ... More >> Non-Hodgkin's Lymphoma Less << Phase 1 Completed - Israel ... More >> Hematology Institute - Davidoff Center - Rabin Medical Center Petach Tikva, Israel, 49100 Italy Divisione di Ematologia - Ospedale S Eugenio - P. le dell'Umanesimo Rome, Italy, 10001 Poland Medical Academy - Dept of Hematology and Transplantology Gdansk, Poland, 80-952 Klinika Nowotworow Ukladu - Chlonnego - Centrum Onkologii - Instytut Warszawa, Poland, 02-781 South Africa Hematological Oncology Parow, Cape Town, South Africa Department of Hematology - University of the Free State Bloemfontein, South Africa, 9300 Department of Medical Oncology - Ward 51 - Pretoria Academic Hospital Pretoria, South Africa, 0001 United Kingdom Plymouth Hospitals NHS Trust - Derriford Hospital Derriford, Plymouth, United Kingdom, PL68DH Hematology Department Combined Laboratories - Derriford Hospital Plymouth, United Kingdom, PL6 8DH Less <<
NCT00734149 Multiple Myeloma Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00777114 Non-Hodgkin's Lymphoma Phase 1 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States United States, New York Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT00608907 - Completed - -
NCT01497093 Multiple Myeloma Phase 1 Active, not recruiting September 12, 2019 United States, Georgia ... More >> Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115-6084 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01322776 Mantle Cell Lymphoma Recurrent Phase 1 Phase 2 Unknown October 2013 China, Guang Dong ... More >> SunYat-sen University Cancer Centre Recruiting Guang Zhou, Guang Dong, China Contact: Huiqiang Huang       huanghq@sysucc.org.cn    Principal Investigator: Huiqiang Huang          Sub-Investigator: Xiaoxiao Wang Less <<
NCT01504776 Mantle Cell Lymphoma Phase 1 Completed - United States, Georgia ... More >> Georgia Regents University Augusta, Georgia, United States, 30912 Less <<
NCT00425503 Prostate Neoplasms Phase 2 Completed - United States, Texas ... More >> Scott Department of Urology, Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01034553 Refractory Multiple Myeloma Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, California University of California, San Francisco San Fransisco, California, United States, 94143 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00425503 - Completed - -
NCT01255527 Multiple Myeloma Patients Who ... More >>Candidate for Autologous Peripheral Blood Stem Cell Transplantation Less << PHASE1|PHASE2 UNKNOWN 2025-12-14 National Cancer Center, Goyang... More >>, Korea, Republic of|Gachon University Gill Hospital, Incheon, Korea, Republic of|Severance Hospital, Seoul, 120-752, Korea, Republic of|ASAN Medical Center, Seoul, Korea, Republic of|Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Seoul St. Mary's Hospital, Seoul, Korea, Republic of Less <<
NCT01034553 - Completed - -
NCT00611325 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00536575 - Completed - -
NCT00536575 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Maryland ... More >> Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT03695744 Multiple Myeloma ... More >> Myeloma Less << Phase 2 Not yet recruiting October 2023 Singapore ... More >> Singapore General Hospital Singapore, Singapore Less <<
NCT01568866 Multiple Myeloma Phase 3 Completed - -
NCT01174888 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> The Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00611325 - Completed - -
NCT01129180 Adult Nasal Type Extranodal NK... More >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Hepatosplenic T-cell Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Prolymphocytic Leukemia Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Small Intestine Lymphoma T-cell Large Granular Lymphocyte Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01568866 - Completed - -
NCT02353468 Refractory Plasma Cell Myeloma Phase 2 Terminated(Principle investiga... More >>tor left the institution) Less << - United States, Colorado ... More >> University of Colorado Aurora, Colorado, United States, 80045 Less <<
NCT02353468 - Terminated(Principle investiga... More >>tor left the institution) Less << - -
NCT00510887 - Terminated(Low accrual.) - -
NCT01531998 Myeloma Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00298766 - Completed - -
NCT00510887 Lymphoma, Follicular Phase 2 Terminated(Low accrual.) - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00416793 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Stage IV Pancreatic Cancer Less << Phase 2 Completed - United States, Texas ... More >> MD Anderson Cancer Network Houston, Texas, United States, 77030 Less <<
NCT00832234 Waldenstroms Macroglobulinemia Phase 2 Completed - Greece ... More >> University of Athens School of Medicine Athens, Greece Less <<
NCT01531998 - Completed - -
NCT00303797 Refractory Chronic Lymphocytic... More >> Leukemia Refractory Multiple Myeloma Stage III Multiple Myeloma Stage IV Chronic Lymphocytic Leukemia Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00636311 Hodgkin Disease Phase 2 Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00298766 Amyloidosis Phase 1 Phase 2 Completed - United States, California ... More >> Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States, 90049 United States, Georgia Winship Cancer Center - Emory Clinic School of Medicine Atlanta, Georgia, United States, 30322 United States, Massachusetts Boston Medical Center Boston, Massachusetts, United States, 02118 United States, New York MSKCC New York, New York, United States, 10017 Less <<
NCT01160484 Multiple Myeloma Phase 2 Completed - United States, California ... More >> Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 Hematology-Oncology Medical Group of Fresno, Inc. Fresno, California, United States, 93720 Loma Linda University Loma Linda, California, United States, 92354 Santa Barbara Hematology Oncology Santa Barbara, California, United States, 93105 James R. Berenson, M.D., Inc. West Hollywood, California, United States, 90069 United States, Florida Watson Clinic, LLP, Center for Care and Research Lakeland, Florida, United States, 33805 United States, New York Bassett Cancer Institute Cooperstown, New York, United States, 13326 Broome Oncology Johnson City, New York, United States, 13790 Less <<
NCT00872352 Multiple Myeloma ... More >> Peripheral Neuropathy Less << Phase 3 Unknown August 2009 Israel ... More >> Wolfson MC Not yet recruiting Holon, Israel, 58100 Contact: Husam Ghoti, MD    972-5028778    drghoti123@yahoo.com Less <<
NCT00416793 - Completed - -
NCT02559154 Multiple Myeloma Phase 4 Active, not recruiting December 2018 China ... More >> Shanghai General Hospital Shanghai, China, 200080 Less <<
NCT01160484 - Completed - -
NCT03201965 Amyloidosis Phase 3 Recruiting October 30, 2025 -
NCT00641706 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 2 Completed - -
NCT01142401 Estrogen Receptor Positive ... More >> Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Phase 2 Active, not recruiting - United States, Connecticut ... More >> University of Connecticut Farmington, Connecticut, United States, 06030 Yale University New Haven, Connecticut, United States, 06520 United States, Florida Cleveland Clinic-Weston Weston, Florida, United States, 33331 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Maimonides Medical Center Brooklyn, New York, United States, 11219 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Beth Israel Medical Center New York, New York, United States, 10003 Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York, United States, 10016 Saint Luke's Roosevelt Hospital Center - Roosevelt Division New York, New York, United States, 10019 Saint Luke's Roosevelt Hospital Center - Saint Luke's Division New York, New York, United States, 10025 Mount Sinai Hospital New York, New York, United States, 10029 Columbia University/Herbert Irving Cancer Center New York, New York, United States, 10032 Weill Medical College of Cornell University New York, New York, United States, 10065 Montefiore Medical Center-Einstein Campus The Bronx, New York, United States, 10461 Montefiore Medical Center-Weiler Hospital The Bronx, New York, United States, 10461 Eastchester Center for Cancer Care The Bronx, New York, United States, 10469 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT01464112 Multiple Myeloma Phase 1 Completed - France ... More >> Lille Cedex, France Nantes, France Tours, France Less <<
NCT00114738 Lymphoma, Mantle Cell ... More >> Mantle Cell Lymphoma Less << Phase 2 Active, not recruiting August 11, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03319667 Plasma Cell Myeloma Phase 3 Recruiting January 2025 -
NCT00114738 - Active, not recruiting - -
NCT00066625 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Terminated(Administratively co... More >>mplete.) Less << - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 Less <<
NCT00641706 - Completed - -
NCT00088855 DS Stage I Plasma Cell Myeloma... More >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Less << Phase 2 Active, not recruiting - -
NCT00581919 - Completed - -
NCT00581919 Multiple Myeloma Phase 2 Completed - United States, Wisconsin ... More >> Mercy Health Systems Janesville, Wisconsin, United States Gundersen Lutheran LaCrosse, Wisconsin, United States University of Wisconsin Cancer Center Madison, Wisconsin, United States, 53792 Regional Cancer Center Waukesha/Oconomowoc, Wisconsin, United States Aspirus Wausau Hospital, Aspirus Regional Cancer Center Wausau, Wisconsin, United States Less <<
NCT03234972 Multiple Myeloma Phase 3 Recruiting August 31, 2022 China ... More >> Beijing Chaoyang Hospital Withdrawn Beijing, China, 100020 Peking Union Medical College Hospital Recruiting Beijing, China, 100032 Peking University First Hospital Recruiting Beijing, China, 100034 Beijing Chaoyang Hospital Withdrawn Beijing, China, 100043 Peking University People's Hospital Recruiting Beijing, China, 100044 Peking University Third Hospital Recruiting Beijing, China, 100083 The First Hospital of Jilin University Recruiting Changchun, China, 130021 West China Hospital, Si Chuan University Recruiting Chengdu, China, 610041 Xinqiao Hospital of the Third Military Medical University Recruiting Chongqing, China, 400037 Fujian Meidical University Union Hospital Recruiting Fuzhou, China, 350001 Guangdong General Hospital Recruiting Guangzhou, China, 510080 The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, China, 510080 Nanfang Hospital Recruiting Guangzhou, China, 510515 First affiliated Hospital of Zhejiang University Recruiting Hangzhou, China, 310020 First Affiliated Hospital, Medical School of Zhejiang University Recruiting Hangzhou, China, 310020 Nanjing Drum Tower Hospital Not yet recruiting Nanjing, China, 210008 Zhongda Hospital,Southeast University Recruiting Nanjing, China, 210009 Jiangsu Province Hospital Recruiting Nanjing, China, 210029 Shanghai Changzheng Hospital Recruiting Shanghai, China, 200003 Ruijin Hospital, Shanghai Jiao Tong University Recruiting Shanghai, China, 200025 Shanghai Zhongshan Hospital Withdrawn Shanghai, China, 200032 First Affiliated Hospital, SooChow University Recruiting Suzhou, China, 215006 Institute of Hematology & Blood Diseases Hospital Recruiting Tianjin, China, China, 300320 Tianjin cancer hospital Recruiting Tianjin, China, 300040 Tianjin Medical University General Hospital Not yet recruiting Tianjin, China, 300052 Tongji Hospital, Tongji Medical College of HUST Recruiting Wuhan, China, 430030 Tangdu Hospital Recruiting Xian, China, 710038 Henan Cancer Hospital Not yet recruiting Zhengzhou, China, 450008 Taiwan National Taiwan University Hospital Recruiting Taipei, Taiwan, 10048 Tri-Service General Hospital Recruiting Taipei, Taiwan, 11490 Less <<
NCT03051841 Myeloma, Multiple Phase 1 Recruiting June 2021 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Sung-Soo Yoon    +82-2-2072-3079    ssysmc@gmail.com Less <<
NCT03217812 Multiple Myeloma Phase 3 Recruiting October 31, 2022 China ... More >> Beijing Chaoyang Hospital Not yet recruiting Beijing, China, 100020 Peking Union Medical College Hospital Recruiting Beijing, China, 100032 Peking University First Hospital Recruiting Beijing, China, 100034 Beijing Chaoyang Hospital Not yet recruiting Beijing, China, 100043 Peking University Third Hospital Recruiting Beijing, China, 100083 The First Hospital of Jilin University Recruiting Changchun, China, 130021 The Third Xiangya Hospital, Central South University Not yet recruiting Changsha, China, 410013 West China Hospital, Si Chuan University Recruiting Chengdu, China, 610041 Xinqiao Hospital of the Third Military Medical University Recruiting Chongqing, China, 400037 Fujian Meidical University Union Hospital Recruiting Fuzhou, China, 350001 Guangdong General Hospital Recruiting Guangzhou, China, 510080 The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, China, 510080 Nanfang Hospital Recruiting Guangzhou, China, 510515 First affiliated Hospital of Zhejiang University Recruiting Hangzhou, China, 310020 First Affiliated Hospital, Medical School of Zhejiang University Recruiting Hangzhou, China, 310020 Harbin medical university cancer hospital Not yet recruiting Harbin, China, 150081 Zhongda Hospital,Southeast University Recruiting Nanjing, China, 210009 Jiangsu Province Hospital Recruiting Nanjing, China, 210029 The Affiliated Hospital of Medical College Qingdao University Withdrawn Qingdao, China, 266003 Shanghai Changzheng Hospital Recruiting Shanghai, China, 200003 Ruijin Hospital, Shanghai Jiao Tong University Recruiting Shanghai, China, 200025 Shanghai Zhongshan Hospital Terminated Shanghai, China, 200032 Renji Hospital, Shanghai Jiaotong University School of Medicine Recruiting Shanghai, China, 200127 First Affiliated Hospital, SooChow University Recruiting Suzhou, China, 215006 Institute of Hematology & Blood Diseases Hospital Recruiting Tianjin, China, China, 300320 Tianjin cancer hospital Recruiting Tianjin, China, 300040 The First Affiliated Hospital of Wenzhou Medical University Recruiting Wenzhou, China, 325000 Tongji Hospital, Tongji Medical College of HUST Recruiting Wuhan, China, 430030 Tangdu Hospital Recruiting Xian, China, 710038 Henan Cancer Hospital Recruiting Zhengzhou, China, 450008 Hong Kong Queen Mary Hospital, University of Hong Kong Not yet recruiting Hong Kong, Hong Kong Korea, Republic of Inje University Busan Paik Hospital Recruiting Busan, Korea, Republic of, 47392 Chonnam National University Hwasun Hospital Recruiting Hwasun Gun, Korea, Republic of, 58128 Gachon University Gil Hospital Not yet recruiting Incheon, Korea, Republic of, 405-760 Seoul National University Bundang Hospital Recruiting Seongnam-Si, Korea, Republic of, 13620 Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of, 06351 Taiwan National Taiwan University Hospital Recruiting Taipei, Taiwan, 10048 Taipei Veterans General Hospital Not yet recruiting Taipei, Taiwan, 11217 Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan, 33305 Less <<
NCT01206205 Multiple Myeloma Phase 2 Completed - France ... More >> Centre François Baclesse Caen, cedex 5, France, 14076 University Hospital of Dijon, Hôpital des Enfants Dijon, France, 21000 University Hospital of Grenoble, Hôpital A.Michallon, BP 217 X Grenoble Cedex 09, France, 38043 University Hospital Of Lille, Hôpital Claude Huriez Lille Cedex, France, 59037 Institut Paoli Calmette Marseille Cedex, France, 13273 University Hospital of Bordeaux, "Hôpital du Haut Lévêque " Pessac, France, 33604 University Hospital of Toulouse, Purpan Toulouse, France, 31059 Hôpital Bretonneau, Tours Tours Cedex, France, 37044 Hôpitaux de Brabois Nancy Vandoeuvre cedex, France, 54511 Less <<
NCT00440635 - Completed - -
NCT01323751 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Georgia ... More >> Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10029 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin Medical College of Wisconsin - Clinical Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00602511 Multiple Myeloma Phase 3 Completed - Denmark ... More >> Ålborg university Hospital Aalborg, Denmark, 9000 Herlev University Hospital Herlev, Denmark, 2730 Rigshospitalet Koebenhavn, Denmark, 2100 Odense University Hospital Odense, Denmark, 5000 Århus University Hospital Århus, Denmark, 8000 Norway Ullevål Sykehus Oslo, Norway, 0407 Diakonhjemmet Oslo, Norway Stavanger Universitetssykehus Stavanger, Norway, 4068 Trondheim University Hospital Trondheim, Norway, N-7006 Sweden Falun Hospital Falun, Sweden, 79182 Gävle Hospital Gävle, Sweden, 80187 Sahlgrenska University Hospital Göteborg, Sweden, 41345 Helsingborg Hospital Helsingborg, Sweden, 25187 Lidköping Hospital Lidköping, Sweden, 53185 Lund University Hospital Lund, Sweden, 22185 Malmö University Hospital Malmö, Sweden, 20502 Mölndal hospital Mölndal, Sweden, 43180 Skövde Hospital Skövde, Sweden, 54185 St Göran Hospital Stockholm, Sweden, 11281 Sundsvall Hospital Sundsvall, Sweden, 85186 Uddevalla Hospital Uddevalla, Sweden, 45180 Norrland University Hospital Umeå, Sweden, 90185 Uppsala University Hospital Uppsala, Sweden, 75185 Västerås Hospital Västerås, Sweden, 72189 Växjö Hospital Växjö, Sweden, 35185 Örebro University Hospital Örebro, Sweden, 70185 Örnsköldsvik Hospital Örnsköldsvik, Sweden, 89189 Less <<
NCT01002248 Multiple Myeloma Phase 3 Terminated - -
NCT02489500 AL Amyloidosis Phase 3 Terminated(Enrollment held for... More >> toxicity evaluation; then closed due to competing trial) Less << - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT00513877 Malignant Mesothelioma Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 Ireland Cork University Hospital Cork, Ireland Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland, 24 St. Vincent's University Hospital Dublin, Ireland, 4 Mater Misericordiae University Hospital Dublin, Ireland, 7 St. James's Hospital Dublin, Ireland, 8 Beaumont Hospital Dublin, Ireland, 9 Galway University Hospital Galway, Ireland Netherlands Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 BE United Kingdom Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Centre for Cancer Research and Cell Biology at Queen's University Belfast Belfast, Northern Ireland, United Kingdom, BT9 7BL Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00813150 Multiple Myeloma Phase 3 Completed - Germany ... More >> Augsburg, Germany Berlin, Germany Bielefeld, Germany Bremerhaven, Germany Darmstadt, Germany Donauwörth, Germany Dresden, Germany Frankfurt, Germany Halle, Germany Hamburg, Germany Hamm, Germany Hannover, Germany Hildesheim, Germany Hof, Germany Koblenz, Germany Köln, Germany Lebach, Germany Leer, Germany Lübeck, Germany Magdeburg, Germany Mannheim, Germany Moers, Germany München, Germany Münster, Germany Neunkirchen, Germany Offenburg, Germany Oldenburg, Germany Osnabrück, Germany Passau, Germany Porta Westfalica, Germany Ravensburg, Germany Rostock, Germany Saarbrücken, Germany Singen, Germany Stuttgart, Germany Velbert, Germany Weiden, Germany Wiesbaden, Germany Würselen, Germany Würzburg, Germany Less <<
NCT00544284 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Less <<
NCT00469209 Myeloma Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00025584 Recurrent Breast Cancer ... More >> Stage IV Breast Cancer Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00813150 - Completed - -
NCT00021216 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00045695 Lymphoma Phase 2 Completed - United States, Illinois ... More >> Hinsdale Hematology Oncology Associates Hinsdale, Illinois, United States, 60521 United States, Pennsylvania Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Canada, Alberta Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada, H1T 2M4 Canada, Saskatchewan Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT01541644 Peripheral Neuropathies ... More >> Multiple Myeloma Less << Not Applicable Completed - United States, Maryland ... More >> University of Maryland Marlene & Stewart Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Less <<
NCT01541644 - Completed - -
NCT02489500 - Terminated(Enrollment held for... More >> toxicity evaluation; then closed due to competing trial) Less << - -
NCT00379574 Lymphoma, Large-Cell, Diffuse ... More >> Lymphoma, B-Cell Less << Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Asan Medical Cener Seoul, Korea, Republic of Less <<
NCT00379574 - Completed - -
NCT00307086 Multiple Myeloma ... More >> Plasma Cell Leukemia Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT03591744 Plasma Cell Leukemia Phase 1 Not yet recruiting October 25, 2019 United States, California ... More >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Contact: Amrita Y. Krishnan, MD    626-256-4673    akrishnan@coh.org    Principal Investigator: Amrita Y. Krishnan, MD          United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Shaji K. Kumar    507-284-2511    kumar.shaji@mayo.edu    Principal Investigator: Shaji K. Kumar          United States, Missouri Siteman Cancer Center at Washington University Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Ravi Vij    314-454-8323    rvij@wustl.edu    Principal Investigator: Ravi Vij          United States, North Carolina Carolinas Medical Center/Levine Cancer Institute Not yet recruiting Charlotte, North Carolina, United States, 28203 Contact: Saad Z. Usmani    980-442-2000    saad.usmani@carolinashealthcare.org    Principal Investigator: Saad Z. Usmani          United States, Tennessee Sarah Cannon Cancer Center Not yet recruiting Nashville, Tennessee, United States, 37203 Contact: Jesus G. Berdeja    615-329-7274    jberdeja@tnonc.com    Principal Investigator: Jesus G. Berdeja Less <<
NCT00469209 - Completed - -
NCT00839956 DS Stage I Plasma Cell Myeloma... More >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01127009 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00996385 Mesothelioma Phase 2 Unknown September 2014 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Principal Investigator: Robert N Taub, MD, PhD          Sub-Investigator: Alain C Borczuk, MD Less <<
NCT00703300 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00077428 Recurrent Adenoid Cystic Carci... More >>noma of the Oral Cavity Recurrent Salivary Gland Cancer Salivary Gland Adenoid Cystic Carcinoma Stage III Adenoid Cystic Carcinoma of the Oral Cavity Stage III Salivary Gland Cancer Stage IV Adenoid Cystic Carcinoma of the Oral Cavity Stage IV Salivary Gland Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT02874742 Multiple Myeloma Phase 2 Active, not recruiting December 2021 -
NCT00307086 - Completed - -
NCT00227513 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT02375555 Multiple Myeloma Phase 2 Active, not recruiting June 2022 United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Virginia Virginia Cancer Specialists Fairfax, Virginia, United States, 22031 Less <<
NCT00839956 - Completed - -
NCT01083316 Amyloidosis Phase 2 Active, not recruiting December 2040 United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT00652041 Multiple Myeloma Phase 4 Completed - Spain ... More >> Hospital Morales Messeguer Murcia, Spain Hospital Virgen de la Vega Murcia, Spain Hospital de la Diputación de Navarra Navarra, Spain Hospital Clínico de Salamanca Salamanca, Spain Hospital La Fe Valencia, Spain Less <<
NCT00401843 - Active, not recruiting - -
NCT02082405 Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Withdrawn(Funding unavailable) - -
NCT00401843 Multiple Myeloma Phase 2 Active, not recruiting September 1, 2020 -
NCT00473590 Multiple Myeloma Phase 2 Completed - -
NCT00473590 - Completed - -
NCT00151320 - Completed - -
NCT02484261 Leukemia Phase 1 Active, not recruiting August 2020 United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 Less <<
NCT01083316 - Active, not recruiting - -
NCT01729338 Multiple Myeloma Phase 2 Terminated - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00103506 Multiple Myeloma Phase 3 Completed - -
NCT00151320 Non-Hodgkin's Lymphoma Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Nebraska Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10021 Columbia University College of Physicians and Surgeons New York, New York, United States, 10032 Less <<
NCT00030368 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01729338 - Terminated - -
NCT00061932 - Completed - -
NCT00515138 Lymphoma, B-Cell Early Phase 1 Terminated(Investigator left i... More >>nstitution. 7 patients accrued and there is insufficient data to analyze.) Less << - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 Less <<
NCT00103506 - Completed - -
NCT00548717 Graft-vs-Host Disease Phase 2 Terminated(First two patients ... More >>enrolled after trial reopened, developed grade III-IV acute GVHD and subsequently passed away.) Less << - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT03481556 Multiple Myeloma Phase 1 Phase 2 Recruiting December 31, 2021 United States, Florida ... More >> University of Florida Health Cancer Center Not yet recruiting Gainesville, Florida, United States, 32610 Contact: Jan Moreb          United States, Massachusetts Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Paul Richardson          United States, Ohio The Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Yvonne Efebera          Czechia Fakultní nemocnice Brno Recruiting Brno, Czechia Contact: Ludek Pour          Fakultní nemocnice Hradec Králové Recruiting Hradec Králové, Czechia Contact: Vladimir Maisnar          Fakultní nemocnice Ostrava Recruiting Ostrava, Czechia Contact: Roman Hajek          Všeobecná fakultní nemocnice Recruiting Praha, Czechia Contact: Jan Straub          France Hôpital Morvan Not yet recruiting Brest, France Contact: Jean-Richard Eveillard          Centre Jean Bernard - Clinique Victor Hugo Not yet recruiting Le Mans, France Contact: Katell Le Du          Hôpital privé du Confluent Not yet recruiting Nantes, France Contact: Jacques Delaunay          Centre Hospitalier Lyon Sud Not yet recruiting Pierre-Bénite, France Contact: Lionel Karlin          Centre Hospitalier Universitaire Institut Gustave Roussy Not yet recruiting Villejuif, France Contact: Vincent Ribrag          Spain Hospital Universitai Germans Trias i Pujol Recruiting Badalona, Spain Contact: Albert Oriol          Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain Contact: Miquel Granell          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain Contact: Joaquín Martinez          Complejo Hospitalario de Salamanca Recruiting Salamanca, Spain Contact: María-Victoria Mateos Less <<
NCT00548717 - Terminated(First two patients ... More >>enrolled after trial reopened, developed grade III-IV acute GVHD and subsequently passed away.) Less << - -
NCT03589222 Refractory Multiple Myeloma Phase 2 Recruiting June 2022 Spain ... More >> Hospital Germans Trials i Pujol Recruiting Badalona, Spain Contact: Albert Oriol, Dr       aoriol@iconcologia.net    Hospital Clinic de Barcelona Recruiting Barcelona, Spain Contact: Joan Bladé, Dr       JBLADE@clinic.cat    Hospital ICO de Girona Recruiting Girona, Spain Contact: Yolanda Gonzalez, Dr       ygonzalez@iconcologia.net    Hospital ICO de L'hospitalet Recruiting L'Hospitalet De Llobregat, Spain Contact: Anna Sureda, Dr       asureda@iconcologia.net    Hospital 12 de Octubre Recruiting Madrid, Spain Contact: Juan José Lahuerta, Dr       JJLAHUERTA@telefonica.net    Hospital Clinico de Madrid Recruiting Madrid, Spain Contact: Rafael Martinez, Dr       rafaelbenigno.martinez@salud.madrid.org    Hospital Morales Meseguer Recruiting Murcia, Spain Contact: Felipe de Arriba, Dr       farriba@um.es    Hospital Central de Asturias Recruiting Oviedo, Spain Contact: Ana Pilar Gonzalez, Dr       anapilargonzalez@gmail.com    Clinica Universitaria de Navarra Recruiting Pamplona, Spain Contact: Jesús San Miguel, Prof       sanmiguel@unav.es    Hospital Clinico Universitario de Salamanca Recruiting Salamanca, Spain Contact: Mª Victoria Mateos, Dr       mateos@usal.es    Hospital Universitario de Donostia Recruiting San Sebastián, Spain Contact: Maialen Sirvent, Dr       MAIALEN.SIRVENTAUZMENDI@osakidetza.eus    Hospital Universitario de Santiago Recruiting Santiago De Compostela, Spain Contact: Marta Sonia Gonzalez, Dr       marta.sonia.gonzalez.perez@sergas.es    Hospital Virgen del Rocio Recruiting Sevilla, Spain Contact: Jesus Martín, Dr       jesus.martin.sspa@juntadeandalucia.es    Hospital Universitario de Canarias Recruiting Tenerife, Spain Contact: Miguel Hernandez, Dr       mthernan@ull.es    Hospital Dr Peset Recruiting Valencia, Spain Contact: Javier de la Rubia, Dr       delarubia_jav@gva.es Less <<
NCT03763162 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 2 Not yet recruiting December 31, 2023 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Hans C. Lee    713-792-2860       Principal Investigator: Hans C. Lee Less <<
NCT01056276 Multiple Myeloma Phase 2 Completed - United States, California ... More >> Los Robles Hospital and Medical Center Thousand Oaks, California, United States, 91360 United States, Florida Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 United States, Louisiana Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States, 70809 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Ohio Oncology Hematology Care Inc. Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas Leading Edge Research, PA Arlington, Texas, United States, 75213 The Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT02158702 Multiple Myeloma ... More >> Relapse After Use of Lenalidomide and Bortezomib Less << Phase 2 Active, not recruiting November 2018 Singapore ... More >> National University Hospital Singapore, Singapore, 119074 Singapore General Hospital Singapore, Singapore Less <<
NCT00023764 Recurrent Grade 1 Follicular L... More >>ymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00023764 - Completed - -
NCT00061932 Adenocarcinoma of the Gastroes... More >>ophageal Junction Diffuse Adenocarcinoma of the Stomach Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Recurrent Gastric Cancer Stage IIIB Gastric Cancer Stage IIIC Gastric Cancer Stage IV Gastric Cancer Less << Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 Less <<
NCT01163357 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Less << Phase 1 Active, not recruiting September 2019 United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less <<
NCT00790647 Multiple Myeloma Phase 2 Completed - United States, Massachusetts ... More >> Boston University Cancer Research Center Boston, Massachusetts, United States, 02118 Less <<
NCT01445405 Carcinoma, Squamous ... More >> Head and Neck Cancer Oral Cancer Laryngeal Cancer Pharyngeal Cancer Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00262873 Myelodysplastic Syndromes Phase 2 Completed - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT01056276 - Completed - -
NCT00790647 - Completed - -
NCT00262860 Lymphoma Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00262873 - Completed - -
NCT00262860 - Completed - -
NCT00005064 Adult Acute Promyelocytic Leuk... More >>emia (M3) Blastic Phase Chronic Myelogenous Leukemia Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Relapsing Chronic Myelogenous Leukemia Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00553644 Recurrent Mantle Cell Lymphoma Phase 2 Completed - -
NCT00553644 - Completed - -
NCT01863004 Dysferlinopathy PHASE1 TERMINATED 2017-09-15 Neuromuskul?res Zentrum, Unive... More >>rsit?tsspital Basel, Basel, 4031, Switzerland Less <<
NCT01728259 Light Chain Deposition Disease... More >> Primary Systemic Amyloidosis Less << Phase 1 Suspended(Temporarily enrollme... More >>nt suspension due to unknown cause of death of participant) Less << June 2017 United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Massachusetts Boston University School of Medicine Boston, Massachusetts, United States, 02118-2393 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Canada, Ontario Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01998503 Amyloidosis Phase 3 Completed - China, Jiangsu ... More >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 Less <<
NCT01950611 Relapsed Acute Promyelocytic L... More >>eukemia Less << PHASE2 UNKNOWN 2025-05-18 Department of Haematology, Chr... More >>istian Medical College, Vellore, TN, 632004, India Less <<
NCT00258245 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00958256 Mantle Cell Lymphoma ... More >> Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00136591 Follicular Lymphoma Phase 2 Terminated(An arm closed due t... More >>o lack of efficacy) Less << - Belgium ... More >> Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France Less <<
NCT00994500 Childhood Burkitt Lymphoma ... More >> Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Germ Cell Tumor Childhood Central Nervous System Germinoma Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Teratoma Childhood Central Nervous System Yolk Sac Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Medulloepithelioma Childhood Meningioma Childhood Mixed Glioma Childhood Nasal Type Extranodal NK/T-cell Lymphoma Childhood Oligodendroglioma Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Central Nervous System Embryonal Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Malignant Germ Cell Tumor Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Recurrent Childhood Visual Pathway Glioma Recurrent/Refractory Childhood Hodgkin Lymphoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Illinois ... More >> Childrens Memorial Hospital Chicago, Illinois, United States, 60614 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00958256 - Completed - -
NCT00271804 Myelodysplastic Syndrome Phase 1 Terminated(New study with lena... More >>lidomide pending) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00182637 Lymphoma Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT01132911 Lymphoma Sarc... More >>oma WilmsTumor Neuroblastoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02112916 Adult T Acute Lymphoblastic Le... More >>ukemia Ann Arbor Stage II Adult Lymphoblastic Lymphoma Ann Arbor Stage II Childhood Lymphoblastic Lymphoma Ann Arbor Stage III Adult Lymphoblastic Lymphoma Ann Arbor Stage III Childhood Lymphoblastic Lymphoma Ann Arbor Stage IV Adult Lymphoblastic Lymphoma Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma Childhood T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Suspended(Other - Temporary cl... More >>osure) Less << - -
NCT00861250 Multiple Myeloma Phase 2 Phase 3 Completed - Finland ... More >> Tampere University Hospital Tampere, Pirkanmaa, Finland, 33 521 Less <<
NCT00182637 - Completed - -
NCT01381692 Cognitive Side Effects of Canc... More >>er Therapy Fatigue Neurotoxicity Syndrome Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Therapy-Related Toxicity Waldenstrom Macroglobulinemia Less << Phase 1 Phase 2 Active, not recruiting - United States, Colorado ... More >> Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Georgia Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States, 17822 University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Wisconsin Gundersen Lutheran Medical Center La Crosse, Wisconsin, United States, 54601 Marshfield Clinic Marshfield, Wisconsin, United States, 54449 Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Marshfield Clinic-Minocqua Center Minocqua, Wisconsin, United States, 54548 Less <<
NCT00440479 Multiple Myeloma|Hematological... More >> Neoplasms Less << COMPLETED 2025-01-11 Bergen Op Zoom, Netherlands|Br... More >>eda, Netherlands|Ede Gld, Netherlands|Nijmegen, Netherlands|Rotterdam, Netherlands|Terneuzen, Netherlands|Tilburg, Netherlands|Utrecht, Netherlands|Vlissingen, Netherlands Less <<
NCT00383474 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Blastic Phase Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Disease Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 Less <<
NCT00023712 Primary Peritoneal Cavity Canc... More >>er Recurrent Ovarian Epithelial Cancer Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00980395 Lymphoma Mant... More >>le Cell Lymphoma Indolent Lymphoma SLL Less << Phase 2 Active, not recruiting December 31, 2021 United States, Arizona ... More >> The University of Arizona Cancer Center Tucson, Arizona, United States, 85724-5024 Less <<
NCT01913730 Multiple Myeloma Phase 2 Active, not recruiting November 2020 Italy ... More >> Irccs Crob Rionero in Vulture, Potenza, Italy Less <<
NCT02844322 Waldenstr?m Macroglobulinemia Phase 4 Recruiting May 2020 China ... More >> Shuhua Yi Recruiting Tianjin, China, 300020 Contact: Shuhua Yi, Doc    86-22-23909106    yishuhua@ihcams.ac.cn    Contact: Lugui Qiu, Doc    86-22-23909172    qiulg@ihcams.ac.cn Less <<
NCT00998010 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Active, not recruiting June 30, 2019 United States, California ... More >> University of California Los Angeles Los Angeles, California, United States, 90095 Less <<
NCT01435395 Glioblastoma Multiforme Phase 1 Completed - United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00416273 Multiple Myeloma Phase 3 Completed - Germany ... More >> Augsburg, Germany Bamberg, Germany Berg, Germany Berlin, Germany Bremen, Germany Dresden, Germany Duisburg, Germany Erlangen, Germany Eschweiler, Germany Frankfurt / Main, Germany Freiburg, Germany Goch, Germany Greifswald, Germany Göttingen, Germany Halle, Germany Hamburg, Germany Hamm, Germany Hannover, Germany Homburg, Germany Jena, Germany Karlsruhe, Germany Kempten, Germany Kiel, Germany Köln, Germany Magdeburg, Germany Mainz, Germany Mutlangen, Germany München, Germany Münster, Germany Nürnberg, Germany Oldenburg, Germany Regensburg, Germany Rostock, Germany Stuttgart, Germany Ulm, Germany Villingen-Schwenningen, Germany Wiesbaden, Germany Würzburg, Germany Less <<
NCT00972959 Multiple Myeloma Phase 2 Completed - Greece ... More >> Department of Clinical Therapeutics, University of Athens School of Medicine, "Alexandra" General Hospital Athens, Greece, 115 28 Department of Hematology & Medical Research, 251 General Air Force Hospital Athens, Greece, 11525 Department of Hematology, "Theagenion" Cancer Center Thessaloniki, Greece, 540 07 Less <<
NCT00023712 - Completed - -
NCT00972959 - Completed - -
NCT00440765 - Completed - Netherlands ... More >> 'S-Hertogenbosch, Netherlands Alkmaar, Netherlands Amersfoort, Netherlands Amstelveen, Netherlands Amsterdam Zuidoost, Netherlands Apeldoorn, Netherlands Bergen Op Zoom, Netherlands Blaricum, Netherlands Breda, Netherlands Capelle Aan Den Ijss, Netherlands Delfzijl, Netherlands Den Haag, Netherlands Deventer, Netherlands Dirksland, Netherlands Doetinchem, Netherlands Dordrecht, Netherlands Drachten, Netherlands Ede Gld, Netherlands Eindhoven, Netherlands Geldrop, Netherlands Goes, Netherlands Gouda, Netherlands Groningen, Netherlands Hardenberg, Netherlands Heerenveen, Netherlands Hoofddorp, Netherlands Hoogeveen, Netherlands Leiden, Netherlands Maastricht, Netherlands Nieuwegein, Netherlands Nijmegen, Netherlands Oss, Netherlands Roosendaal, Netherlands Rotterdam, Netherlands Schiedam, Netherlands Terneuzen, Netherlands Tilburg, Netherlands Utrecht, Netherlands Veghel, Netherlands Veldhoven, Netherlands Vlissingen, Netherlands Woerden, Netherlands Zaandam, Netherlands Zutphen, Netherlands Less <<
NCT01267812 Contiguous Stage II Mantle Cel... More >>l Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Recurrent Mantle Cell Lymphoma Stage I Mantle Cell Lymphoma Stage III Mantle Cell Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 2 Active, not recruiting June 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00522392 Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 3 Terminated(Slow accrual) - -
NCT00522392 - Terminated(Slow accrual) - -
NCT00366106 Multiple Myeloma Phase 2 Terminated(Study was closed to... More >> enrollment when it became clear that enrollment was too slow to complete full enrollment target within time frame allowed.) Less << - United States, California ... More >> Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 United States, Connecticut Medical Oncology & Hematology Waterbury, Connecticut, United States, 06708 United States, Florida Advanced Medical Specialties Miami, Florida, United States, 33176 United States, Georgia Northeast Georgia Cancer Care Athens, Georgia, United States, 30607 Augusta Oncology Associates, PC Augusta, Georgia, United States, 30901 Northwest Georgia Oncology Centers, PC Marietta, Georgia, United States, 30060 United States, Idaho North Idaho Cancer Center Coeur d'Alene, Idaho, United States, 83814 United States, Maryland Oncology-Hematology Associates, P.A. Clinton, Maryland, United States, 20735 United States, Montana Hematology Oncology Centers of the Northern Rockies, PC Billings, Montana, United States, 59101 United States, New York Arena Oncology Associates Lake Success, New York, United States, 11042 United States, Ohio Tri-County Hematology and Oncology Associates Canton, Ohio, United States, 44718 Mid Ohio Oncology/Hematology, Inc. Columbus, Ohio, United States, 43215 United States, Pennsylvania Lancaster Cancer Center, Ltd. Lancaster, Pennsylvania, United States, 17605 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Virginia Cancer Specialists of Tidewater, Ltd. Chesapeake, Virginia, United States, 23320 Less <<
NCT00428142 Lymphoma Phase 2 Completed - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 BCCA - Vancouver Island Cancer Centre Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada, E1C 6Z8 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Credit Valley Hospital Mississauga, Ontario, Canada, L5M 2N1 Regional Cancer Program of the Hopital Regional Sudbury, Ontario, Canada, P3E 5J1 Thunder Bay Regional Health Science Centre Thunder Bay, Ontario, Canada, P7B 6V4 Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Humber River Regional Hospital Toronto, Ontario, Canada, M9N 1N8 Canada, Quebec Hopital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 CHA-Hopital Du St-Sacrement Quebec City, Quebec, Canada, G1S 4L8 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT01078441 Refractory Multiple Myeloma Phase 2 Terminated(The study was close... More >>d early due to weak accrual on June 26, 2012.) Less << - -
NCT00124579 - Terminated(poor accrual) - -
NCT01078441 - Terminated(The study was close... More >>d early due to weak accrual on June 26, 2012.) Less << - -
NCT03335098 Waldenstrom Macroglobulinemia|... More >>Lymphoplasmacytic Lymphoma Less << PHASE2 UNKNOWN 2025-12-20 Seoul National University Bund... More >>ang Hospital, Seongnam, 13620, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of Less <<
NCT00366106 - Terminated(Study was closed to... More >> enrollment when it became clear that enrollment was too slow to complete full enrollment target within time frame allowed.) Less << - -
NCT00507416 Multiple Myeloma Phase 3 Completed - -
NCT00507416 - Completed - -
NCT00374699 Peripheral T-Cell Lymphomas ... More >> Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00358020 Multiple Myeloma Phase 2 Completed - Italy ... More >> Divisione Di Ematologia, Ospedale Centrale Bolzano, Italy Unità Operativa Complessa Di Ematologia, Presidio Ospedaliero Dell’Annunziata, Azienda Ospedaliera Di Cosenza Cosenza, Italy Divisione Di Ematologia E Trapianto Di Midollo Osseo, Azienda Ospedaliera Cervello Palermo, Italy Divisione Di Ematologia, Ospedali Riuniti Reggio Calabria, Italy Cattedra E Divisione Di Ematologia, Università Tor Vergata, Ospedale S.Eugenio Roma, Italy Divisione Universitaria Ematologia - Az.Osp. San Giovanni Battista Torino, Italy, 10126 Ematologia, Azienda Ospedaliera S.Giovanni Battista Torino, Italy, 10126 Less <<
NCT00193557 Multiple Myeloma PHASE2 COMPLETED 2025-01-09 Florida Cancer Specialists, Fo... More >>rt Myers, Florida, 33901, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37023, United States Less <<
NCT00708292 Relapsed or Refractory Multipl... More >>e Myeloma Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic - Arizona Cancer Clinical Research Unit Scottsdale, Arizona, United States, 85259 United States, Texas Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) San Antonio, Texas, United States, 78229 Australia Novartis Investigative Site Melbourne, Australia, 3004 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Wuerzburg, Germany, 97070 Singapore Novartis Investigative Site Singapore, Singapore, 169608 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28006 Less <<
NCT01186458 Lymphoma, Non-Hodgkin Phase 2 Terminated(Slow accrual) - United States, Indiana ... More >> Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Arnett Cancer Care Lafayette, Indiana, United States, 47904 United States, New Jersey Virtua Health Cancer Program Mount Holly, New Jersey, United States, 08060 South Jersey Health Care Vineland, New Jersey, United States, 08360 United States, New York University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Case Comprehensive Cancer Center - University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Seidman Cancer Center Cleveland, Ohio, United States, 44106 United States, Pennsylvania Reading Hospital Regional Cancer Center W. Reading, Pennsylvania, United States, 19611 Less <<
NCT00028587 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01045681 Multiple Myeloma Phase 2 Unknown June 2013 France ... More >> CHRU Hôpital Sud Amiens, France, 80054 CHRU, Hôpital du Bocage Angers, France, 49033 Centre Hospitalier H.Duffaut Avignon, France, 84902 Centre Hospitalier de la Cote Basque Bayonne, France, 64109 Hôpital Jean Minjoz / CHU BESANCON Besançon, France, 25030 Centre Hospitalier Blois, France, 41016 Hôpital Avicenne Bobigny, France, 93009 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, 33000 Hôpital A.Morvan Brest, France, 29609 Centre F.Baclesse Caen, France, 14076 CHU Clermont Ferrand Clermont Ferrand, France, 63003 CH Sud Francilien Corbeil-essonnes, France, 91106 CHU DIJON, Hôpital Le Bocage Dijon, France, 21034 Centre Hospitalier Général Dunkerque, France, 59385 Hôpital A.Michallon Grenoble, France, 38043 CH Départemental La Roche Sur Yon, France, 85925 Centre Hospitalier de Chartres Le Coudray, France, 28629 Centre Jean Bernard Le Mans, France, 72000 CHRU Hôpital Claude Huriez Lille, France, 59038 Institut Paoli Calmette Marseille, France, 13273 CH Meaux Meaux, France, 77104 CHRU Hôtel Dieu Nantes, France, 44035 Hôpital de l'Archet 1 Nice, France, 06202 Intitut Curie Paris, France, 75005 CHU Hôpital St-Antoine Paris, France, 75571 Centre Hopsitalier Lyon Sud Pierre Benite, France, 69495 Centre Hospitalier René Dubos Pontoise, France, 95300 Centre Hospitalier de la Région d'Annecy Pringy, France, 74374 CHU Reims Hôpital R.Debré Reims, France, 51032 CHRU - Hôpital sud Rennes, France, 35056 Centre Henri Becquerel Rouen, France, 76038 Centre René Huguenin Saint-cloud, France, 92210 CHRU Hopital Purpan Toulouse, France, 31059 CHRU Hopital Bretonneau Tours, France, 37044 Centre Hospitalier Valence, France, 26953 CHRU - Hôpitaux de Brabois Vandoeuvre, France, 54511 CH P.Chubert Vannes, France, 56017 Less <<
NCT00038571 Lymphoma, B-Cell Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01365559 Multiple Myeloma Phase 1 Phase 2 Completed - United States, California ... More >> Pacific Oncology and Hematology Encinitas, California, United States, 92024 Pacific Cancer Care Salinas, California, United States, 93901 Central Coast Medical Oncology Santa Maria, California, United States, 93454 James R. Berenson, MD, Inc. West Hollywood, California, United States, 90069 United States, Illinois Cancer Centers of America Zion, Illinois, United States, 60099 United States, Indiana Franciscan St. Francis Health Indianapolis, Indiana, United States, 46237 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Tennessee Family Cancer Center Foundation, Inc. Memphis, Tennessee, United States, 38119 United States, Virginia Virginia Cancer Specialists Fairfax, Virginia, United States, 233031 Less <<
NCT01190787 Multiple Myeloma Phase 2 Active, not recruiting May 2020 Italy ... More >> Division of Hematology, A.O.U. San Giovanni Battista Torino, Italy, 10126 Less <<
NCT01186458 - Terminated(Slow accrual) - -
NCT01910987 Multiple Myeloma Phase 3 Completed - -
NCT00401804 Multiple Myeloma ... More >> Renal Insuficiency Less << Phase 2 Completed - Austria ... More >> Landeskrankenhaus Feldkirch Feldkirch, Austria Klinischen Abteilung für Hämatologie, Medizinische Universitätsklinik Graz Graz, Austria, 8036 Landeskrankenhaus Leoben Leoben, Austria Dep. of Internal Medicine I, Oncology, SALK - Gemeinnützige Salzburger Landeskliniken Salzburg, Austria, 5020 Medical University of Vienna, Dep. of Internal Medicine I Vienna, Austria, 1090 Universitätsklinik für Innere Medizin I Vienna, Austria, 1090 Wilhelminenspital Vienna, 1st Med. Department - center for Oncology and Hematology Vienna, Austria, 1160 Klinikum Kreuzschwestern Wels GmbH Wels, Austria, 4600 Czech Republic FN Brno Interni Hematoonkolog. klinika Brno, Czech Republic, 62500 Less <<
NCT00532389 Multiple Myeloma Phase 1 Completed - United States, Florida ... More >> Innovative Medical Research of South Florida Dept.ofInnovativeMedResearch Miami Shores, Florida, United States, 33138 United States, Massachusetts Dana Farber Cancer Institute Clinical Research Coordinator Boston, Massachusetts, United States, 02115 United States, New Jersey Hackensack University Medical Center Multiple Myeloma Division Hackensack, New Jersey, United States, 07601 United States, Washington Swedish Medical Center Dept.ofSwedishMedicalCtr. Seattle, Washington, United States Australia, Australian Capital Territory Novartis Investigative Site Canberra, Australian Capital Territory, Australia, 2606 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H1T 2M4 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site München, Germany, 80336 Novartis Investigative Site Wuerzburg, Germany, 97070 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Torino, TO, Italy, 10126 Spain Novartis Investigative Site Salamanca, Castilla y Leon, Spain, 37007 Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Less <<
NCT00378209 - Completed - -
NCT00985959 Multiple Myeloma Phase 1 Completed - Japan ... More >> Fukuoka, Japan Hiroshima N/A, Japan Hitachi, Japan Isehara, Japan Kamogawa, Japan Kanazawa, Japan Kawagoe, Japan Kobe, Japan Koto-Ku, Japan Kumamoto, Japan Kurashiki, Japan Kurume, Japan Kyoto, Japan Nagasaki, Japan Nagoya, Japan Narita, Japan Niigata, Japan Okayama, Japan Osaka-Sayama, Japan Sapporo, Japan Shibukawa, Japan Suita, Japan Tokushima N/A, Japan Tokyo, Japan Toyama-City, Japan Toyohashi, Japan Utsunomiya, Japan Yokohama, Japan Less <<
NCT01592981 Waldenstrom's Macroglobulinaem... More >>ia Less << Phase 2 Active, not recruiting July 2021 United Kingdom ... More >> Basingstoke & North Hampshire Hospital Basingstoke, United Kingdom Royal United Hospital Bath, United Kingdom Birmingham Heartlands Hospital Birmingham, United Kingdom, B9 5SS City Hospital Birmingham, United Kingdom Pilgrim Hospital Boston, United Kingdom Colchester General Hospital Colchester, United Kingdom Darent Valley Hospital Dartford, United Kingdom Derriford Hospital Derriford, United Kingdom Dewsbury and District Hospital Dewsbury, United Kingdom Royal Devon and Exeter Hospital Exeter, United Kingdom Grantham and District Hospital Grantham, United Kingdom St James University Hospital Leeds, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, United Kingdom Lincoln County Hospital Lincoln, United Kingdom Royal Liverpool University Hospital Liverpool, United Kingdom St Bartolomew's Hospital London, United Kingdom, EC1A 7BE University College Hospital London, United Kingdom, NW1 2BU King's College Hospital London, United Kingdom Northwick Park Hospital London, United Kingdom Royal Free Hospital London, United Kingdom Maidstone Hospital Maidstone, United Kingdom Pontefract Hospital Pontefract, United Kingdom Queen's Hospital Romford, United Kingdom Salisbury District Hospital Salisbury, United Kingdom Musgrove Park Hospital Taunton, United Kingdom Torbay Hospital Torbay, United Kingdom Tunbridge Wells Hospital Tunbridge Wells, United Kingdom Pinderfields Hospital Wakefield, United Kingdom Sandwell Hospital West Bromwich, United Kingdom Royal Hampshire County Hospital Winchester, United Kingdom Less <<
NCT00985959 - Completed - -
NCT00378209 Multiple Myeloma Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00378105 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting February 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00378105 - Active, not recruiting - -
NCT01460602 Follicular Lymphoma ... More >> Marginal Zone Lymphoma Mantle Cell Lymphoma Less << Phase 1 Phase 2 Terminated(Investigator has re... More >>located to MD Anderson) Less << October 2014 United States, Louisiana ... More >> LSU - Shreveport Health Sciences Center, Feist-Weiller Cancer Center Shreveport, Louisiana, United States, 71103 Less <<
NCT03710603 Multiple Myeloma Phase 3 Not yet recruiting November 2029 Australia ... More >> Alfred Hospital Melbourne, Australia Belgium University Hospital Leuven Not yet recruiting Leuven, Belgium Contact: Delforge          Principal Investigator: Delforge          Czechia University Hospital Ostrava Not yet recruiting Ostrava, Czechia Contact: Hajek          Principal Investigator: Hajek          Denmark Odense University Hospital Not yet recruiting Odense, Denmark Contact: Abligaard          Principal Investigator: Abligaard          France CHRU Hôtel Dieu Not yet recruiting Nantes, France Contact: Moreau          Principal Investigator: Moreau          Greece Regional General Hospital Alexandra Athens, Greece Italy Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi Di Ancona Ancona, Italy Netherlands Erasmus MC Not yet recruiting Rotterdam, Netherlands Contact: Pieter Sonneveld          Principal Investigator: Pieter Sonneveld          Norway Oslo University Hospital Not yet recruiting Oslo, Norway Contact: Schjesvold          Principal Investigator: Schjesvold          Poland Uniwersytet Jagiellonski Collegium Medicum Not yet recruiting Kraków, Poland Contact: Jurczyszyn          Principal Investigator: Jurczyszyn          Spain Hospital Clinic I Provincial de Barcelona Not yet recruiting Barcelona, Spain Contact: Rosiñol          Principal Investigator: Rosiñol          Switzerland Kantonsspital St. Gallen Not yet recruiting Saint Gallen, Switzerland Contact: Driessen          Principal Investigator: Driessen          Turkey Ankara University Ankara, Turkey Less <<
NCT00858234 Multiple Myeloma Phase 1 Completed - -
NCT01782963 Multiple Myeloma Phase 2 Completed - United States, Maryland ... More >> John Hopkins University Baltimore, Maryland, United States United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Massachusetts General Hospital/North Shore Cancer Center Danvers, Massachusetts, United States, 01923 Less <<
NCT01782963 - Completed - -
NCT01233895 Multiple Myeloma Phase 1 Completed - France ... More >> Sanofi-Aventis Investigational Site Number 250002 Lille, France, 59037 Sanofi-Aventis Investigational Site Number 250001 Nantes, France, 44093 Sanofi-Aventis Investigational Site Number 250003 Vandoeuvre Les Nancy, France, 54511 Italy Sanofi-Aventis Investigational Site Number 380001 Torino, Italy, 10126 Less <<
NCT02522572 Transplants and Implants Phase 1 Phase 2 Recruiting December 2018 United States, Ohio ... More >> The Christ Hospital Recruiting Cincinnati, Ohio, United States, 45219 Contact: E. Steve Woodle, MD    513-558-6001    Woodlees@uc.edu    Sub-Investigator: Adele Rike-Shields, PharmD          Sub-Investigator: Michael Cardi, MD          Principal Investigator: Ervin S Woodle, MD          University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: E. Steve Woodle, MD    513-558-6001    Woodlees@uc.edu    Sub-Investigator: Rita R Alloway, PharmD          Principal Investigator: Ervin S Woodle, MD          Sub-Investigator: Amit Govil, MD Less <<
NCT00052338 Malignant Pleural Effusion ... More >> Recurrent Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 1 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less <<
NCT01312818 Acute Lymphoblastic Leukemia Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> Masonic Cancer Center, University if Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02955810 Multiple Myeloma Phase 1 Active, not recruiting November 2020 Ireland ... More >> Galway University Hospital Galway, Ireland Less <<
NCT02542111 Diffuse Large B-cell Lymphoma Phase 2 Recruiting May 2018 China, Shanghai ... More >> Ruijin Hospital Recruiting Shanghai, Shanghai, China Contact: Pengpeng XU, MD    64370045 ext 610707 Less <<
NCT01312818 - Terminated(Slow accrual) - -
NCT00750815 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01706666 Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Texas Baylor Medical Center Garland, Texas, United States, 75042 Less <<
NCT01208662 Multiple Myeloma Phase 3 Active, not recruiting September 2018 -
NCT00407303 Mantle-Cell Lymphoma Phase 1 Phase 2 Completed - United States, Georgia ... More >> NW Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Medical Center Buffalo, New York, United States, 14263 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT03729804 Multiple Myeloma Phase 3 Not yet recruiting December 24, 2023 United States, Illinois ... More >> University Of Chicago Medicine Comprehensive Cancer Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Andrzej Jakubowiak, MD    773-834-1592       Principal Investigator: Andrzej Jakubowiak, MD Less <<
NCT01453101 Multiple Myeloma Phase 2 Active, not recruiting May 2019 United States, New Jersey ... More >> John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00750815 - Completed - -
NCT01706666 - Completed - -
NCT00064012 Lung Cancer Phase 2 Completed - -
NCT01537861 Multiple Myeloma Early Phase 1 Terminated(Unexpected toxicity... More >> (2 early deaths)) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00295932 - Completed - -
NCT00295932 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Completed - United States, Georgia ... More >> Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, New Jersey Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Less <<
NCT00199212 Carcinoma Breast Stage IV Phase 1 Completed - Belgium ... More >> Jules Bordet Institute Brussels, Belgium, 1000 Less <<
NCT00511069 Leukemia PHASE2 COMPLETED 2025-02-08 Policlinico "S.Orsola-Malpighi... More >>"-Istituto di Ematologia "L e A Seragnoli", Bologna, 40138, Italy Less <<
NCT01794507 Relapsed/Refractory Multiple M... More >>yeloma Less << Phase 1 Active, not recruiting January 3, 2019 United States, Arizona ... More >> University Arizona Cancer Ctr /ID# 117876 Tucson, Arizona, United States, 85719-1478 United States, Florida Mayo Clinic /ID# 121495 Jacksonville, Florida, United States, 32224 United States, Illinois Northwestern University /ID# 117477 Chicago, Illinois, United States, 60611-2927 United States, Michigan University of Michigan Hospitals /ID# 80353 Ann Arbor, Michigan, United States, 48109-5008 United States, Minnesota Mayo Clinic - Rochester /ID# 77235 Rochester, Minnesota, United States, 55905-0001 Australia, Victoria Peter MacCallum Cancer Ctr /ID# 79553 Melbourne, Victoria, Australia, 3000 Royal Melbourne Hospital /ID# 79533 Parkville, Victoria, Australia, 3050 France CHRU Lille - Hôpital Claude Huriez /ID# 77234 Lille CEDEX, Hauts-de-France, France, 59045 CHU de Nantes, Hotel Dieu -HME /ID# 78773 Nantes, France, 44093 Less <<
NCT02093910 Multiple Myeloma Phase 2 Unknown April 2018 China, Guangdong ... More >> Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Recruiting Guangzhou, Guangdong, China, 510060 Contact: Liang Wang, M.D.    0086-02087342438    wangliang@sysucc.org.cn    Principal Investigator: Zhong-jun Xia, M.D. Less <<
NCT00411593 Lung Cancer Phase 1 Phase 2 Withdrawn(Lack of Patient Accr... More >>ual) Less << - -
NCT01539083 - Completed - -
NCT03617731 Multiple Myeloma Phase 3 Recruiting December 2025 Germany ... More >> HELIOS Klinikum, Klinik für Hämatologie, Onkologie und Immunologie Not yet recruiting Berlin, Germany, 13125 Contact: Stephan Fuhrmann, Dr.    030 ext 940112151    stephan.fuhrmann@helios-kliniken.de    Contact: Judith Niederland, Dr.       judith.niederland@helios-kliniken.de    Klinikum Bielefeld, Klinik für Hämatologie, Onkologie und Palliativmedizin Not yet recruiting Bielefeld, Germany, D-33604 Contact: Martin Görner, Dr. med.    0521-581-3601    martin.goerner@klinikumbielefeld.de    Contact: Ulrich Krümpelmann, Dr.       ulrich.kruempelmann@klinikumbielefeld.de    Medizinische Universitätsklinik, Knappschaftskrankenhaus Not yet recruiting Bochum, Germany, D-44892 Contact: Roland Schroers, Prof. Dr. med.    0234-2993447    roland.schroers@rub.de    Contact: Lars Petersen, Dr.          Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik III, Schwerpunkt Onkologie, Hämatologie und Rheumatologie Not yet recruiting Bonn, Germany, 53105 Contact: Annkristin Heine, Dr.    0228 ext 28717232    annkristin.heine@ukb.uni-bonn.de;    Contact: Jai-Juen Shiue, Dr.          Klinikum Chemnitz GmbH, Innere Medizin III Not yet recruiting Chemnitz, Germany, D-09116 Contact: Mathias Hänel, PD Dr. med.    0371-333-43045    m.haenel@skc.de    Contact: Anke Morgner, Dr.          Onkologisches Studienzentrum Darmstadt Not yet recruiting Darmstadt, Germany, 64283 Contact: Gerrit Dingeldein          Contact: Georgi Kojouharoff, Dr.    06151-130480       Klinikum Darmstadt, Med. Klinik V, Hämatologie/Onkologie Not yet recruiting Darmstadt, Germany, D-64283 Contact: Helga Bernhard, Prof. Dr.    06151-107-6651    helga.bernhard@mail.klinikum-darmstadt.de    Contact: Tu-Anh Dang, Dr.       tu-anh.dang@mail.klinikum-darmstadt.de    HELIOS St. Johannes Klinik, Akademisches Krankenhaus der Heinrich-Heine-Universität Düsseldorf Not yet recruiting Duisburg, Germany, 47166 Contact: Michael n.a. Heinsch, Dr.    0203 ext 5462442    michael.heinsch@helios-kliniken.de    Universitätsklinikum Düsseldorf, Klinik für Hämatologie,Onkologie und Klin. Immunologie Not yet recruiting Düsseldorf, Germany, D-40225 Contact: Roland Fenk, Prof. Dr.    0211-811-7760    fenk@med.uni-duesseldorf.de    Contact: Amelie Boquoi, Dr.          Universitätsklinik Erlangen Not yet recruiting Erlangen, Germany, 91054 Contact: Barbara Ferstl, Dr.    09131 ext 8543104    Barbara.Ferstl@uk-erlangen.de    Contact: Andreas Mackensen, Prof.       Andreas.Mackensen@uk-erlangen.de    Universitätsklinikum Essen, Klinik für Hämatologie Not yet recruiting Essen, Germany, D-45147 Contact: Jan Dürig, Prof. Dr.    0201-72384621    jan.duerig@uni-essen.de    Contact: Karl Richard Maria Noppeney, Dr.    0201-72384215       Ev. Krankenhaus Essen-Werden gGmbH, Zentrum für Innere Medizin, Klinik für Hämatologie, Onkologie und Stammzelltransplantation Not yet recruiting Essen, Germany, D-45239 Contact: Mohammed Wattad, Dr.    0201-4089 2246    m.wattad@kliniken-essen-sued.de    Contact: Peter Reimer, Prof. Dr.    0201-4089-0    p.reimer@kliniken-essen-sued.de    Universitätsklinikum Frankfurt, Goethe-Universität Medizinische Klinik II Not yet recruiting Frankfurt am Main, Germany, 60590 Contact: Wilde Birgit    069-6301 ext 86708    Birgit.Wilde@kgu.de    Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie Not yet recruiting Hagen, Germany, D-58095 Contact: Hans-Walter Lindemann, Dr.    02331-129-0    w.lindemann@kkh-hagen.de    Contact: Cordula Maria Elisabeth Maciejewski       maciejewskic@kkh-hagen.de    Asklepios Klinik Hamburg Altona, II. Med. Klinik Not yet recruiting Hamburg, Germany, D-22763 Contact: Hans Salwender, Dr.    040-181881-1212    h.salwender@asklepios.com    KRH Klinikum Siloah, Klinik für Hämatologie und Onkologie Not yet recruiting Hannover, Germany, 30459 Contact: Martin Müller, PD Dr.          Contact: Kim Marienhagen          University Hospital Heidelberg, Med. Klinik V Recruiting Heidelberg, Germany, D-69120 Contact: GMMG Study Office       studiensekretariat.gmmg@med.uni-heidelberg.de    Principal Investigator: Hartmut Goldschmidt, Prof. Dr.          SLK Kliniken Heilbronn, Med. Klinik III Not yet recruiting Heilbronn, Germany, D-74078 Contact: Uwe Martens, Prof. Dr.       uwe.martens@slk-kliniken.de    Contact: Markus Lindauer, Dr.          Praxisklinik für Hämatologie und Onkologie Not yet recruiting Koblenz, Germany, D-56068 Contact: Jörg Thomalla, Dr. med.    0261-30493-0    thomalla@onkologie-koblenz.de    Contact: Rudolf Weide, Prof. Dr.          Med. Klinik A, Klinikum der Stadt Ludwigshafen am Rhein gGmbH Not yet recruiting Ludwigshafen am Rhein, Germany, 67063 Contact: Martin Hoffmann, Dr.    0621 ext 50340702    HoffmanM@klilu.de    Contact: Michael Uppenkamp, Prof. Dr.    0621 ext 50340702       Universitätsmedizin der Johannes Gutenberg-Universität Mainz, III. Med. Klinik Not yet recruiting Mainz, Germany, D-55131 Contact: Markus Munder, PD. Dr. med.    06131-17-5948    markus.munder@unimedizin-mainz.de    Contact: Georg Heß, PD Dr.          III. Medizinische Klinik Hämatologie und Internistische Onkologie Not yet recruiting Mannheim, Germany, 68167 Contact: Stefan Klein, PD Dr.    0621-383-4114    stefan.klein@umm.de    Mannheimer Onkologie Praxis Not yet recruiting Mannheim, Germany, D-68161 Contact: Manfred Hensel, Prof. Dr. med.       hensel@mannheimer-onkologie-praxis.de    Contact: Dieter Schuster, Dr. med.          Philipps-Universität Marburg, Hämatologie/Onkologie/Immunologie Not yet recruiting Marburg, Germany, 35032 Contact: Andreas Neubauer, Prof. Dr.       neubauer@med.uni-marburg.de    Contact: Ellen Wollmer, Dr.       wollmer@med.uni-marburg.de    Mühlenkreiskliniken (AöR) Johannes Wesling Klinikum Minden, Hämatologie/Onkologie, Hämostaseologie und Palliativmedizin Not yet recruiting Minden, Germany, 32429 Contact: Hans-Joachim Tischler, Dr.    0571 ext 7904202    hans-joachim.tischler@muehlenkreiskliniken.de    Contact: Kai Wille, Dr.    0571 ext 79051193    kai.wille@muehlenkreiskliniken.de    Krankenhaus Maria Hilf GmbH, Franziskuskrankenhaus, Med. Klinik I Not yet recruiting Mönchengladbach, Germany, D-41063 Contact: Ullrich Graeven, PD Dr.    02161-892-2201    Ullrich.Graeven@mariahilf.de    Contact: Heidi Herfert    02161-892-2372    heidi.herfert@mariahilf.de    Krankenhaus Barmherzige Brüder, Klinik für Onkologie und Hämatologie Not yet recruiting Regensburg, Germany, 93049 Contact: Bernhard Heilmeier, Dr.    0941 ext 36992152    bernhard.heilmeier@barmherzige-regensburg.de    Contact: Anke Schlenska-Lange, Dr.       anke.schlenska-lange@barmherzige-regensburg.de;    Diakonie-Klinikum Schwäbisch Hall gGmbH, Innere Medizin III Not yet recruiting Schwäbisch Hall, Germany, 74523 Contact: Sabine Kraft    0791-753-4018 ext 4486    sabine.kraft@dasdiak.de    Contact: Samiha Priwitzer       Samiha.priwitzer@dasdiak.de    ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg Not yet recruiting Siegburg, Germany, D-53721 Contact: Stefan Fronhoffs, Dr.       sfronhoffs@zaho-rheinland.de    Contact: Bettina Bürgel    02241-5954-23    studienbuero@zaho-rheinland.de    Onkologische Schwerpunktpraxis Speyer Not yet recruiting Speyer, Germany, D-67346 Contact: Joachim Behringer, Dr. med.       j.behringer@onkologie-speyer.de    Contact: Lars Scheuer, Dr.    06232-604460    onkologie-speyer@t-online.de    University Hospital Tübingen, Med. Klinik und Poliklinik, Abt. II Not yet recruiting Tübingen, Germany, D-72076 Contact: Katja Weisel, PD Dr.    07071-29-84321    katja.weisel@med.uni-tuebingen.de    Contact: Britta Besemer, Dr.       britta.besemer@med.uni-tuebingen.de Less <<
NCT01539083 Multiple Myeloma Phase 3 Completed - Australia ... More >> Adelaide, Australia Camperdown, Australia Geelong, Australia Greenslopes, Australia Heidelberg, Australia Herston, Australia Malvern, Australia Melbourne, Australia Nedlands, Australia Newcastle, Australia Prahran, Australia Sydney, Australia Westmead, Australia Woodville South, Australia Woolloongabba, Australia China Beijing, China Guangzhou, China Shanghai, China Tianjin, China Korea, Republic of Busan, Korea, Republic of Daegu, Korea, Republic of Hwasun Gun, Korea, Republic of Ulsan, Korea, Republic of Less <<
NCT00431990 Multiple Myeloma Phase 1 Phase 2 Unknown January 2012 Australia, Victoria ... More >> Peter MacCallum Cancer Centre Recruiting Melbourne, Victoria, Australia, 8006 Sub-Investigator: Alvin Milner Less <<
NCT01449344 Mantle Cell Lymphoma Phase 3 Active, not recruiting December 2018 -
NCT01072773 - Completed - -
NCT00108069 Glioma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00555906 - Completed - -
NCT00243035 Refractory Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Phase 2 Terminated - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00108069 - Completed - -
NCT01936090 DS Stage I Plasma Cell Myeloma... More >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Refractory Plasma Cell Myeloma Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00555906 Multiple Myeloma Phase 2 Completed - United States, Illinois ... More >> Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 Northwestern Memorial Hospital/Main Labs Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States, 66205 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110-1093 Barnes-Jewish Hospital St. Louis, Missouri, United States, 63110 Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 New York Presbyterian, Weill Cornell Medical College New York, New York, United States, 10065 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 Czech Republic Vseobecna fakultni nemocnice v Praze Praha 2, Czech Republic, 12808 Germany Universitaetsklinikum Heidelberg Heidelberg, Germany, 69120 Klinikum Johannes-Gutenberg -Universitaet, III. Medizinische Klinik und Poliklinik Mainz, Germany, 55131 Less <<
NCT00085410 Adenocarcinoma of the Extrahep... More >>atic Bile Duct Adenocarcinoma of the Gallbladder Advanced Adult Primary Liver Cancer Gastrointestinal Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Recurrent Extrahepatic Bile Duct Cancer Recurrent Gallbladder Cancer Unresectable Extrahepatic Bile Duct Cancer Unresectable Gallbladder Cancer Less << Phase 2 Terminated(The trial was disco... More >>ntinued early due to no confirmed partial responses.) Less << - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT01072773 Primary Systemic Amyloidosis Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00068315 Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Hematopoietic/Lymphoid Cancer Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 1 Completed - United States, Ohio ... More >> Mercy Medical Center Canton, Ohio, United States, 44708 Case Western Reserve University Cleveland, Ohio, United States, 44106 Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Southwest General Health Center Ireland Cancer Center Middleburg Heights, Ohio, United States, 44130 UHHS-Chagrin Highlands Medical Center Orange Village, Ohio, United States, 44122 University Suburban Medical Center South Euclid, Ohio, United States, 44121 UHHS-Westlake Medical Center Westlake, Ohio, United States, 44145 Less <<
NCT00629226 Head and Neck Cancer Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 United States, Pennsylvania UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00085410 - Terminated(The trial was disco... More >>ntinued early due to no confirmed partial responses.) Less << - -
NCT01324596 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 3 Completed - -
NCT00744354 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Terminated(Drugs unavailable- ... More >>study terminated 1/2/18) Less << - United States, New York ... More >> Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00411905 Myelodysplastic Syndromes PHASE1|PHASE2 COMPLETED 2011-08-01 CHU Angers, Angers, 43033, Fra... More >>nce|Hopital Avicenne, Bobigny, 93009, France|Institut Bergonie, Bordeaux, 33076, France|CHU de Caen, Caen, 14033, France|CHU Dijon, Dijon, 21000, France|CHU Albert Michallon, Grenoble, 38043, France|CHU de Limoges, Limoges, 87046, France|Hopital Paoli Calmette, Marseille, 13273, France|CHU Archet, Nice, 06202, France|Hopital Cochin, Paris, 75014, France|Centre Hospitalier Joffre, Perpignan, 66046, France|Centre Henry Becquerel, Rouen, 76038, France|Centre Hospitalier Universitaire de STRASBOURG, Strasbourg, 67098, France|CHU Purpan, Toulouse, 31059, France|CHU Brabois, Vandoeuvre, 54511, France Less <<
NCT01084837 Multiple Myeloma Phase 2 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain Hospital Clinic Barcelona, Spain Hospital de Sant Pau Barcelona, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Universitario Salamanca, Spain Hospital General Segovia, Spain Hospital Universitario de Canarias Tenerife, Spain Hospital La Fe Valencia, Spain Hospital Lozano Blesa Zaragoza, Spain Less <<
NCT00096005 Adult Grade III Lymphomatoid G... More >>ranulomatosis AIDS-related Peripheral/Systemic Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Waldenstr?m Macroglobulinemia Less << Phase 1 Terminated - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00075751 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00082966 Adult Lymphocyte Depletion Hod... More >>gkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Recurrent Adult Hodgkin Lymphoma Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00440076 MDS Phase 2 Terminated(Low accrual) - Italy ... More >> Centro Oncologico Basilicata Rionero in Vulture, Potenza, Italy Istituto di Ematologia e Oncologia Medica L. e A. Seragnoli Bologna, Italy Ospedale Niguarda "Ca Grande" Milano, Italy A.O Umberto I Roma, Italy Less <<
NCT00510939 Acute Myeloid Leukemia Phase 2 Unknown - Italy ... More >> Istituto di Ematologia "L e A Seragnoli" Policlinico S.Orsola-Malpighi Recruiting Bologna, Italy, 40138 Contact: Giovanni Martinelli, MD    +039 051 6363829    martg@tin.it Less <<
NCT01668719 DS Stage I Plasma Cell Myeloma... More >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Less << Phase 1 Phase 2 Active, not recruiting September 2021 -
NCT00948922 - Active, not recruiting - -
NCT02485613 - Completed - -
NCT00346645 STAGE IIIB OR IV NON-SMALL CEL... More >>L LUNG CANCER Less << Phase 2 Terminated(stopped after plann... More >>ed interim analysis for lack of efficacy) Less << - France ... More >> Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT01078454 - Completed - -
NCT00124579 Multiple Myeloma Phase 2 Terminated(poor accrual) - -
NCT01078454 Light Chain Deposition Disease... More >> Primary Systemic Amyloidosis Less << Phase 3 Completed - -
NCT00458822 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00458822 - Completed - -
NCT00948922 Multiple Myeloma Phase 2 Active, not recruiting December 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 Less <<
NCT01300793 Non-Hodgkin's Lymphoma ... More >> B-cell Lymphoma Less << Phase 1 Terminated(closed for low accr... More >>ual and no data is available.) Less << - United States, California ... More >> Unviersity of California Medical Center San Francisco, California, United States, 94143 Less <<
NCT00509379 Lymphoma Non-... More >>Hodgkin Lymphoma Less << Phase 2 Completed - Italy ... More >> Ospedale Cardinale Panico Tricase, Lecce, Italy Istituto Clinico Humanitas Rozzano, Milano, Italy Istituto per la ricerca e la cura del cancro Candiolo, Torino, Italy Ospedale Civico Chivasso, Torino, Italy Stabilimento Ospedaliero Ciriè, Torino, Italy ASO SS Antonio e Biagio e Cesare Arrigo Alessandria, Italy Ospedale Oncologico Bari, Italy Policlinico S.Orsola Malpighi Bologna, Italy Spedali Civili Brescia, Italy Ospedale Armando Businco Cagliari, Italy ASO S. Croce e Carle Cuneo, Italy Az. Ospedaliero Universitaria Careggi Firenze, Italy IRCCS San Raffaele Milano, Italy Ospedale Cà Granda Niguarda Milano, Italy Univ. Studi Federico II Napoli, Italy ASO Maggiore della Carità Ematologia Novara, Italy Policlinico Monteluce Perugia, Italy Ospedale Bianchi-Melacrino-Morelli Reggio Calabria, Italy Università La sapienza Policlinico Umberto I Roma, Italy Spedali Riuniti Siena, Italy ASO San Giovanni Battista SC Ematologia 2 Torino, Italy Policlinico Universitario Udine, Italy Less <<
NCT01805557 Diffuse Large B-cell Lymphoma ... More >>Refractory Diffuse Large B-cell Lymphoma Recurrent Less << Phase 2 Phase 3 Unknown February 2018 Italy ... More >> AOU Careggi Terminated Firenze, FI, Italy, 50134 A.O. Niguarda Recruiting Milano, MI, Italy, 20162 Contact: Chiara Rusconi, MD    +39 02 - 64442668    chiara.rusconi@ospedaleniguarda.it    Principal Investigator: Chiara Rusconi, MD          Osp. San Gerardo Not yet recruiting Monza, MI, Italy, 20052 Contact: Enrico Pogliani, MD    039-2339435    enrico.pogliani@unimib.it; marziaborsetto@yahoo.it    Principal Investigator: Enrico Pogliani, MD          Ospedale Civile Guglielmo da Saliceto Recruiting Piacenza, PC, Italy, 29121 Contact: Daniele Vallisa, MD    +39 0523-303701/719    d.vallisa@auslpc.it    Principal Investigator: Daniele Vallisa, MD          CRO Aviano Recruiting Aviano, Pordenone, Italy, 33081 Contact: Mariagrazia Michieli, M.D.       mmichieli@cro.it    Principal Investigator: Mariagrazia Michieli, M.D.          Osp. Umberto I Recruiting Nocera Inferiore, SA, Italy, 84014 Contact: Alfonso M. D'Arco, MD    +39 081-9213370    medint.nocera@libero.it    Principal Investigator: Alfonso M. D'Arco, MD          Medicina Interna 2 ad indirizzo Ematologico AOU San Luigi Gonzaga Not yet recruiting Orbassano, Torino, Italy, 10043 Contact: Giuseppe Saglio, Prof.    00390119026721    giuseppe.saglio@unito.it    Principal Investigator: Giuseppe Saglio, Prof.          AOU San Giovanni Battista-Ematologia 1 Recruiting Torino, TO, Italy, 10126 Contact: Marco Ladetto, MD    +39 011-6334264    marco.ladetto@unito.it;antonella.fiorillo@yahoo.it    Principal Investigator: Marco Ladetto, MD          Azienda Ospedaliero - Universitaria di Udine Recruiting Udine, UD, Italy, 33100 Contact: Francesco Zaja, MD    +39 0432-559662    zaja.francesco@aoud.sanita.fvg.it;d'odorico.cristina@aoud.sanita.fvg.it    Principal Investigator: Francesco Zaja, MD          Osp. S. Antonio Abate Gallarate Recruiting Gallarate, Varese, Italy Principal Investigator: Fabrizio Ciambelli, MD          Ospedale di Circolo e Fondazione Macchi - Ematologia Not yet recruiting Varese, VA, Italy, 21100 Contact: Francesco Passamonti    +39 0332-393648    francesco.passamonti@ospedale.varese.it    Principal Investigator: Francesco Passamonti, MD          A.O. SS. Antonio e Biagio e C. Arrigo Recruiting Alessandria, Italy, 15121 Contact: Flavia Salvi, MD    +39 0131206294    segreteria@filinf.it    Principal Investigator: Flavia Salvi, MD          Clinica di ematologia AOU Umberto I Ospedali Riuniti Recruiting Ancona, Italy, 60100 Contact: Guido Gini, M.D    00390713580384    g.gini@ospedaliriuniti.marche.it    Principal Investigator: Guido Gini, M.D.          Divisione di Ematologia Spedali Civili Recruiting Brescia, Italy Principal Investigator: Alessandra Tucci, MD          Presidio Ospedaliero A.Perrino - Divisione di Ematologia Terminated Brindisi, Italy Divisione di Ematologia Osp. Businco Recruiting Cagliari, Italy Principal Investigator: Giuseppina Cabras, MD          Ospedale Roberto Binaghi Not yet recruiting Cagliari, Italy Principal Investigator: Giorgio La Nasa, DM          Università Cattolica Campobasso Terminated Campobasso, Italy A.O. Universitaria Ospedali Riuniti di Foggia Not yet recruiting Foggia, Italy Principal Investigator: Silvana Capalbo, MD          Ematologia 1 Ospedale S. Martino Not yet recruiting Genova, Italy, 16132 Principal Investigator: Angelo Michele Carella, PROF          Azienda Universitaria San Martino Not yet recruiting Genova, Italy Principal Investigator: Marco Gobbi, MD          Ospedale Santa Maria Goretti Not yet recruiting Latina, Italy Principal Investigator: Angelo De Blasio, MD          Ospedale Vito Fazzi Not yet recruiting Lecce, Italy Principal Investigator: Nicola Di Renzo, MD          SC Ematologia ‐ Trapianto di midollo osseo Fond. IRCCS Istituto Nazionale Tumori Recruiting Milano, Italy, 20133 Contact: Paolo Corradini, Prof.    00390223902950    paolo.corradini@unimi.it    Principal Investigator: Paolo Corradini, Prof.          Ospedale Maggiore IRCCS-Dipartimento di Ematologia Not yet recruiting Milano, Italy Principal Investigator: Luca Baldini, MD          AORN Cardarelli U.O.Ematologia Not yet recruiting Napoli, Italy Principal Investigator: Vincenzo Mettivier, MD          SCDU Ematologia ‐ Università del Piemonte Orientale Recruiting Novara, Italy, 28100 Contact: Gianluca Gaidano, Prof.    00390321660663       Principal Investigator: Gianluca Gaidano, Prof.          Ematologia e Immunologia Clinica, Dipartimento di Medicina Università di Padova Recruiting Padova, Italy, 35100 Contact: Giampiero Semenzato, Prof.    00390498212298    g.semenzato@unipd.it    Principal Investigator: Giampiero Semenzato, Prof.          Ospedale S. Antonio Not yet recruiting Padova, Italy Principal Investigator: Dario Marino, MD          Oncoematologia Dipartimento oncologico La Maddalena Not yet recruiting Palermo, Italy, 90146 Contact: Maurizio Musso, M.D.    00390916806801    mamusso@libero.it    Principal Investigator: Maurizio Musso, M.D.          U.O. Complessa di Ematologia Ospedale di Parma Recruiting Parma, Italy, 43100 Contact: Franco Aversa, Prof.    00390521903263    franco.aversa@unipr.it    Principal Investigator: Franco Aversa, Prof.          Fond. Maugeri - Centro medico Not yet recruiting Pavia, Italy Principal Investigator: Vittorio Fregoni, MD          Osp. S. Maria delle Croci Recruiting Ravenna, Italy Principal Investigator: Alfonso Zaccaria, MD          AO Bianchi Melacrino Morelli UO Ematologia Recruiting Reggio Calabria, Italy Principal Investigator: Caterina Stelitano, MD          AO Arcispedale S.Maria Nuova Ematologia Recruiting Reggio Emilia, Italy Principal Investigator: Francesco Merli, MD          Osp. degli Infermi Divisione di Oncologia Not yet recruiting Rimini, Italy Principal Investigator: Annalisa Molinari, MD          Ospedale Oncologico regionale CROB Not yet recruiting Rionero in Vulture (PZ), Italy Principal Investigator: Pellegrino Musto, MD          Ematologia Ospedale S.Camillo Forlanini Not yet recruiting Roma, Italy, 00149 Contact: Roberta Battistini, M.D.       rbattistini@scamilloforlanini.rm.it    Principal Investigator: Roberta Battistini, M.D.          A.O. Universitaria S. Andrea Recruiting Roma, Italy Principal Investigator: Maria Cristina, Cox          Osp.Sant'Eugenio Divisione di Ematologia Not yet recruiting Roma, Italy Principal Investigator: Elisabetta Abruzzese, MD          Policlinico Universitario Tor Vergata Not yet recruiting Roma, Italy Principal Investigator: Maria Cantonetti, MD          Universita' La Sapienza Not yet recruiting Roma, Italy Principal Investigator: Maurizio Martelli, MD          Clinica Humanitas Recruiting Rozzano (MI), Italy Sub-Investigator: Balzarotti Monica, MD          Policlinico Le Scotte Clinica Ematologica Not yet recruiting Siena, Italy Principal Investigator: Alberto Fabbri, MD          SC Oncoematologia con autotrapianto AO Santa Maria Recruiting Terni, Italy, 05100 Contact: Anna Marina Liberati, Prof    0744/205971    marinal@unipg.it    Principal Investigator: Anna Marina Liberati, M.D.          Osp. San Giovanni Battista_Molinette Ematologia 2 Recruiting Torino, Italy Principal Investigator: Umberto Vitolo, MD          Divisione di Ematologia Ospedale S. Nicola Not yet recruiting Trani, Italy Principal Investigator: Gaetano De Santis, MD Less <<
NCT01769209 - Completed - -
NCT00288041 Ciliary Body and Choroid Melan... More >>oma, Medium/Large Size Extraocular Extension Melanoma Iris Melanoma Recurrent Intraocular Melanoma Recurrent Melanoma Stage IV Melanoma Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01769209 B-cell Adult Acute Lymphoblast... More >>ic Leukemia (ALL) Ph-positive Adult Acute Lymphoblastic Leukemia (ALL) Recurrent Adult Acute Lymphoblastic Leukemia (ALL) T-cell Adult Acute Lymphoblastic Leukemia (ALL) Less << Phase 2 Completed - United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less <<
NCT01349595 Disorder of Transplanted Kidne... More >>y Less << PHASE2 TERMINATED 2025-03-15 Mayo Clinic, Rochester, Minnes... More >>ota, 55905, United States Less <<
NCT01349595 Disorder of Transplanted Kidne... More >>y Less << PHASE2 TERMINATED 2025-03-15 Mayo Clinic, Rochester, Minnes... More >>ota, 55905, United States Less <<
NCT00335348 Multiple Myeloma Phase 2 Completed - Australia, Victoria ... More >> Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 8006 Less <<
NCT01177683 Multiple Myeloma Phase 1 Phase 2 Terminated(Lack of accrual) - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 IU Health Central Indiana Cancer Centers Indianapolis, Indiana, United States, 46219 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 IU Health Arnett Cancer Center Lafayette, Indiana, United States, 47904 United States, Michigan Metro Health Cancer Care Wyoming, Michigan, United States, 49519 United States, Ohio University Hospitals Seidman Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT02755597 Relapsed/Refractory Multiple M... More >>yeloma Less << Phase 3 Active, not recruiting September 3, 2019 -
NCT00084747 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00084747 - Completed - -
NCT00077467 Blastic Phase Chronic Myelogen... More >>ous Leukemia Childhood Acute Promyelocytic Leukemia (M3) Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Less << Phase 1 Completed - United States, California ... More >> COG Phase I Consortium Arcadia, California, United States, 91006-3776 Less <<
NCT00024011 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00863369 Lymphoma Phase 1 Phase 2 Active, not recruiting July 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 South Pasadena Cancer Center South Pasadena, California, United States, 91030 Less <<
NCT02783625 Lymphoma Rela... More >>psed/Refractory T-cell Lymphomas Less << Phase 1 Recruiting May 2019 United States, California ... More >> Stanford University Medical Center Recruiting Stanford, California, United States, 94305-5408 Contact: Youn Kim, MD    650-498-6000       United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Eric Jacobsen, MD    617-582-9086       United States, Missouri University of Washington School of Medicine in St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Neha Mehta-Shah, MD    314-362-5654       Principal Investigator: Neha Mehta-Shah, MD          Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Neha Mehta-Shah, MD    314-362-5654       Principal Investigator: Neha Mehta-Shah, MD          United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge Recruiting Basking Ridge, New Jersey, United States Contact: Steven Horwitz, MD    212-639-3045       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Steven Horwitz, MD    212-639-3045       United States, New York Memorial Sloan Kettering Cancer Center @ Commack Recruiting Commack, New York, United States, 11725 Contact: Steven Horwitz, MD    212-639-3045       Memoral Sloan Kettering Westchester Recruiting Harrison, New York, United States Contact: Steven Horwitz, MD    212-639-3045       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Steven Horwitz, MD    212-639-3045       Contact: Alison Moskowitz, MD    212-639-4839       Principal Investigator: Steven Horwitz, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Steven Horwitz, MD    212-639-3045 Less <<
NCT00091117 Hepatic Complications ... More >> Malignant Neoplasm Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 United States, Michigan Wayne State University Detroit, Michigan, United States, 48202 Less <<
NCT00726869 Multiple Myeloma Phase 1 Terminated(Enrollment has been... More >> halted) Less << - United States, California ... More >> Site Reference ID/Investigator# 63853 Los Angeles, California, United States, 90033 United States, Illinois Site Reference ID/Investigator# 63855 Chicago, Illinois, United States, 60637 United States, Massachusetts Site Reference ID/Investigator# 63847 Boston, Massachusetts, United States, 02115 United States, Michigan Site Reference ID/Investigator# 63852 Ann Arbor, Michigan, United States, 48109-5936 United States, New Jersey Site Reference ID/Investigator# 63854 Hackensack, New Jersey, United States, 07601 United States, New York Site Reference ID/Investigator# 63850 Buffalo, New York, United States, 14263 United States, Ohio Site Reference ID/Investigator# 63849 Columbus, Ohio, United States, 43210 United States, Washington Site Reference ID/Investigator# 63848 Seattle, Washington, United States, 98109 Less <<
NCT00520767 Primary Systemic Amyloidosis ... More >> Light Chain Deposition Disease Less << Phase 2 Active, not recruiting December 2017 United States, Colorado ... More >> Rocky Mountain Cancer Centers/Rocky Mountain Blood & Marrow Transplant Program Denver, Colorado, United States, 80218 United States, Massachusetts Boston University Cancer Research Center Boston, Massachusetts, United States, 02118 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 Providence Cancer Institute at Providence Hospital - Southfield Campus Southfield, Michigan, United States, 48075 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT03314181 Multiple Myeloma Phase 2 Recruiting March 22, 2023 -
NCT00520767 - Active, not recruiting - -
NCT00547534 - Completed - -
NCT01788020 Waldenstr?m's Macroglobulinemi... More >>a Less << Phase 3 Recruiting September 2023 Germany ... More >> University Hospital Ulm Recruiting Ulm, Germany, 89081 Contact: Christian Buske, MD    +49 731 500 ext 65888    christian.buske@uni-ulm.de    Principal Investigator: Christian Buske, MD Less <<
NCT00311337 Multiple Myeloma Phase 2 Unknown - Austria ... More >> Medizinische Univ.-Klinik Graz Recruiting Graz, Austria, 8036 Contact: Werner Linkesch, MD    ++43(0)316/385-4086    werner.linkesch@kfunigraz.ac    Principal Investigator: Werner Linkesch, MD          Klin. Abt. für Onkologie, AKH Wien Recruiting Vienna, Austria, 1090 Contact: Johannes Drach, MD       heinz.gisslinger@akh-wien.ac.at    Principal Investigator: Johannes Drach, MD          Germany Dept. of Hematology/Oncology, Charité Berlin Recruiting Berlin, Germany, 10098 Contact: Orhan Sezer, MD    030/450-513105    sezer@charite.de    Principal Investigator: Orhan Sezer, MD          Dept. of Internal Medicine A, University Muenster Recruiting Muenster, Germany, 48129 Contact: Martin Kropff, MD       kropff@uni-muenster.de    Sub-Investigator: Martin Kropff, MD          Dept. of Internal Medicine, Ludwig-Maximilian-University Munich Recruiting Munich, Germany, 80336 Contact: Christian Straka, MD    089/5160-2278    cstraka@medinn.med.uni-muenchen.de    Principal Investigator: Christian Straka, MD          Dept. of Internal Medicine III, University of Ulm Recruiting Ulm, Germany, 89081 Contact: Peter Liebisch, MD    0731/500-33809    peter.liebisch@medizin.uni-ulm.de    Principal Investigator: Peter Liebisch, MD          Dept. of Internal Medicine II, University of Wuerzburg Recruiting Wuerzburg, Germany, 97070 Contact: Hermann Einsele, MD    +4993120170011    einsele_h@klinik.uni-wuerzburg.de    Sub-Investigator: Volker Kunzmann, MD          Sub-Investigator: Stefan Knop, MD          Italy Regionalkrankenhaus Bozen Recruiting Bozen, Italy, 39100 Contact: Paolo Coser, MD    0039/471/908807    emat@asbz.it    Principal Investigator: Paolo Coser, MD Less <<
NCT00590603 Multiple Myeloma Phase 1 Terminated(Poor accrual - term... More >>inated during Phase I; Phase II never started.) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00103259 Recurrent Squamous Cell Carcin... More >>oma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IV Verrucous Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00667641 Breast Cancer ... More >> Colorectal Cancer Head and Neck Cancer Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Cancer Prostate Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, New Jersey ... More >> Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 Less <<
NCT00103259 - Completed - -
NCT00547534 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, Nebraska ... More >> Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York Cornell Wiell Medical College New York, New York, United States, 10021 University of Rochester Medical Center (James P. Wilmot Cancer Center) Rochester, New York, United States, 14642 Less <<
NCT01439750 Mantle Cell Lymphoma Phase 1 Active, not recruiting August 2020 United States, Pennsylvania ... More >> Penn State Cancer Institute Hershey, Pennsylvania, United States, 17033 Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00027898 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado Denver, Colorado, United States, 80217-3364 Less <<
NCT03701321 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Phase 2 Not yet recruiting October 31, 2023 -
NCT01386398 Lymphoma Phase 3 Withdrawn(Company withdrew int... More >>erest) Less << - -
NCT01971658 Multiple Myeloma Phase 3 Completed - -
NCT01554852 Multiple Myeloma Phase 3 Active, not recruiting December 2022 United Kingdom ... More >> 112 sites UK wide United Kingdom, United Kingdom Less <<
NCT00098982 Colorectal Cancer Phase 1 Completed - Italy ... More >> Istituto Nazionale per lo Studio e la Cura dei Tumori Naples, Italy, 80131 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Less <<
NCT00715208 - Completed - -
NCT01754389 - Completed - -
NCT00312845 Non-Hodgkin's Lymphoma Phase 3 Completed - -
NCT00715208 Relapsed Follicular Lymphoma Phase 2 Completed - -
NCT02145715 Multiple Myeloma Phase 1 Phase 2 Unknown January 2016 United Kingdom ... More >> Birmingham Heartlands Hospital Birmingham, UK, United Kingdom, B9 5SS Royal Liverpool University Hospital Liverpool, United Kingdom, L7 8XP St Bartholomew's Hospital London, United Kingdom, EC1A 7BE University College London Hospitals NHS Foundation Trust London, United Kingdom, WC1E 6AG Guy's Hospital London, United Kingdom Less <<
NCT01754389 Graft Versus Host Disease Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Insitute Boston, Massachusetts, United States, 02215 Less <<
NCT00312845 - Completed - -
NCT00577668 Multiple Myeloma Phase 2 Withdrawn(Poor accrual) - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00136565 Peripheral T-cell Lymphoma Phase 2 Completed - Belgium ... More >> Groupe d'Etude des Lymphomes de l'Adulte Yvoir, Belgium France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France Less <<
NCT00023881 Leukemia Phase 2 Terminated(Lack of efficacy) - United States, Texas ... More >> MD Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00193232 Prostate Cancer Phase 2 Completed - -
NCT00636792 - Completed - -
NCT00636792 Follicular Lymphoma Phase 2 Completed - United States, District of Col... More >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20057 United States, North Dakota MidDakota Clinic - Cancer Treatment and Research Center Bismarck, North Dakota, United States, 58501 Less <<
NCT01863550 Plasma Cell Myeloma Phase 3 Recruiting - -
NCT01783522 Chemotherapeutic Agent Toxicit... More >>y Multiple Myeloma Peripheral Neuropathy Less << Phase 2 Terminated(Research Cancelled) - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00458705 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00458705 - Completed - -
NCT00216697 Multiple Myeloma Phase 2 Completed - -
NCT00389701 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Unknown - United States, Michigan ... More >> Sparrow Regional Cancer Center Recruiting Lansing, Michigan, United States, 48909-7980 Contact: Gordan Srkalovic, MD, PhD    517-364-2467    gordan.srkalovic@sparrow.org Less <<
NCT00722566 Multiple Myeloma Phase 3 Completed - Belgium ... More >> UZ Brussel Department Medical Oncology Laarbeeklaan 101 Brussel, Belgium, 1090 France Hôtel DIEU, Service D'Hématologie Place Alexis RICORDEAU NANTES Cedex 01, France, 44093 Germany Universitätsklinikum Münster Onkologische Ambulanz West Albert-Schweitzer-Str. 33 Münster, Germany, 48129 Less <<
NCT00561743 Multiple Myeloma Phase 2 Completed - -
NCT00028912 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00598169 Lymphoma Phase 1 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States, 90095-1793 University of California at Davis Center for Aids Research and Education Services Sacramento, California, United States, 95814 United States, Florida University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 United States, Georgia Emory Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Hawaii Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 United States, Illinois Northwestern Cancer Center Chicago, Illinois, United States, 60611 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467-2490 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Pennsylvania Oncology Hematology Associates, Incorporated - Philadelphia Philadelphia, Pennsylvania, United States, 19106 United States, Texas Thomas Street Health Center Houston, Texas, United States, 77009 Baylor College of Medicine Houston, Texas, United States, 77030-2707 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT01314625 - Unknown August 2012 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Naveen Sanath Kumar, MD, MHSA    501-681-1972    nsanathkumar@uams.edu    University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: naveen sanathkumar, MD, MHSA    501-526-6990 ext 8924    nsanathkumar@uams.edu    Sub-Investigator: Naveen sanath kumar, MD, MHSA Less <<
NCT00500422 Solid Tumors Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01359657 Multiple Myeloma Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Kansas University Of Kansas Cancer Center And Medical Pavillion Westwood, Kansas, United States, 66205 United States, Massachusetts Dana Faber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Washington University Of Washington School Of Medicine Seattle, Washington, United States, 98109 Less <<
NCT00722566 - Completed - -
NCT00477412 Mantle Cell Lymphoma Phase 1 Phase 2 Active, not recruiting April 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00514371 Multiple Myeloma Phase 2 Phase 3 Completed - United States, California ... More >> Local Institution Berkeley, California, United States, 94704 Local Institution San Francisco, California, United States, 94143 United States, Georgia Local Institution Augusta, Georgia, United States, 30912 United States, Maryland Local Institution Baltimore, Maryland, United States, 21201 United States, Massachusetts Local Institution Boston, Massachusetts, United States, 02215 United States, Nebraska Local Institution Omaha, Nebraska, United States, 68114 United States, New York Local Institution New York, New York, United States, 10011 Local Institution New York, New York, United States, 10021 United States, North Carolina Local Institution Winston Salem, North Carolina, United States, 27157 United States, Pennsylvania Local Institution Pittsburgh, Pennsylvania, United States, 15224 United States, South Carolina Local Institution Columbia, South Carolina, United States, 29210 Less <<
NCT02195479 Multiple Myeloma Phase 3 Active, not recruiting October 20, 2021 -
NCT00431340 Multiple Myeloma Phase 2 Terminated(Terminated due to d... More >>ose limiting toxicity) Less << - United States, California ... More >> Oncotherapeutics West Hollywood, California, United States, 90069 United States, Maryland Center for cancer and blood disorders Bethesda, Maryland, United States, 20817 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 Less <<
NCT00257114 Multiple Myeloma Phase 4 Completed - United States, Maryland ... More >> Sinai Hospital of Baltimore Baltimore, Maryland, United States, 21215 Less <<
NCT01394354 Multiple Myeloma in Relapse Phase 1 Phase 2 Completed - Germany ... More >> University Medical Center Freiburg Freiburg, Germany, 79106 Less <<
NCT00706953 Multiple Myeloma Phase 2 Withdrawn June 2010 -
NCT00378755 Multiple Myeloma Phase 2 Unknown - Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Less <<
NCT01438177 Multiple Myeloma Phase 2 Terminated(PI left institution... More >>.) Less << - United States, New York ... More >> NYU Cancer Institute New York, New York, United States, 10016 Less <<
NCT02419755 Mixed Lineage Acute Leukemia ... More >> Acute Myeloid Leukemia Acute Lymphoid Leukemia Less << Phase 2 Terminated(Accrual goals were ... More >>no longer feasible based on restrictions imposed by the DSMB.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02419755 - Terminated(Accrual goals were ... More >>no longer feasible based on restrictions imposed by the DSMB.) Less << - -
NCT00381940 Adult Lymphocyte Depletion Hod... More >>gkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Childhood Lymphocyte Depletion Hodgkin Lymphoma Childhood Lymphocyte Predominant Hodgkin Lymphoma Childhood Mixed Cellularity Hodgkin Lymphoma Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma Childhood Nodular Sclerosis Hodgkin Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Adult Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Childhood Hodgkin Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Childhood Hodgkin Lymphoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01438177 - Terminated(PI left institution... More >>.) Less << - -
NCT00425750 Head and Neck Cancer Phase 2 Completed - United States, Kentucky ... More >> Jennie Stuart Medical Center Hopkinsville, Kentucky, United States, 42240-2400 Purchase Cancer Group - Paducah Paducah, Kentucky, United States, 42001 United States, Tennessee Tennessee Plateau Oncology - Crossville Crossville, Tennessee, United States, 38555 West Tennessee Cancer Center at Jackson-Madison County General Hospital Jackson, Tennessee, United States, 38301 Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States, 37901 MBCCOP - Meharry Medical College - Nashville Nashville, Tennessee, United States, 37208-3599 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00425750 - Completed - -
NCT00361088 Multiple Myeloma Phase 1 Phase 2 Terminated(Initial Principal I... More >>nvestigator left Moffitt) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00068289 Lung Cancer Phase 2 Completed - -
NCT00316940 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Completed - United States, California ... More >> Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309-0633 Hematology-Oncology Medical Group of Fresno, Incorporated Fresno, California, United States, 93720 West Hollywood, California, United States, 90069 United States, Maryland Center for Cancer and Blood Disorders at Suburban Hospital Bethesda, Maryland, United States, 20817 Less <<
NCT00381940 - Completed - -
NCT00066352 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States, 62526 CCOP - Evanston Evanston, Illinois, United States, 60201 Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153-5500 Oncology/Hematology Associates of Central Illinois, P.C. Peoria, Illinois, United States, 61615-7828 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62701 United States, Indiana Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States, 46885-5099 CCOP - Northern Indiana CR Consortium South Bend, Indiana, United States, 46601 United States, Michigan Oncology Care Associates, P.L.L.C. Saint Joseph, Michigan, United States, 49085 United States, Wisconsin Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Canada, Ontario Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Ottawa Hospital Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00074009 Gastric Cancer Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, New York Queens Cancer Center of Queens Hospital Jamaica, New York, United States, 11432 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-3236 Less <<
NCT00068484 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06520-8032 Less <<
NCT00129207 Tumors Phase 1 Completed - United States, Pennsylvania ... More >> Medical Center, UPMC Cancer Pavilion Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00027716 Sarcoma Phase 2 Completed - United States, Colorado ... More >> University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States, 80010 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Albert Einstein College of Medicine Bronx, New York, United States, 10461 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 University of Chicago Cancer Research Center New York, New York, United States, 10021 United States, Pennsylvania Abramson Cancer Center at University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00541359 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 City of Hope Medical Group Inc Pasadena, California, United States, 91105 Less <<
NCT02424851 Multiple Myeloma ... More >> Chronic Kidney Disease Less << Phase 2 Recruiting June 2019 United Kingdom ... More >> Basingstoke & North Hampshire Hospital Not yet recruiting Basingstoke, United Kingdom Principal Investigator: Noel Ryman          Kent & Canterbury Hospital Recruiting Canterbury, United Kingdom, CT1 3NG Principal Investigator: Jindrinska Lindsay          St Helier Hospital Recruiting Epsom, United Kingdom Principal Investigator: Simon Stern          Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Nauman Butt          Churchill Hospital Recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Karthik Ramasamy          Queen Alexandra Hospital Recruiting Portsmouth, United Kingdom Contact: Helen Dignum          Principal Investigator: Helen Dignum          Great Western Hospital Suspended Swindon, United Kingdom Less <<
NCT00066508 Lymphoma Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095 Less <<
NCT01534143 - Terminated(Data was not collec... More >>ted, because funding was unavailable to continue study.) Less << - -
NCT01534143 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Terminated(Data was not collec... More >>ted, because funding was unavailable to continue study.) Less << - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00052507 Colorectal Cancer Phase 2 Completed - Canada, Ontario ... More >> Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre Ottawa, Ontario, Canada, K1H 1C4 Princess Margaret Hospital at University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01313897 Multiple Myeloma PHASE2 COMPLETED 2025-10-16 University of Arkansas for Med... More >>ical Sciences, Little Rock, Arkansas, 72205, United States Less <<
NCT00799539 - - - Canada, British Columbia ... More >> Burnaby, British Columbia, Canada Canada, Manitoba Winnipeg, Manitoba, Canada Canada N/a N/a, Canada Less <<
NCT00388089 Lung Cancer U... More >>nspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00884546 Advanced Cancer, Various, NOS Phase 1 Completed - United States, California ... More >> City Of Hope National Medical Center Duarte, California, United States, 91010 Moores Ucsd Cancer Center La Jolla, California, United States, 92093 Local Institution Los Angeles, California, United States, 90048 United States, Maryland The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 United States, Michigan Local Institution Detroit, Michigan, United States, 48201 United States, New Jersey John Theurer Cancer Center Hackensack, New Jersey, United States, 07601 United States, Texas Oncology Consultants, Pa Houston, Texas, United States, 77024 Cancer Therapy And Research Center San Antonio, Texas, United States, 78229 Less <<
NCT01478048 Multiple Myeloma Phase 2 Completed - -
NCT01313897 Multiple Myeloma PHASE2 COMPLETED 2025-10-16 University of Arkansas for Med... More >>ical Sciences, Little Rock, Arkansas, 72205, United States Less <<
NCT02605356 Multiple Myeloma Phase 1 Phase 2 Withdrawn(Study restarted unde... More >>r new study number 18987) Less << July 2021 -
NCT01478048 - Completed - -
NCT00740415 Lymphoma Phase 2 Completed - France ... More >> CHU de Grenoble - Hopital Michallon Grenoble, France, 38043 Less <<
NCT00030875 Lymphoma Phase 2 Completed - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia British Columbia Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Ontario Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Kingston Regional Cancer Centre Kingston, Ontario, Canada, K7L 5P9 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada, H1T 2M4 McGill University Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT00573391 Multiple Myeloma Phase 3 Terminated(low accrual) - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00093756 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 1 Phase 2 Completed - -
NCT00573391 - Terminated(low accrual) - -
NCT00377052 Lymphoma Phase 2 Completed - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 QEII, CCR, Hematology Research Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Canada, Saskatchewan Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT00440726 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 United States, New York New York University Medical Center New York, New York, United States, 10016 Children's Hospital New York-Presbyterian New York, New York, United States, 10032 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00210392 Lymphoma, Mucosa-Associated Ly... More >>mphoid Tissue Less << Phase 2 Terminated(After IELSG25A stud... More >>y amendment, patients subject of the present study were eligible for inclusion in the IELSG25A study) Less << - Switzerland ... More >> Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland, 6500 Less <<
NCT00093756 - Completed - -
NCT00458913 Malignant Mesothelioma Phase 2 Completed - United Kingdom ... More >> Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Less <<
NCT00118183 Adenocarcinoma of the Lung ... More >> Adenosquamous Cell Lung Cancer Large Cell Lung Cancer Malignant Pleural Effusion Recurrent Non-small Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Completed - United States, Florida ... More >> Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States, 33140 Less <<
NCT03136653 Multiple Myeloma in Relapse Phase 1 Phase 2 Recruiting December 2019 Germany ... More >> University of Essen, Haematology Recruiting Essen, Germany University of Heidelberg, Haematology, Oncology Recruiting Heidelberg, Germany University of Würzburg, Haematology, Oncology Recruiting Würzburg, Germany Italy University of Bari Medical School, Oncology Recruiting Bari, Italy Healthcare Institution Arcispedale Santa Maria Nuova Not yet recruiting Reggio Emilia, Italy University of Turin, Oncology Recruiting Turin, Italy Poland Medical University of Gdańsk, Haematology Recruiting Gdańsk, Poland University of Krakow, Haematology Recruiting Kraków, Poland Medical University of Lublin, Haematology Recruiting Lublin, Poland Less <<
NCT00052689 Duct Cell Adenocarcinoma of th... More >>e Pancreas Stage IV Pancreatic Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT01769443 - Terminated(Inability to enroll... More >> within funding period) Less << - -
NCT00731952 Non Small Cell Lung Cancer Phase 1 Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT03053024 - Active, not recruiting January 19, 2019 China ... More >> Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China, 100021 Peking University Cancer Hospital Beijing, China, 100142 The First Hospital of Jilin University Changchun, China, 130021 Xiangya Hospital Central South University Changsha, China, 410008 Nanfang Hospital Guangzhou, China, 510515 Jiangsu Province Hospital Nanjing, China, 210029 Ruijin Hospital, Shanghai Jiao Tong University Shanghai, China, 200025 Huashan Hospital Fudan University Shanghai, China, 200040 Blood Disease Hospital of Chinese Academy of Medical Sciences Tianjin, China, 300020 Less <<
NCT00290680 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, South Carolina ... More >> Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02219178 Multiple Myeloma Phase 2 Active, not recruiting November 2019 Ireland ... More >> University Hospital Waterford Waterford, Co Waterford, Ireland Cork University Hospital Cork, Ireland Beaumont Hospital Dublin, Ireland Mater Misericordiae University Hospital Dublin, Ireland St James's Hospital Dublin, Ireland University Hospital Galway Galway, Ireland University Hospital Limerick Limerick, Ireland Midlands Regional Hospital Tullamore, Ireland Less <<
NCT00504101 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Withdrawn(Temporarily closed t... More >>o accrual pending availablity of drug.) Less << - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT01191060 Myeloma Phase 3 Active, not recruiting September 2020 -
NCT00148018 Hodgkin Disease Phase 2 Terminated - Germany ... More >> University of Cologne Cologne, NRW, Germany, 50924 Less <<
NCT01286272 Ann Arbor Stage III Grade 1 Fo... More >>llicular Lymphoma Ann Arbor Stage III Grade 2 Follicular Lymphoma Ann Arbor Stage III Grade 3 Follicular Lymphoma Ann Arbor Stage IV Grade 1 Follicular Lymphoma Ann Arbor Stage IV Grade 2 Follicular Lymphoma Ann Arbor Stage IV Grade 3 Follicular Lymphoma Grade 3a Follicular Lymphoma Less << Phase 2 Completed - -
NCT01769443 Primary Heart Transplant ... More >> Heart Transplantation Heart Transplant Less << Phase 2 Terminated(Inability to enroll... More >> within funding period) Less << - United States, California ... More >> Cedars Sinai Heart Institute Beverly Hills, California, United States, 90211 University of California at San Francisco San Francisco, California, United States, 94143 United States, Connecticut Yale New Haven Hospital New Haven, Connecticut, United States, 06510 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota Minneapolis Heart Institute Minneapolis, Minnesota, United States, 55407 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania Drexel University College of Medicine Philadelphia, Pennsylvania, United States, 19102 University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas The Methodist Hospital Houston, Texas, United States, 77030 United States, Utah Intermountain Medical Center Murray, Utah, United States, 84157 University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT00007878 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033-0804 Less <<
NCT00082784 Extranodal Marginal Zone Lymph... More >>oma of Mucosa-Associated Lymphoid Tissue Nodal Marginal Zone Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Refractory Plasma Cell Myeloma Splenic Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Less << Phase 1 Completed - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT01522872 Multiple Myeloma Phase 1 Phase 2 Unknown September 2017 United States, California ... More >> Pacific Cancer Care Monterey, California, United States, 93940 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Maine Maine Center for Cancer Medicine Scarborough, Maine, United States, 04074 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Mississippi The West Clinic Southaven, Mississippi, United States, 38671 United States, New York New York Oncology Hematology Albany, New York, United States, 12208 New York Oncology Hematology Hudson, New York, United States, 12534 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Less <<
NCT00513955 Lymphoma Phase 2 Completed - United Kingdom ... More >> Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom, RG24 9NA Good Hope Hospital Birmingham, England, United Kingdom, B75 7RR Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS Blackpool Victoria Hospital Blackpool, England, United Kingdom, FY3 8NR Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Darent Valley Hospital Dartford, England, United Kingdom, DA2 8DA Harrogate District Hospital Harrogate, England, United Kingdom, HG2 7SX Leeds General Infirmary Leeds, England, United Kingdom, LS1 3EX Royal Liverpool University Hospital Liverpool, England, United Kingdom, L7 8XP Guy's Hospital London, England, United Kingdom, SE1 9RT Mid Kent Oncology Centre at Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP James Paget Hospital Norfolk, England, United Kingdom, NR31 6LA Norfolk and Norwich University Hospital Norwich, England, United Kingdom, NR4 7UY Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Whiston Hospital Prescot Merseyside, England, United Kingdom, L35 5DR Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Sunderland Royal Hospital Sunderland, England, United Kingdom, SR4 7TP Musgrove Park Hospital Taunton, England, United Kingdom, TA1 5DA Torbay Hospital Torquay, England, United Kingdom, TQ2 7AA Royal Cornwall Hospital Truro, Cornwall, England, United Kingdom, TR1 3LJ Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Ysbyty Gwynedd Bangor, Wales, United Kingdom, LL57 2PW Prince Philip Hospital Llanelli, Wales, United Kingdom, SA14 8QF Less <<
NCT01332617 Myeloma Phase 2 Withdrawn(Investigators no lon... More >>ger interested in activating study) Less << February 2019 -
NCT00666588 Adult Acute Monoblastic Leukem... More >>ia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myelomonocytic Leukemia (M4) Childhood Acute Basophilic Leukemia Childhood Acute Eosinophilic Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Less << Phase 2 Completed - -
NCT00666588 - Completed - -
NCT00280176 Colorectal Cancer Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT01605032 DS Stage I Plasma Cell Myeloma... More >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Refractory Plasma Cell Myeloma Less << Phase 2 Unknown - United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Albert Einstein College of Medicine Bronx, New York, United States, 10461 NYU Cancer Institute New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00689507 Multiple Myeloma Phase 1 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294-3300 United States, California UCLA Los Angeles, California, United States, 90024 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00849251 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Phase 2 Terminated(One of the study dr... More >>ugs is not available.) Less << - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00644228 DS Stage I Plasma Cell Myeloma... More >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Less << Phase 3 Active, not recruiting - -
NCT00564200 Multiple Myeloma Phase 2 Completed - Spain ... More >> H. Clinic I Provincial Barcelona, Spain H. de la Santa Creu I Sant Pau Barcelona, Spain Instituto Catalán de Oncología Barcelona, Spain H. de Jerez Jerez de la Frontera, Spain H. 12 de Octubre Madrid, Spain H. Univ. Gregorio Marañón Madrid, Spain H. Univ. La Princesa Madrid, Spain H. Univ. Morales Meseguer Murcia, Spain H. Univ. Son Dureta Palma de Mallorca, Spain H. Univ. de Salamanca Salamanca, Spain Less <<
NCT03544281 Multiple Myeloma Phase 2 Recruiting November 28, 2022 United States, Alabama ... More >> GSK Investigational Site Recruiting Birmingham, Alabama, United States, 35294 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT00967369 Hodgkin's Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00512798 Brain and Central Nervous Syst... More >>em Tumors Melanoma Solid Tumor Less << Phase 1 Phase 2 Terminated(This study was term... More >>inated due to lack of efficacy) Less << - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00644228 - Active, not recruiting - -
NCT02513186 Plasma Cell Myeloma Phase 1 Recruiting August 2022 France ... More >> Investigational Site Number 250002 Active, not recruiting Nantes Cedex 01, France, 44093 Investigational Site Number 250003 Completed Pierre Benite, France, 69310 Investigational Site Number 250001 Active, not recruiting Toulouse Cedex 9, France, 31059 Germany Investigational Site Number 276003 Active, not recruiting Berlin, Germany, 12200 Investigational Site Number 276002 Active, not recruiting Leipzig, Germany, 04103 Italy Investigational Site Number 380003 Active, not recruiting Milano, Italy, 20132 Investigational Site Number 380002 Completed Roma, Italy, 00161 Investigational Site Number 380001 Active, not recruiting Torino, Italy, 10126 Spain Investigational Site Number 724003 Recruiting Madrid, Spain, 28041 Investigational Site Number 724001 Recruiting Pamplona, Spain, 31008 Investigational Site Number 724002 Recruiting Salamanca, Spain, 37007 Less <<
NCT00291538 Multiple Myeloma Phase 1 Completed - France ... More >> Lille UH Lille, France, 59000 Nancy UH Nancy, France, 54000 Nantes UH Nantes, France, 44093 Less <<
NCT00107341 Esophageal Cancer Phase 2 Completed - -
NCT00512798 - Terminated(This study was term... More >>inated due to lack of efficacy) Less << - -
NCT00329589 Brain Cancer ... More >>Head and Neck Cancer Cervix Cancer Central Nervous System Neoplasms Less << Phase 1 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00531453 Multiple Myeloma Phase 2 Completed - Austria ... More >> Wilhelminenspital-1 Vienna, Austria, A-1160 Less <<
NCT00849251 - Terminated(One of the study dr... More >>ugs is not available.) Less << - -
NCT00025376 Kidney Cancer Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Louis A. Weiss Memorial Hospital Chicago, Illinois, United States, 60640 Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States, 62526 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 LaGrange Memorial Hospital LaGrange, Illinois, United States, 60525 Loyola University Medical Center Maywood, Illinois, United States, 60153 Oncology/Hematology Associates of Central Illinois, P.C. Peoria, Illinois, United States, 61602 United States, Indiana Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Indiana, United States, 46885-5099 Michiana Hematology/Oncology P.C. South Bend, Indiana, United States, 46617 United States, Michigan Oncology Care Associates, P.L.L.C. Saint Joseph, Michigan, United States, 49085 Less <<
NCT00080405 Multiple Myeloma PHASE1 COMPLETED - -
NCT00531453 - Completed - -
NCT00634179 Lymphoma, B-Cell ... More >> Follicular Lymphoma Less << Phase 1 Phase 2 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00634179 - Completed - -
NCT00064610 Prostatic Neoplasms Phase 1 Phase 2 Completed - United States, California ... More >> Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, New York Columbia-Presbyterian Hospital New York, New York, United States, 10032 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00438841 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Unknown - United States, California ... More >> Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States, 94704 Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Desert Regional Medical Center Comprehensive Cancer Center Palm Springs, California, United States, 92262 Sutter Cancer Center Sacramento, California, United States, 95816 United States, Florida Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus Boca Raton, Florida, United States, 33486 United States, New York St. Vincent's Comprehensive Cancer Center - Manhattan New York, New York, United States, 10011 United States, Oregon Oregon Health and Science University Cancer Institute Portland, Oregon, United States, 97239 United States, Texas Lone Star Oncology - Austin Austin, Texas, United States, 78759 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00200382 Non-small Cell Lung Cancer Phase 2 Terminated(The study did not a... More >>chieve the statistical success to continue.) Less << - United States, Massachusetts ... More >> HealthAlliance Hospitals Fitchburg, Massachusetts, United States, 01420 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New York Albert Einstein Cancer Center Bronx, New York, United States, 10461 Jacobi Medical Center Bronx, New York, United States, 10461 Montefiore Medical Center Bronx, New York, United States, 10467 Less <<
NCT00574080 Multiple Myeloma Phase 3 Terminated(low accrual) - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00054665 B-Cell Lymphoma Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 United States, New York Roswell Parck Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01521533 Multiple Myeloma Phase 2 Completed - Austria ... More >> University Hospital Salzburg, Department of Medicine III, Center of Oncology and Hematology Salzburg, Austria Wilhelminenspital, Department of Medicine I, Center of Oncology and Hematology Vienna, Austria France Hôpital Huriez, Centre Hospitalier Régional Universitaire de Lille Lille, France Hôpital Saint Antoine - Service des maladies du sang et de thérapie cellulaire Paris, France Germany University Hospital Freiburg, Medizinische Universitätsklinik, Innere Medizin I, Haematologie und Onkologie Freiburg, Germany University Hospital Münster, Medizinische Klinik und Poliklinik A Münster, Germany University Hospital Ulm, Zentrum für Innere Medizin, Ulm, Germany Italy University Hospital San Martino, Department of Hematology and Oncology Genova, Italy Niguarda Ca'Granda Hospital, Department of Hematology Milano, Italy Sapienza University of Rome, Department of Hematology Rome, Italy Less <<
NCT00049088 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Terminated(Administratively co... More >>mplete.) Less << - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT00011778 Squamous Cell Carcinoma Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00850499 - Terminated - -
NCT00064636 Advanced Non-Small Cell Lung C... More >>ancer Other Solid Tumors Less << Phase 1 Terminated - -
NCT00574080 - Terminated(low accrual) - -
NCT01249690 Multiple Myeloma Phase 4 Unknown June 2014 China, Shang Hai ... More >> Shanghai Changzheng Hospital Recruiting Shang Hai, Shang Hai, China, 200003 Contact: Hou       houjian_czyy@sina.cn    Principal Investigator: Jian Hou Less <<
NCT00850499 Follicular Lymphoma Phase 2 Terminated - -
NCT01445587 Cancer Phase 2 Withdrawn(Based on the clinica... More >>l activity, not safety data, of the AKT inhibitor, GSK has decided at this time to suspend further development of GSK2110183 as monotherapy.) Less << November 2011 Australia, Victoria ... More >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 Less <<
NCT00051974 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Alabama ... More >> U of Alambama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California Cedars-Sinai Comprehensive Cancer Center Los Angeles, California, United States, 90048 UCLA Medical Center Thoracic Malignancy Los Angeles, California, United States, 90095 United States, Colorado University of Colorado Health Sciences Center Aurora, Colorado, United States, 80010 United States, Connecticut Yale University School Of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Univeristy of Florida Shands Cancer Center Gainesville, Florida, United States, 32610 Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Georgia Winship Cancer Institute Atlanta, Georgia, United States, 30322 Atlanta VAMC Decatur, Georgia, United States, 30033 United States, Massachusetts Mass. General Hospital Hem/Onc. Associates Boston, Massachusetts, United States, 02114 United States, Missouri DBA Kansas City Cancer Centers Kansas City, Missouri, United States, 64154 St. Louis University Health Sciences Center St. Louis, Missouri, United States, 63110 Washington University, Barnard Cancer Center St. Louis, Missouri, United States, 63110 United States, North Carolina Carolinas Hematology-Oncology Associates Charlotte, North Carolina, United States, 28203 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Kimmel Cancer Center at Jefferson Philadelphia, Pennsylvania, United States, 19107 United States, Tennessee Vanderbilt University-Clinical Trials Center Nashville, Tennessee, United States, 37232 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Hunstman Cancer Institute-University of Utah Salt Lake City, Utah, United States, 84112 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00367718 Nasopharyngeal Carcinoma Phase 2 Unknown - China ... More >> Chinese University of Hong Kong Not yet recruiting Hong Kong, China Contact: Brigette Ma, M.D.       Brigette@clo.cuhk.edu.hk    Principal Investigator: Brigette Ma, M.D.          Singapore Johns Hopkin Singapore International Medical Center Singapore, Singapore National University Hospital of Singapore Recruiting Singapore, Singapore Contact: Boon Cher Goh, M.D.       GohBC@nuh.com.sg    Principal Investigator: Boon Cher, M.D. Less <<
NCT03474458 Cardiac AL Amyloidosis Phase 2 Phase 3 Not yet recruiting January 2021 -
NCT02928029 Multiple Myeloma Phase 1 Phase 2 Recruiting January 3, 2022 United States, California ... More >> Pacific Oncology/Hematology Associates Recruiting Encinitas, California, United States, 92024 California Cancer Associates for Research & Excellence, Inc. Not yet recruiting Fresno, California, United States, 93720 United States, New York Columbia University Not yet recruiting New York, New York, United States, 10032-3729 United States, North Carolina Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109-4417 Korea, Republic of National Cancer Center Recruiting Goyang-si, Gyeonggido, Korea, Republic of, 410-769 Chonnam National University Hwasun Hospital Not yet recruiting Hwasun, Jeollanam-do, Korea, Republic of, 519-763 Kyungpook National University Hospital Not yet recruiting Daegu, Korea, Republic of, 41404 Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Asan Medical Center Not yet recruiting Seoul, Korea, Republic of, 05505 Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of, 06351 Seoul St. Mary's Hospital Not yet recruiting Seoul, Korea, Republic of, 06591 Spain Institut Català d'Oncologia Badalona Not yet recruiting Badalona, Barcelona, Spain, 08916 Hospital Universitari Son Espases Recruiting Palma de Mallorca, Illes Baleares, Spain, 07120 Ciutat Sanitària i Universitaria de la Vall d'Hebron Not yet recruiting Barcelona, Spain, 08035 Hospital Universitario de la Princesa Not yet recruiting Madrid, Spain, 28006 Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain, 41013 Hospital Universitario Dr. Peset Not yet recruiting Valencia, Spain, 46017 Less <<
NCT03401372 Amyloidosis; Systemic Not Applicable Recruiting April 20, 2020 China ... More >> Peking Union Medical College Hospital Recruiting Beijing, China, 100730 Contact: Jian Li, MD Less <<
NCT00265928 Lymphoma Phase 2 Terminated(Withdrawn for poor ... More >>accrual) Less << - United States, Virginia ... More >> University of Virginia Cancer Center at UV Health System Charlottesville, Virginia, United States, 22908 Less <<
NCT00337506 Multiple Myeloma Phase 2 Terminated - France ... More >> Jean-Luc HAROUSSEAU Nantes, France, 44093 Less <<
NCT00772668 Lymphoma Foll... More >>icular Lymphoma Marginal Zone Lymphoma Less << Not Applicable Terminated(Funding) - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00772668 - Terminated(Funding) - -
NCT00742404 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Unknown - United States, Arizona ... More >> Arizona Clinical Research Center, Incorporated Tucson, Arizona, United States, 85712 United States, California Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309-0633 San Diego Pacific Oncology and Hematology Associates, Incorporated - Escondido Escondido, California, United States, 92025 Loma Linda University Cancer Institute at Loma Linda University Medical Center Loma Linda, California, United States, 92354 Oncology Care Medical Associates - San Gabriel Los Angeles, California, United States, 90057 Desert Cancer Care Rancho Mirage, California, United States, 92270 Sutter Cancer Center at Roseville Medical Center Roseville, California, United States, 95661 Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara Santa Barbara, California, United States, 93105 James R. Berenson MD, Incorporated West Hollywood, California, United States, 90069 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, New York New York Medical College Valhalla, New York, United States, 10595 United States, South Carolina Charleston Hematology Oncology Associates, PA Charleston, South Carolina, United States, 29403 Less <<
NCT00148317 Multiple Myeloma Phase 2 Completed - United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT00793572 Refractory Plasma Cell Myeloma Phase 2 Active, not recruiting - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00148317 - Completed - -
NCT02541383 Multiple Myeloma Phase 3 Active, not recruiting August 2024 -
NCT00054665 - Completed - -
NCT00793572 - Active, not recruiting - -
NCT00507442 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Colorado ... More >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55904-0001 Less <<
NCT00135187 Multiple Myeloma Not Applicable Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00051987 Colorectal Carcinoma Phase 2 Completed - -
NCT00911859 Multiple Myeloma Phase 2 Completed - -
NCT00083460 Multiple Myeloma Phase 1 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00413959 Lymphoma, Non-Hodgkin ... More >> Lymphoma, B-Cell Less << Phase 2 Terminated - United States, Illinois ... More >> Onocology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 Less <<
NCT00610792 Ovarian Cancer Phase 2 Withdrawn(Study never submitte... More >>d to IND. Study is being sponsored by Johnson and Johnson in the EU only.) Less << - Italy ... More >> Division of Gynecologic Oncology, Università Catholica Sacre Cuore Campbasso, Italy Istituto Europeo di Oncologia (IEO) Milan, Italy Istituto Nazionale dei Tumori Milan, Italy Dept. Procreational Medicine, Università di Pisa Pisa, Italy Switzerland Kantonsspital St. Gallen St. Gallen, CH, Switzerland Gynecologic Oncology Unit Ospedale Sant' Anna, Turin, Switzerland Istituto Oncologico della Svizzera Italiana Bellinzona, Switzerland Less <<
NCT00413959 - Terminated - -
NCT00908232 - Completed - -
NCT00908232 Multiple Myeloma Phase 2 Completed - -
NCT00063713 Mantle Cell Lymphoma Phase 2 Completed - -
NCT02206425 Multiple Myeloma Phase 1 Phase 2 Terminated(Data collection for... More >> endpoints have been reached) Less << - United States, California ... More >> Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 John Muir Health Clinical Research Center Concord, California, United States, 94520 California Cancer Associates for Research & Excellence (cCARE) Encinitas, California, United States, 92024 Robert A. Moss, MD, FACP, Inc Fountain Valley, California, United States, 92708 cCARE Fresno Fresno, California, United States, 93720 Comprehensive Cancer Center at Desert Regional Medical Center Palm Springs, California, United States, 92262 James Berenson, MD, Inc West Hollywood, California, United States, 90069 United States, Florida Cancer Specialists of North Florida Fleming Island, Florida, United States, 32003 United States, Georgia Lewis Hall Singletary Oncology Center Thomasville, Georgia, United States, 31792 United States, Illinois Oncology Specialists, SC Niles, Illinois, United States, 60714 United States, Mississippi Hattiesburg Clinic Hematology/Oncology Hattiesburg, Mississippi, United States, 39401 United States, Washington Vista Oncology Olympia, Washington, United States, 98502 Less <<
NCT03641456 Myeloma Newly... More >> Diagnosed High Risk Less << Phase 2 Not yet recruiting September 30, 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Center GuangZhou, Guangdong, China, 510060 Less <<
NCT01208766 Multiple Myeloma Phase 3 Active, not recruiting April 2021 Netherlands ... More >> Erasmus MC Rotterdam, Netherlands, 3075 EA Less <<
NCT01548573 - Terminated(Met study stopping ... More >>rules) Less << - -
NCT00911859 - Completed - -
NCT01420926 - Active, not recruiting - -
NCT01420926 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Therapy-Related Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting - -
NCT00507442 - Completed - -
NCT01266811 Multiple Myeloma Phase 3 Withdrawn(Study canceled based... More >> on results of different study with similar hypothesis, investigational agent, & patient) Less << December 2014 -
NCT00006362 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Precancerous Condition Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT00873093 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Lymphoblastic Lymphoma T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - -
NCT00103103 Gastric Cancer Phase 2 Terminated - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 City of Hope Medical Group Pasadena, California, United States, 91105 University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT03402295 Multiple Myeloma ... More >> Effects of Chemotherapy Less << Phase 3 Completed - -
NCT02720510 - Terminated(A study was termina... More >>ted due to low enrollment.) Less << - -
NCT00873093 - Completed - -
NCT00048230 Multiple Myeloma Phase 3 Completed - -
NCT00117351 Carcinoma, Non-Small-Cell Lung... More >> Adenocarcinoma, Bronchiolo-Alveolar Less << Phase 2 Terminated(insufficient effica... More >>cy) Less << - United States, Washington ... More >> Swedish Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT01548573 Multiple Myeloma Phase 2 Terminated(Met study stopping ... More >>rules) Less << - United States, Iowa ... More >> University of Iowa Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 Less <<
NCT01415752 Lymphoma Neur... More >>otoxicity Therapy-related Toxicity Less << Phase 2 Recruiting March 2019 -
NCT01599949 Mantle Cell Lymphoma Phase 2 Completed - -
NCT00478075 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT02720510 Multiple Myeloma Phase 2 Terminated(A study was termina... More >>ted due to low enrollment.) Less << - United States, California ... More >> David Geffen School of Medicine at UCLA UCLA Los Angeles, California, United States, 90095 United States, Florida Memorial West Cancer Center Memorial Cancer Institute Pembroke Pines, Florida, United States, 33028 United States, Georgia Northside Hospital Central Research Dept. Atlanta, Georgia, United States, 30342 United States, Nebraska Oncology Hematology West Nebraska Cancer Specialists dbaNebraska Cancer Specialists Omaha, Nebraska, United States, 68124 United States, Texas Brooke Army Medical Center Hematology/Oncology San Antonio, Texas, United States, 78234 Less <<
NCT00568880 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104-4283 Contact: Clinical Trials Office - Abramson Cancer Center of the Univers    800-474-9892 Less <<
NCT00200681 Multiple Myeloma Phase 3 Completed - France ... More >> CHU de Nantes, Service d'Hématologie Nantes, France, 44093 Less <<
NCT01470131 Multiple Myeloma Phase 3 Terminated(Sponsor decision ba... More >>sed on portfolio prioritization) Less << - United States, Illinois ... More >> Medical and Surgical Specialists Galesburg, Illinois, United States, 61401 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28203 Southeastern Medical Oncology Center Goldsboro, North Carolina, United States, 27534 United States, Wisconsin Froedtert & Medical College of Wisconsin-CLCC Milwaukee, Wisconsin, United States, 53226 France CHU Estaing Clermont Ferrand, France Centre Hospitalier Sud Francilien Corbeil-Essonnes, France CH Le Mans Le Mans, France Hôpital Universitaire Dupuytren Limoges, France Hôpital Ambroise Paré Marseille, France Hôpital de l'Hôtel Dieu Nantes, France Hôpital Saint Louis Paris, France Centre Hospitalier Saint Jean Perpignan, France Less <<
NCT03590171 Acute Lymphoblastic Leukemia (... More >>ALL) Less << PHASE2 RECRUITING 2027-12-31 Australian & New Zealand Child... More >>hood Hematology & Oncology Group, Clayton, Victoria, 3168, Australia|St. Anna Kinderkrebsforschung, CCRI, Vienna, 1090, Austria|Hòpital Universitaire des Enfants Reine Fabiola, Bruxelles, 1020, Belgium|University Hospital Motol, Prague, Czechia|Copenhagen University Hospital (Rigshospitalet), Copenhagen, 2100, Denmark|Turku University Central Hospital, Turku, SF-20520, Finland|CHU Nice, Nice, France|Tel Aviv Sourasky Medical Centre, Tel Aviv, 64239, Israel|Ospedale Pediatrico Bambino Gesù, Roma, 00165, Italy|Prinses Máxima Centrum, Lundlaan, Utrecht, Netherlands|Oslo University Hospital, Oslo, 0027, Norway|Dpt. SCT and Hematology/Oncology University Wroclaw, Wroclaw, 50354, Poland|Instituto Português de Oncologia de Lisboa, Lisboa, Portugal|University Hospital Stockholm, Stockholm, 17176, Sweden|Royal Manchester Children's Hospital, Manchester, M13 9WL, United Kingdom Less <<
NCT00256776 Multiple Myeloma Phase 3 Unknown June 2013 -
NCT00063791 Multiple Myeloma NO_LONGER_AVAILABLE - Michael Meshad, Oncology Cente... More >>r, Mobile, Alabama, 36608, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Toledo Clinic, Toledo, Ohio, 43623, United States Less <<
NCT00028639 Breast Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00017199 Gastrointestinal Carcinoid Tum... More >>or Islet Cell Tumor Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Ohio Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210-1240 Less <<
NCT00004002 Lymphoma Smal... More >>l Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT00063726 Multiple Myeloma Phase 3 Completed - -
NCT01371981 Acute Myeloid Leukemia ... More >> Leukemia Cutis Myeloid Neoplasm Myeloid Sarcoma Untreated Adult Acute Myeloid Leukemia Untreated Childhood Myeloid Neoplasm Less << Phase 3 Active, not recruiting - -
NCT00388635 Multiple Myeloma Phase 1 Phase 2 Completed - Spain ... More >> Hospital Central de Asturias Oviedo, Asturias, Spain Hospital Universitario de Canarias Tenerife, Islas Canarias, Spain Hospital Son Llatzer Palma de Mallorca, Mallorca, Spain Clínica Universitaria de Navarra Pamplona, Navarra, Spain Hospital Clínic Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Hospital Germans Trias i Pujol Barcelona, Spain Hospital Virgen Blanca de León Leon, Spain Hospital Clínico San Carlos de Madrid Madrid, Spain Hospital Doce de Octubre Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Universitario de la Princesa Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Clínico Universitario de Salamanca Salamanca, Spain Hospital General de Segovia Segovia, Spain Hospital Clínic Valencia, Spain Hospital La Fe Valencia, Spain Hospital Universitario Dr. Peset Valencia, Spain Hospital Clínico Lozano Blesa Zaragoza, Spain Less <<
NCT00711828 - Active, not recruiting - -
NCT00111319 Multiple Myeloma Phase 3 Completed - United States, Indiana ... More >> Investigative Clinical Research of Indiana, LLC Indianapolis, Indiana, United States, 46254 Less <<
NCT00334932 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Phase 2 Unknown - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Contact: Clinical Trials Office - UCSF Helen Diller Family Comprehensi    877-827-3222       United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Clinical Trials Office - Herbert Irving Comprehensive Cancer C    212-305-8615 Less <<
NCT00017329 Kidney Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00910897 Multiple Myeloma Phase 3 Unknown - -
NCT00711828 Extranodal Marginal Zone Lymph... More >>oma of Mucosa-Associated Lymphoid Tissue Nodal Marginal Zone Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Splenic Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Less << Phase 2 Active, not recruiting December 2018 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00931918 Non-Germinal B-Cell-like (GCB)... More >> Diffuse Large B-cell Lymphoma (DLBCL) Less << Phase 2 Completed - -
NCT01685814 Previously Untreated Symptomat... More >>ic Multiple Myeloma Less << Phase 3 Active, not recruiting May 2020 Germany ... More >> Universitätsklinikum Aachen, Med. Klinik IV, Hämatologie u. Onkologie Aachen, Germany, 52074 Schön Klinik Starnberger See, Hämatologie und Onkologie Berg, Germany, 82335 Campus Virchow-Klinikum Charite´, Charite´- Centrum 14, Med. Klinik Hämatologie u. Onkologie Berlin, Germany, 13353 Klinikum Bremen-Mitte gGmbH, Klinik für Innere Medizin I Bremen, Germany, 28177 Universitätsklinikum Carl Gustav Carus an der TU Dresden, Medizinische Klinik und Poliklinik I Dresden, Germany, 01307 Universitätsklinikum Erlangen, Medizinische Klinik 5 Erlangen, Germany, 91054 Malteser Krankenhaus St. Franziskus-Hospital, medizinische Klinik I Flensburg, Germany, 24939 Klinikum der Johann Woflgang Goethe Universität, Frankfurt am Mai Frankfurt am Main, Germany, 60596 Klinikum Frankfurt (Oder) GmbH Medizinische Klinik I Frankfurt/Oder, Germany, 15236 Universitätsklinikum Freiburg, Abteilung für Innere Medizin I Freiburg, Germany, 79106 Universitätmedizin Greifswald, Klinik und Poliklinik für Innere Medizin C Greifswald, Germany, 174751 St. Marien-Hospital gem. GmbHKna Hamm, Germany, 59071 Universitätsklinikum des Saarlandes Innere Medizin I Homburg/Saar, Germany, 66421 Klinikum der Friedrich-Schiller-Universität Jena, Klinikum für Innrere Medizin II Jena, Germany, 07747 Städtisches Klinikum Karlsruhe Medizinische Klinik III, Abt. Hämatologie u. Onkologie Karlsruhe, Germany, 76133 Universitätsklinikum Schleswig-Holstein Campus Kiel, II. Med. Poliklinik Kiel, Germany, 24105 Universitätsklinikum Schleswig-Holstein, Medizinische Klinik und Poliklinik II im städtischen Krankenhaus Kiel Kiel, Germany, 24116 Stiftungsklinikum Mittelrhein GmbH, Klinik für Innere Medizin Koblenz, Germany, 56068 Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Medizinische Klinik I Lübeck, Germany, 23538 Universitätsmedizin Mannheim medizinische Klinik III Mannheim, Germany, 68167 Klinikum Schwabing München, Germany, 80804 Klinikum der Universität München-Großhadern München, Germany, 81366 III. Med. Klinik und Poliklinik, Klinikum rechts der Isar der TU München München, Germany, 81675 Universitätsklinikum Münster, Medizinische Klinik u. Poliklinik A Münster, Germany, 48149 Klinikum Nürnberg Nord, 5. Medizinische LKinik, Onkologie/Hämatologie Nürnberg, Germany, 90419 Klinikum Oldenburg GmbH, Klinik für Innere Medizin II Oldenburg, Germany, 26133 Klinikum Ernst von Bergmann, Klinik für Hämatologie, Onkologie Potsdam, Germany, 14467 Uniklinikum Regensburg, Abteilung für Hämatologie und internistische Onkologie Regensburg, Germany, 93053 Klinikum Stuttgart, Katharinenhospital Stuttgart, Germany, 70174 Robert-Bosch-Krankenhaus, Abt. Hämatologie, Onkologie u. Palliativmedizin Stuttgart, Germany, 70376 Universitätsklinikum Ulm,Klinik für Innere Medizin III Ulm, Germany, 89081 Schwarzwald-Baar Klinkum Villingen-Schwennigen GmbH Villingen-Schwenningen, Germany, 78048 Dr. Horst Schmidt Kliniken, Klinik Innere Medizin III Wiesbaden, Germany, 65199 Universitätsklinikum Wuerzburg, Medizinische Klinik II Wuerzburg, Germany, 97080 Less <<
NCT01216683 Lymphoma Phase 2 Active, not recruiting April 2023 -
NCT01848132 Diffuse, Large B-Cell, Lymphom... More >>a Less << Phase 2 Completed - Spain ... More >> Hospital Clínico Universitario Lozano Blesa Zaragoza, Aragón, Spain, 50009 Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Institut Català d'Oncologia, Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11407 Hospital Son Llàtzer Palma, Islas Baleares, Spain, 07198 Hospital Universitario Fundación Alcorcón Alcorcón, Madrid, Spain, 28922 Complejo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain, 36036 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital Universitari de Girona Doctor Josep Trueta Girona, Spain, 17007 Hospital Universitario Infanta Leonor Madrid, Spain, 28031 Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Centro Integral Oncológico Clara Campal Madrid, Spain, 28050 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario de Canarias Santa Cruz de Tenerife, Spain, 38320 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Hospital Universitario Doctor Peset Valencia, Spain, 46017 Hospital Universitari i Politècnic La Fe Valencia, Spain, 46026 Less <<
NCT02362165 Multiple Myeloma Phase 3 Unknown May 2018 China, Guangdong ... More >> Sun Yat-sen university cancer center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhongjun Xia, MD    020-87342439    xiazhj@sysucc.org.cn Less <<
NCT00931918 - Completed - -
NCT00609167 - Completed - -
NCT01647165 Multiple Myeloma Phase 2 Withdrawn June 26, 2015 -
NCT00436059 Multiple Myeloma Phase 2 Completed - Denmark ... More >> University Hospital Odense Odense, Denmark, 5000 Vejle Hospital Vejle, Denmark, 7100 Less <<
NCT00609167 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2N9 Less <<
NCT00546780 Multiple Myeloma Phase 3 Completed - -
NCT00343720 Non-Small Cell Lung Cancer Phase 2 Completed - Belgium ... More >> Hopital de Jolimont Haine-Saint-Paul, Belgium, 7100 Less <<
NCT00210327 Lymphoma, Mucosa-Associated Ly... More >>mphoid Tissue Less << Phase 2 Completed - Switzerland ... More >> Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland, 6500 Less <<
NCT00006098 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02773030 Multiple Myeloma Phase 1 Phase 2 Recruiting January 14, 2023 -
NCT00085696 B-Cell Lymphoma ... More >> Follicular Lymphoma Marginal Lymphoma Less << Phase 2 Completed - United States, California ... More >> UCLA School of Medicine Los Angeles, California, United States, 90095 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Emory University Cancer Institute, Winship Cancer Institute Atlanta, Georgia, United States, 30322 Georgia Cancer Specialists Marietta, Georgia, United States, 30060 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 Midwest Cancer Research Group Skokie, Illinois, United States, 60077 United States, Kansas Cancer Center of Kansas Wichita, Kansas, United States, 67214 United States, Missouri Oncology/Henmatology Associates of Kansas City Kansas City, Missouri, United States, 64111 United States, Ohio Mid Ohio Oncology/Hematology Inc. Columbus, Ohio, United States, 43213 United States, South Carolina Charleston Cancer Center Charleston, South Carolina, United States, 29406 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 United States, Virginia FNVHO - US Oncology Fairfax, Virginia, United States, 20031 Less <<
NCT00184015 Renal Cell Cancer Phase 1 Phase 2 Active, not recruiting August 21, 2018 United States, California ... More >> Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00362882 Non-small Cell Lung Cancer ... More >> Recurrent Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT01954784 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Terminated(Funding unavailable... More >>) Less << - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT03210753 - Recruiting July 2020 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Huang Shang-Yi    02-23123456 ext 63575    syhuang55@ntuh.gov.tw Less <<
NCT00317811 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, California ... More >> Hematology-Oncology Medical Group of Fresno, Incorporated Fresno, California, United States, 93720 Hematology Oncology Medical Group of Orange County, Incorporated Orange, California, United States, 92868 Oncotherapeutics West Hollywood, California, United States, 90069 United States, Florida Florida Cancer Specialists - Bonita Springs Bonita Springs, Florida, United States, 34135 Florida Oncology Associates Orange Park, Florida, United States, 32073 United States, Georgia Atlanta Cancer Care - Roswell Roswell, Georgia, United States, 30076 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, New York SUNY Downstate Medical Center Brooklyn, New York, United States, 11203 Less <<
NCT00362882 - Completed - -
NCT00169468 B Cell Lymphoma Phase 2 Completed - France ... More >> Hôpital Saint-Louis Paris, Paris 10, France, 75475 Institut Gustave Roussy Villejuif, Villejuif Cedex, France, 94805 Hôpital Henri Mondor Créteil, France, 94010 Hôpital Lyon Sud Pierre Bénite, France, 69310 Less <<
NCT00361621 Non-Hodgkin's Lymphoma Phase 2 Terminated(Closed due to slow ... More >>accrual) Less << - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00792142 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Neurotoxicity Less << Phase 2 Active, not recruiting April 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT01248923 Multiple Myeloma, Plasma Cell ... More >>Leukemia Less << Phase 1 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, Arizona Arizona Clinical Research Center, Inc. Tucson, Arizona, United States, 85715 United States, California City of Hope Duarte, California, United States, 91010 United States, Georgia Emory University, Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Associates in Oncology/Hematology Rockville, Maryland, United States, 20850 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York NYU Cancer Center New York, New York, United States, 10016 Mount Sinai Medical Center New York, New York, United States, 10029 United States, South Carolina Charleston Hematology Oncology Associates Charleston, South Carolina, United States, 29414 United States, Tennessee The Jones Clinic Germantown, Tennessee, United States, 38138 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37212 United States, Texas Baylor Charles A. Sammons Cancer Center at Dallas Dallas, Texas, United States, 75246 Less <<
NCT00720785 Chronic Myeloid Leukemia (CML)... More >> Pancreatic Ca Colon/ Rectal Ca Multiple Myeloma Carcinoma, Non-Small -Cell Lung Less << Phase 1 Recruiting January 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00464178 Multiple Myeloma PHASE2 TERMINATED 2025-02-09 The Cancer Center at Hackensac... More >>k University Medical Center, Hackensack, New Jersey, 07601, United States Less <<
NCT01916252 Multiple Myeloma Phase 3 Completed - -
NCT00391157 Multiple Myeloma Phase 2 Completed - Spain ... More >> Clínica Universitaria de Navarra Pamplona, Navarra, Spain Hospital Clínic Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Hospital Germans Trias i Pujol Barcelona, Spain Hospital Clínico San Carlos de Madrid Madrid, Spain Hospital Doce de Octubre Madrid, Spain Hospital Universitario de la Princesa Madrid, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital General de Segovia Segovia, Spain Hospital La Fe Valencia, Spain Less <<
NCT00298779 Tumors Non-Ho... More >>dgkins's Lymphoma Less << Phase 1 Completed - United States, Texas ... More >> Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 Less <<
NCT00523848 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00523848 - Completed - -
NCT00441168 Multiple Myeloma Phase 2 Terminated(TRIAL STOPPED due t... More >>o a change in standard of care and the required patient numbers could no longer be achieved) Less << - Croatia ... More >> Zagreb, Croatia Germany Leer, Germany Velbert, Germany Hungary Debrecen, Hungary Lithuania Kaunas, Lithuania Klaipeda, Lithuania Vilnius, Lithuania Poland Bialystok, Poland Gdansk, Poland Poznan, Poland Russian Federation Moscow, Russian Federation Samara, Russian Federation St Petersburg, Russian Federation Turkey Ankara, Turkey Bursa, Turkey Eskisehir, Turkey Less <<
NCT00439556 CD20 Positive ... More >> Hematopoietic and Lymphoid Cell Neoplasm Lymphocytic Neoplasm Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00389805 Lung Cancer U... More >>nspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00389805 - Completed - -
NCT02654990 Multiple Myeloma Phase 2 Recruiting December 15, 2022 -
NCT00441168 - Terminated(TRIAL STOPPED due t... More >>o a change in standard of care and the required patient numbers could no longer be achieved) Less << - -
NCT03412565 Multiple Myeloma Phase 2 Active, not recruiting February 1, 2021 -
NCT00319865 Multiple Myeloma Phase 2 Unknown - Korea, Republic of ... More >> Gachon University Gil Hospital Recruiting Inchon, Korea, Republic of, 405-220 Contact: Jae Hoon Lee, M.D.    82-32-460-2186    jhlee@gilhoospital.com    Contact: Hee Keun Kang, R.N.    82-32-460-3655    happy@gilhospital.com    Principal Investigator: Jae Hoon Lee, M.D.          Sub-Investigator: Eun Mi Nam, M.D. Less <<
NCT00433537 Contiguous Stage II Mantle Cel... More >>l Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Stage I Mantle Cell Lymphoma Stage III Mantle Cell Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00433537 - Completed - -
NCT01408797 Renal Transplantation ... More >> Uremia Less << Phase 1 Phase 2 Unknown March 2013 China, Fujian ... More >> No. 156, Xi er huan Road Recruiting Fuzhou, Fujian, China, 350025 Contact: Tan Jianming, MD,PhD    8613375918000    doctortjm@yahoo.com    Contact: Gao Xia, MD    8615959165311    gaojxia@yahoo.com.cn    Principal Investigator: Tan Jianming, MD,PhD          Principal Investigator: Gao Xia, MD Less <<
NCT01208818 Chronic Renal Failure With Ure... More >>mic Nephropathy Less << Phase 3 Completed - France ... More >> Hôpital Saint Louis Paris, France, 75010 Less <<
NCT02553460 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Recruiting October 2031 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Paul Gaynon, MD    323-361-4110    pgaynon@chla.usc.edu    Principal Investigator: Paul Gaynon, MD          Children's Hospital of Orange County Recruiting Orange, California, United States, 92868 Contact: Ivan Kirov, MD    714-997-3000    ikirov@choc.org    Principal Investigator: Ivan Kirov, MD          Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Norman J. Lacayo, MD          Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5983    dschiff@chsd.org    Principal Investigator: Deborah Schiff, MD          United States, Minnesota Children's Hospital and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55102 Contact: Michael Richards, MD    612-813-5193    Michael.richards@childrensmn.org    Principal Investigator: Michael Richards, MD          United States, North Carolina St. Jude Affiliate-Charlotte Recruiting Charlotte, North Carolina, United States, 28204 Contact: Christine Bolen, MD    704-384-1900    cybolen@novanthealth.org    Principal Investigator: Christine Bolen, MD          United States, Ohio Cincinnati Children's Hospital Recruiting Cincinnati, Ohio, United States, 45229 Contact: Erin Breese, MD, PhD    513-636-2799    erin.breese@cchmc.org    Principal Investigator: Erin Breese, MD, PhD          Rainbow Babies & Children's Hospital Recruiting Cleveland, Ohio, United States, 44106 Contact: Yousif Matloub, MD    216-844-5437    yousif.matloub@uhhospitals.org    Principal Investigator: Yousif Matloub, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Bill Chang, MD    503-494-1080    changb@ohsu.edu    Principal Investigator: Bill Chang, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD    866-278-5833    tanja.gruber@stjude.org    Contact: Referral Office    866-278-5833    referralinfo@stjude.org    Principal Investigator: Tanja A. Gruber, MD, PhD          United States, Virginia Children's Hospital of the King's Daughters (CHKD) Recruiting Norfolk, Virginia, United States, 23507 Contact: Eric Lowe, MD    757-668-7243    eric.lowe@chkd.org    Principal Investigator: Eric Lowe, MD          Canada, Alberta Alberta Children's Hospital Recruiting Calgary, Alberta, Canada, T3A 6A8 Contact: Victor A. Lewis, MD    403-220-6898    victor.lewis@ahs.ca    Principal Investigator: Victor A. Lewis, MD          Stollery Children's Hospital Recruiting Edmonton, Alberta, Canada, T6G 2B7 Contact: Sunil Desai, M.B.Ch.B., FRCP(c)    780-248-5415    sunil.desai@ahs.ca    Principal Investigator: Sunil Desai, M.B.Ch.B., FRCP(c)          Canada, British Columbia Children's & Women's Health Centre of British Columbia Recruiting Vancouver, British Columbia, Canada, V6H 3V4 Contact: Kirk R. Schultz, MD    604-875-2345 ext 6477    kschultz@mail.ubc.ca    Principal Investigator: Kirk R. Schultz, MD          Canada, Ontario McMaster Children's Hospital at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L85 4J9 Contact: Uma Athale, MD    905-521-2100 ext 73376    athaleu@mcmaster.ca    Principal Investigator: Uma Athale, MD          Canada, Quebec The Montreal Children's Hospital (MUHC-McGill) Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Catherine Vezina, MD    514-412-4445    catherine.vezina@muhc.mcgill.ca    Principal Investigator: Catherine Vezina, MD          Centre Hospitalier Universitaire Sainte-Justine Recruiting Montreal, Quebec, Canada, HcT 1C5 Contact: Henrique Bittencourt, MD    514-345-4931    henrique.bittencourt.hsj@ssss.gouv.qc.ca    Contact: Yvan Samson       yvan.samson@umontreal.ca    Principal Investigator: Henrique Bittencourt, MD          Centre Hospitalier Universitaire de Quebec Recruiting Québec, Quebec, Canada, G1V 4G2 Contact: Bruno Michon, MD    418-525-4444    bruno.michon@mail.chuq.qc.ca    Principal Investigator: Bruno Michon, MD Less <<
NCT01868828 Multiple Myeloma Phase 4 Unknown May 2017 China, Beijing ... More >> Peking University People's Hospital, Institute of Hematology, Peking University Recruiting Beijing, Beijing, China, 100044 Contact: Jin Lu, PhD       onco_velcade123@163.com Less <<
NCT02145598 Multiple Myeloma Phase 2 Phase 3 Active, not recruiting December 2018 Germany ... More >> Charité - Campus Benjamin Franklin Medizinische Klinik II Berlin, Germany, 12203 Städtisches Klinikum Brandenburg Brandenburg, Germany, 14770 Klinikum Chemnitz gGmbH Chemnitz, Germany, 09113 Gemeinschaftspraxis Mohm / Prange-Krex Dresden, Germany, 01307 Onkologische Schwerpunktpraxis Dresden, Germany, 01307 Internistische Gemeinschaftspraxis Güstrow, Germany, 18273 Universitätsklinkum Halle Halle, Germany, 06120 Universitätsklinikum Jena, Klinik für Innere Medizin II, Abt. Hämatologie und internistische Onkologie Jena, Germany, 07740 Universitätsklinikum Leipzig, Department für Innere Medizin Leipzig, Germany, 04103 Dr. Aldaoud - Dr. Schwarzer Forschungsgesellschaft mbH Leipzig, Germany, 04289 Gemeinschaftspraxis Uhle, Müller, Kröning, Jentsch-Ullrich Magdeburg, Germany, 39104 Universitätsklinikum Magdeburg AöR Magdeburg, Germany, 39120 Klinikum Magdeburg gGmbH Magdeburg, Germany, 39130 Universitätsmedizin Rostock Rostock, Germany, 18057 Klinikum Südstadt Rostock Rostock, Germany, 18059 Johanniter-Krankenhaus Gethin-Stendal GmbH Stendal, Germany, 39576 Medizinisches Versorgungszentrum GmbH Weiden, Germany, 92637 Universitätsklinikum Würzburg Würzburg, Germany, 97080 Heinrich-Breun-Klinikum gGmbH Zwickau, Germany, 08060 Less <<
NCT00087867 Multiple Myeloma Phase 2 Completed - -
NCT03242460 Relapsed and/or refractorY Mul... More >>tiple Myeloma Less << Phase 2 Recruiting December 31, 2019 Korea, Republic of ... More >> Catholic university of korea, Seoul ST. Mary's Hospital. Recruiting Seoul, Korea, Republic of Contact: Chang-Ki Min, MD, PhD.       ckmin@catholic.ac.kr    Contact: Ho-Sup Lee, MD, PhD.       hs3667@hanmail.net    Principal Investigator: Chang-Ki Min, MD, PhD.          Sub-Investigator: Sung-su Yoon, MD, PhD. Less <<
NCT01852799 Multiple Myeloma Phase 2 Completed - China, Shanghai ... More >> Shanghai Changzheng Hospital Shanghai, Shanghai, China Less <<
NCT01702831 Multiple Myeloma Phase 2 Active, not recruiting December 2022 Canada, Alberta ... More >> Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada, T6G-1Z2 Canada, British Columbia Vancouver General Hospital, Centennial Pavilion, 6th Floor Vancouver, British Columbia, Canada, V5Z 1M9 Canada, New Brunswick Saint John Regional Hospital, 5DN Research Department, 400 University Ave Saint John, New Brunswick, Canada, E2L 4L2 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario London Regional Cancer Program 790 Commissioners Road East London, Ontario, Canada, N6A 4L6 The Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hôpital Maisonneuve-Rosemont, 5415, boul. de l'Assomption Montreal, Quebec, Canada, H1T 2M4 Royal Victoria Hospital, MUHC Glen Site, Cedars Cancer Centre Montreal, Quebec, Canada, H4A 3J1 Canada, Saskatchewan Saskatoon Cancer Centre 20 Campus Drive Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT02858999 Multiple Myeloma Phase 2 Completed - France ... More >> CH Pays d'Aix Aix-en-Provence, France, 13616 CHU Amiens Amiens, France, 80054 CHU Besançon Besançon, France, 25030 CHU Caen Caen, France, 14033 CHU Clermont Ferrand Clermont Ferrand, France, 63003 CHU Dijon Dijon, France, 21034 CH Dunkerque Dunkerque, France, 59385 CHRU Lille Lille, France, 59037 Hospices Civils de Lyon Lyon, France, 69229 CHU Nancy Nancy, France, 54035 CHU Nantes Nantes, France, 44093 CHU Nice Nice, France, 06003 AP-HP Paris, France, 75004 CHU Poitiers Poitiers, France, 86021 CHU Rennes Rennes, France, 35033 CHU Strasbourg Strasbourg, France, 67091 CHU Toulouse Toulouse, France, 31059 CHU Tours Tours, France, 37044 Less <<
NCT02626481 Multiple Myeloma Phase 2 Active, not recruiting January 2021 Belgium ... More >> AZ ST Jan hematology department Bruges, Belgium, 8000 Hematologie Laarbeeklaan Brussel, Belgium, 101 - 1090 Jules Bordet Institute Brussel, Belgium, B - 1000 CHU Dinant Godinne | UCL Namur asbl Yvoir, Belgium, 1 - 5530 France CHRU - Hôpital du Bocage (Amiens) Amiens, France, 49033 CHRU-Hôpital Sud d'Amiens Amiens, France, 80054 Hôpital Avicenne Bobigny, France, 93009 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, 33300 Hôpital du Haut Lévêque Centre François Magendie Bordeaux, France, 33604 Clinique - ICH CHU de Brest Hôpital Morvan Brest, France, 29609 CHRU Côte de Nacre Caen, France, 14033 Centre Hospitalier William Morey Chalon-sur-Saône, France, 71100 Hôpital d'instruction des armées Percy Clamart, France, 92141 Hématologie Clinique CHU DIJON Dijon, France, 21000 Centre Hospitalier Général Dunkerque, France, 59 385 CHRU, Hôpital A.Michallon Grenoble, France, 38043 Médecine interne Centre hospitalier départemental La Roche sur Yon, France, 85025 Service d'Hématologie CHV André Mignot Le Chesnay Cedex, France, 78157 CHRU , Hôpital Claude Huriez Lille, France Sce Hématologie Thérapie Cellulaire CHU Limoges Limoges, France, 87000 Institut Paoli Calmette Marseille, France, 13273 Hopital J Monod Sce Rhumato Nord Montivilliers, France, 76290 Service Hématologie CHRU Montpellier Montpellier, France, 34090 Hopital E Muller Mulhouse, France, 68100 Maladies du sang CHRU Hôtel Dieu Nantes, France, 44035 Hôpital Saint-Louis PARIS cedex 10, France, 75475 CHU - Hôpital St Antoine PARIS cedex 12, France, 75571 URC/CIC Paris Descartes Necker-Cochin Paris, France, 75015 Centre Hospitalier Lyon sud Pierre - Bénite, France, 69495 CHU de la milétrie Poitiers, France, 86000 Unité de Recherche Clinique - CH Périgueux Périgueux, France, 24019 Hôpital R.Debré Reims, France, 51032 Hôpital de Pontchaillou Rennes, France, 35033 Service d'Hématologie Clinique Institut de Cancérologie Lucien Neuwirth Saint Priest en Jarez, France, 42270 Service Hématologie Centre Hospitalier Yves le Foll Saint-Brieuc, France, 22000 Département d'Hématologie et Oncologie Hôpitaux Universitaires de Strasbourg Strasbourg, France, 67091 Hématologie CHRU IUCT Oncopole Toulouse cedex 9, France, 31100 Onco-hématologie CHRU Hôpital Bretonneau Tours cedex, France, 37044 Hôpitaux de Brabois Vandœuvre-lès-Nancy, France, 54511 service hématologie CH Bretagne Atlantique Vannes, France, 56017 Curie Institut ¨Paris, France, 75248 Less <<
NCT00504751 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT03742297 Newly Diagnosed Multiple Myelo... More >>ma Less << Phase 3 Recruiting October 22, 2021 -
NCT01852799 - Completed - -
NCT00581776 Mantle Cell Lymphoma Phase 2 Completed - United States, Wisconsin ... More >> University Of Wisconsin Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00581776 - Completed - -
NCT00572169 Multiple Myeloma Phase 3 Active, not recruiting August 2019 United States, Arkansas ... More >> University of Arkansas for Medical Sciences/Myeloma Institute Little Rock, Arkansas, United States, 72205 Less <<
NCT00903734 Advanced Cancers Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01337752 Multiple Myeloma ... More >> Renal Insufficiency Less << Phase 2 Completed - United States, Illinois ... More >> University Chicago Hospital Dept. of Univ of Chicago (2) Chicago, Illinois, United States, 60637 United States, Washington Medical Oncology Associates, PS Spokane, Washington, United States, 99208 Spain Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site Madrid, Spain, 28006 United Kingdom Novartis Investigative Site Bournemouth, United Kingdom, BH7 7DW Novartis Investigative Site Manchester, United Kingdom, M13 9WL Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ Novartis Investigative Site Southampton, United Kingdom, SO16 6YD Less <<
NCT00504751 - Completed - -
NCT03168100 Multiple Myeloma Phase 2 Recruiting July 2028 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Beth Scanlan    501-686-8274    bscanlan@uams.edu    Contact: Matthew Kovak    501-686-8274    mrkovak@uams.edu Less <<
NCT01813227 Waldenstrom P... More >>rior Bortezomib Therapy Acceptable. Less << Phase 2 Unknown April 2016 United States, New Jersey ... More >> John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT02343042 Multiple Myeloma Phase 1 Phase 2 Recruiting April 2019 United States, California ... More >> Jonnsson Comprehensive Cancer Center / University of Los Angeles Recruiting Los Angeles, California, United States, 0095 Contact: Gary Schiller, MD, PhD    888-798-0719    GSchiller@mednet.ucla.edu    Principal Investigator: Gary Schiller, MD, PhD          United States, New York Columbia University Recruiting New York, New York, United States, 10032 Contact: Suzanne Lentzsch, MD    212-305-5065    CTOInformation@columbia.edu    Principal Investigator: Suzanne Lentzsch, MD          Wilmot Cancer Center/ University of Rochester Recruiting Rochester, New York, United States Contact: Brea Lipe, MD       Brea_Lipe@URMC.Rochester.edu    Principal Investigator: Brea Lipe, MD          United States, North Carolina University of North Carolina - Chapel Hill Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Sascha Alexander Tuchman, MD, MHS    984-974-0000    sascha_tuchman@med.unc.edu    Principal Investigator: Sascha Alexander Tuchman, MD, MHS          Duke Institute of Cancer/ Duke University Recruiting Durham, North Carolina, United States, 27710 Contact: Cristina Gasparetto, MD    919-668-1017    gaspa001@mc.duke.edu    Principal Investigator: Cristina Gasparetto, MD          United States, Washington Swedish Cancer Institute Recruiting Seattle, Washington, United States, 98109 Contact: William Bensinger, MD    855-922-6237       Principal Investigator: William Bensinger, MD          United States, Wisconsin University of Wisconsin School of Medicine and Public Health Recruiting Madison, Wisconsin, United States, 53792 Contact: Natalie Callander, MD    608-265-8554    nsc@medicine.wisc.edu    Principal Investigator: Natalie Callander, MD          Canada, Alberta Tom Baker Cancer Center/Alberta Health Services Recruiting Calgary, Alberta, Canada, T2N 4Z6 Contact: Nizar Bahlis, MD    +1 (403) 944-1880    nbahlis@ucalgary.ca    Principal Investigator: Nizar Bahlis, MD          Cross Cancer Institute / University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Chris Venner    780-432-8771       Principal Investigator: Chris Venner, MD          Canada, British Columbia Vancouver General Hospital Recruiting Vancouver,, British Columbia, Canada, V5Z 1M9 Contact: Heather Sutherland    604.736.2033       Principal Investigator: Heather Sutherland, MD          Canada, Manitoba Cancer Care Manitoba Active, not recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Newfoundland and Labrador Memorial Hospital of Newfoundland Active, not recruiting St. John's, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Queen Elizabeth II Health Sciences Center Recruiting Halifax, Nova Scotia, Canada, B3H 2Y9 Contact: Darrell White          Principal Investigator: Darrell White, MD          Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Saima Dean    416 946 4501 ext 5241       Principal Investigator: Christine Chen          Canada, Quebec Maisonneuve-Rosemont Hospital Active, not recruiting Montreal, Quebec, Canada, H1T 2M4 Royal Victoria Hospital / McGill University Active, not recruiting Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT03188172 Multiple Myeloma Phase 2 Recruiting December 31, 2021 United Kingdom ... More >> Queen Elizabeth Hospital Recruiting Birmingham, United Kingdom, B15 2TH Contact: Guy Pratt    01214243698    guy.pratt@uhb.nhs.uk    Birmingham Heartlands Hospital Recruiting Birmingham, United Kingdom Contact: Anand Lokare          Blackpool Victoria Hospital Recruiting Blackpool, United Kingdom Contact: Mark Grey          Royal Hampshire County Hospital Recruiting Bournemouth, United Kingdom, BH7 7DW Contact: Noel Ryman          Royal Bournemouth Hospital Recruiting Bournemouth, United Kingdom Contact: Rachel Hall          Bristol Haematology & Oncology Centre Recruiting Bristol, United Kingdom Contact: Jenny Bird          Ninewells Hospital Recruiting Dundee, United Kingdom, DD1 9SY Contact: Gordon Marron          Beatson Oncology Centre Recruiting Glasgow, United Kingdom Contact: Jennifer Travers          Kettering General Hosptial Recruiting Kettering, United Kingdom, NN16 8UZ Contact: Auran Razzak          Leicester Royal Infirmary Recruiting Leicester, United Kingdom, LE1 5WW Contact: Mamta Garg          Kings College Hosptial Recruiting London, United Kingdom Contact: Kirsty Cuthill          Manchester Royal Infirmary Recruiting Manchester, United Kingdom Contact: Alberto Rocci          The Christie Hospital Recruiting Manchester, United Kingdom Contact: Jim Cavet          Norfolk and Norwich University Hospital Recruiting Norwich, United Kingdom Contact: Kristian Bowles          Nottingham University Hosptial Recruiting Nottingham, United Kingdom Contact: Dean Smith          Churchill Hospital Recruiting Oxford, United Kingdom Contact: Karthik Ramasamy          Derriford Hospital Recruiting Plymouth, United Kingdom Contact: Hannah Hunter          Southampton General Hospital Recruiting Southampton, United Kingdom, SO16 6YD Contact: Matthew Jenner    02381204438    matthew.jenner@uhs.nhs.uk    Royal Stoke Hospital Recruiting Stoke-on-Trent, United Kingdom Contact: Kamaraj Karunanithi          Royal Marsden Hospital Recruiting Sutton, United Kingdom, SM2 5PT Contact: Martin Kaiser    02087224265    martin.kaiser@icr.ac.uk    Worcester Royal Hospital Recruiting Worcester, United Kingdom, WR5 1DD Contact: Salim Shafeek Less <<
NCT00782821 Kidney Transplantation Phase 4 Completed - United States, Ohio ... More >> The Christ Hospital Cincinnati, Ohio, United States, 45202 The University Hospital Cincinnati, Ohio, United States, 45219 Less <<
NCT02563340 Kidney Transplantation Phase 1 Phase 2 Unknown November 2017 China, Guangdong ... More >> The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT00908583 - Completed - -
NCT01146834 Multiple Myeloma Phase 3 Active, not recruiting December 2022 United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10065 Less <<
NCT00908583 HLA Sensitization Phase 4 Completed - United States, Ohio ... More >> The Christ Hospital Cincinnati, Ohio, United States, 45267 University of Cincinnati Cincinnati, Ohio, United States, 45267 Less <<
NCT01255514 Multiple Myeloma Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center Goyang, Korea, Republic of Chonnam National University Hwasun Hospital Hwasun, Korea, Republic of Gachon University Gill Hospital Incheon, Korea, Republic of Severance Hospital Seoul, Korea, Republic of, 120-752 ASAN Medical Center Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Seoul St. Mary's Hospital Seoul, Korea, Republic of Less <<
NCT01055301 Multiple Myeloma ... More >> Plasma Cell Myeloma Less << Phase 2 Withdrawn(lack of accrual) - United States, Louisiana ... More >> Tulane Cancer Center Office of Clinical Research Alexandria, Louisiana, United States, 71315-3198 Hematology-Oncology Clinic Baton Rouge, Louisiana, United States, 70809 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 United States, Mississippi University of Mississippi Cancer Clinic Jackson, Mississippi, United States, 39216 United States, Washington Island Hospital Cancer Care Center at Island Hospital Anacortes, Washington, United States, 98221 St. Joseph Cancer Center Bellingham, Washington, United States, 98225 Olympic Hematology and Oncology Bremerton, Washington, United States, 98310 Highline Medical Center Cancer Center Burien, Washington, United States, 98166 Columbia Basin Hematology Kennewick, Washington, United States, 99336 Skagit Valley Hospital Cancer Care Center Mount Vernon, Washington, United States, 98274 Harrison Poulsbo Hematology and Onocology Poulsbo, Washington, United States, 98370 Harborview Medical Center Seattle, Washington, United States, 98104 Minor and James Medical, PLLC Seattle, Washington, United States, 98104 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Group Health Central Hospital Seattle, Washington, United States, 98112 Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle, Washington, United States, 98122-4307 University Cancer Center at University of Washington Medical Center Seattle, Washington, United States, 98195 North Puget Oncology at United General Hospital Sedro-Woolley, Washington, United States, 98284 Cancer Care Northwest - Spokane South Spokane, Washington, United States, 99202 Evergreen Hematology and Oncology, PS Spokane, Washington, United States, 99218 Wenatchee Valley Medical Center Wenatchee, Washington, United States, 98801-2028 Less <<
NCT01697839 - Completed - United States, California ... More >> Beaver Medical Group Highland, California, United States, 92346 James R. Berenson M.D., Inc. West Hollywood, California, United States, 90069 United States, Illinois Illinois Cancer Specialists Hinsdale, Illinois, United States, 60521 Less <<
NCT00782821 - Completed - -
NCT01114048 Multiple Myeloma Phase 2 Unknown - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Recruiting Hwasun-gun, Jeollanam-do, Korea, Republic of, 519-809 Principal Investigator: Je-Jung Lee, M.D. and Ph.D. Less <<
NCT00722137 - Completed - -
NCT01309412 Multiple Myeloma Phase 1 Terminated(Protocol was stoppe... More >>d due to the safety issue in Global) Less << - Japan ... More >> Isehara, Japan Kyoto, Japan Nagoya, Japan Niigata, Japan Tokyo, Japan Less <<
NCT00722137 Mantle Cell Lymphoma Phase 3 Completed - -
NCT01109004 Multiple Myeloma Phase 3 Completed - -
NCT02352558 Hematologic Malignancy Phase 1 Active, not recruiting - United States, Colorado ... More >> Rocky Mountain Cancer Centers Denver, Colorado, United States, 80218 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Tennessee West Clinic Germantown, Tennessee, United States, 38138 United States, Texas Cancer Care Centers of South Texas San Antonio, Texas, United States, 78217 Cancer Care Centers of South Texas - HOAST San Antonio, Texas, United States, 78229 United States, Virginia Virginia Cancer Specialists, P.C. Fairfax, Virginia, United States, 22031 Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Northwest Cancer Specialists, PC Vancouver, Washington, United States, 98684 Less <<
NCT02495922 Multiple Myeloma Phase 3 Active, not recruiting March 2021 -
NCT02204553 - - - -
NCT01109004 - Completed - -
NCT01526694 Multiple Myeloma Phase 2 Completed - Italy ... More >> Division of Hematology and CBMT Bolzano, BZ, Italy, 39100 Presidio Ospedaliero di Camposampiero Camposampiero, Padova, Italy, 35012 Ospedale S. Martino Belluno, Italy, 32100 Ospedale di Castelfranco Veneto Castelfranco Veneto, Italy, 31033 Ospedale Civile di Dolo Dolo, Italy, 30031 AULSS 2 Feltre Feltre, Italy, 32032 Azienda Ospedaliera Universitaria G. Martino Messina, Italy, 98125 Ospedale dell'Angelo di Mestre Mestre, Italy, 30170 A.O di Padova Ematologia e Immunologia Clinica Padova, Italy, 35127 A.O di Padova Ematologia Padova, Italy, 35127 AULLS 18 di Rovigo Rovigo, Italy, 45100 Ospedale di Trento - P.O. S. Chiara Trento, Italy, 38100 Ospedale Ca Foncello Treviso, Italy, 31100 A.O.U Ospedali Riuniti di Trieste Medicina II Trieste, Italy, 34142 A.O.U Ospedali Riuniti di Trieste Trieste, Italy, 34142 A.O.U S. Maria della Misericordia Udine, Italy, 33100 Ospedale Policlinico G.B Rossi (Borgo Roma) Ematologia Verona, Italy, 37134 Ospedale Policlinico G.B Rossi (Borgo Roma) Medicina II Verona, Italy, 37134 AULSS 6 Vicenza Vicenza, Italy, 36100 Less <<
NCT00718601 Multiple Myeloma Phase 1 Completed - United States, Michigan ... More >> Karmanos Cancer Center Detroit, Michigan, United States, 48201 United States, New York St. Vincent's Comprehensive Cancer Center New York City, New York, United States, 10011 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00081939 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00261612 Lymphoma, Mantle-Cell Phase 2 Unknown - Austria ... More >> Medical University Vienna, Dept. of Medicine I, Clinical Division of Oncology Vienna, Austria Less <<
NCT00723658 Lymphoma Phase 2 Withdrawn(lack of accrual) - United States, Connecticut ... More >> Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States, 06105 United States, Indiana St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove, Indiana, United States, 46107 Reid Hospital & Health Care Services Richmond, Indiana, United States, 47374 United States, Kansas Lawrence Memorial Hospital Lawrence, Kansas, United States, 66044 Wesley Medical Center Wichita, Kansas, United States, 67214 United States, Michigan Saint Joseph Mercy Cancer Center Ann Arbor, Michigan, United States, 48106-0995 CCOP - Michigan Cancer Research Consortium Ann Arbor, Michigan, United States, 48106 Oakwood Cancer Center at Oakwood Hospital and Medical Center Dearborn, Michigan, United States, 48123-2500 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Genesys Hurley Cancer Institute Flint, Michigan, United States, 48503 Hurley Medical Center Flint, Michigan, United States, 48503 Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods, Michigan, United States, 48236 Foote Memorial Hospital Jackson, Michigan, United States, 49201 Sparrow Regional Cancer Center Lansing, Michigan, United States, 48912-1811 St. Mary Mercy Hospital Livonia, Michigan, United States, 48154 St. Joseph Mercy Oakland Pontiac, Michigan, United States, 48341-2985 Mercy Regional Cancer Center at Mercy Hospital Port Huron, Michigan, United States, 48060 Seton Cancer Institute at Saint Mary's - Saginaw Saginaw, Michigan, United States, 48601 St. John Macomb Hospital Warren, Michigan, United States, 48093 United States, Ohio Grandview Hospital Dayton, Ohio, United States, 45405 Good Samaritan Hospital Dayton, Ohio, United States, 45406 David L. Rike Cancer Center at Miami Valley Hospital Dayton, Ohio, United States, 45409 CCOP - Dayton Dayton, Ohio, United States, 45420 Blanchard Valley Medical Associates Findlay, Ohio, United States, 45840 Middletown Regional Hospital Franklin, Ohio, United States, 45005-1066 Charles F. Kettering Memorial Hospital Kettering, Ohio, United States, 45429 UVMC Cancer Care Center at Upper Valley Medical Center Troy, Ohio, United States, 45373-1300 Clinton Memorial Hospital Wilmington, Ohio, United States, 45177 Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia, Ohio, United States, 45385 Less <<
NCT00320476 Multiple Myeloma Phase 2 Completed - Korea, Republic of ... More >> Gachon University Gil Hospital Inchon, Korea, Republic of, 405-220 Less <<
NCT01053949 Multiple Myeloma Phase 2 Completed - France ... More >> CHRU-Hôpital Sud, avenue Laennec, Amiens, France, 80054 Hématologie, Hôpital Avicenne Bobigny, France, 93009 Hématologie, CHU, avenue G.Clemenceau Caen, France, 14033 Hématologie Clinique, CHU, Hôpital d'Enfants Dijon, France, 21000 Hématologie, CHRU, Hôpital A.Michallon Grenoble, France, 38043 Service des Maladies du Sang, CHRU Lille, France, 59037 Hôpital Edouard HERRIOT Lyon, France, 69437 Hématologie, Institut Paoli Calmette Marseille, France, 13273 Hématologie, CHRU, Hôpitaux de Brabois Nancy, France, 54511 Maladies du Sang, CHRU, Hôtel Dieu Nantes, France, 44035 Service Immuno-Hématologie, Hôpital Saint-Louis Paris, France, 75475 Maladies du Sang, CHU - Hôpital St Antoine Paris, France, 75571 Service des Maladies du Sang, Hôpital Haut-Levèque Pessac, France, 33604 Service d'Hématologie, Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Hématologie Clinique, Hôpital Robert Debré, CHU Reims Reims, France, 51092 Hôpital PONTCHAILLOU, CHU de RENNES Rennes, France, 35033 Médecine Interne, CHRU, Hôpital Sud Rennes, France, 35056 Hématologie, CHRU, Hôpital Purpan Toulouse, France, 31059 Onco-Hématologie, CHRU- Hôpital Bretonneau Tours, France, 37044 Less <<
NCT03697356 Waldenstr?m's Macroglobulinemi... More >>a Less << Phase 2 Not yet recruiting October 31, 2023 -
NCT00081939 - Completed - -
NCT00443235 Multiple Myeloma Phase 3 Completed - -
NCT01371227 Multiple Myeloma Phase 1 Completed - Japan ... More >> Nagoya, Japan Okayama, Japan Less <<
NCT01016028 - Withdrawn(Study assessment too... More >>l development delayed.) Less << - -
NCT01376401 Multiple Myeloma Phase 2 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain Hospital Clínic Barcelona, Spain Institut català d'Oncología Barcelona, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario de la Princesa Madrid, Spain Hospital Universitario Ramón y Cajal Madrid, Spain MD Anderson Internacional Madrid, Spain Hospital General Morales Messeguer Murcia, Spain Hospital Universitario Virgen de la Victoria Málaga, Spain Hospital Universitario Central de Asturias Oviedo, Spain Hospital Universitario Virgen del Rocío Sevilla, Spain Hospital Universitario La Fe Valencia, Spain Hospital Clinico Universitario Lozano Blesa Zaragoza, Spain Less <<
NCT01556347 Heart Transplantation Phase 2 Terminated(Lack of efficacy) - United States, Washington ... More >> Providence Sacred Heart Medical Center Spokane, Washington, United States, 99204 Less <<
NCT01250808 - - - China ... More >> Institute of Hematology,Peking University Peking, China, 100044 Contact: jin Lu       lujinlj@163.com Less <<
NCT01556347 - Terminated(Lack of efficacy) - -
NCT01602224 Multiple Myeloma Phase 2 Completed - -
NCT01633281 Peripheral Neuropathy Grade 2 ... More >>or Greater Less << Phase 2 Terminated(poor recruitment an... More >>d expiry of funding) Less << - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 169608 Less <<
NCT01143779 Advanced Cancer Phase 1 Active, not recruiting June 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01040871 Diffuse Large B-Cell Lymphoma Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis Gent - UZ GENT, Hematologie, 9K12IE 9de verdiep- polikliniek Hematologie Gent, Belgium Less <<
NCT02112175 Multiple Myeloma Phase 3 Active, not recruiting October 12, 2020 -
NCT02518750 Acute Lymphoblastic Leukemia ... More >> Lymphoma, Non-Hodgkin's Leukemia, T-Cell Leukemia, B-Cell Less << Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02568943 - - - -
NCT00116961 Multiple Myeloma Phase 2 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT01481194 Multiple Myeloma Phase 2 Active, not recruiting December 2019 Denmark ... More >> Department of Hematology Vejle, Denmark Less <<
NCT01040871 - Completed - -
NCT01602224 - Completed - -
NCT03000634 Multiple Myeloma Phase 2 Withdrawn(Study was not and wi... More >>ll not be initiated due to lack of funding.) Less << May 2023 -
NCT00691704 Multiple Myeloma Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01237249 Multiple Myeloma Phase 2 Completed - -
NCT00691704 - Completed - -
NCT02500251 Renal Transplant Rejection Phase 1 Phase 2 Active, not recruiting August 2018 United States, Ohio ... More >> The Christ Hospital Cincinnati, Ohio, United States, 45219 University of Cincinnati Cincinnati, Ohio, United States, 45267 Less <<
NCT00670631 - Completed - -
NCT01215344 Multiple Myeloma Phase 2 Completed - United States, Tennessee ... More >> University of Tennessee Cancer Institute, Boston Baskin Cancer Group Memphis, Tennessee, United States, 38104 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT01171443 - Unknown August 2011 Israel ... More >> Wolfsson Medical Center Not yet recruiting Holon, Israel Contact: GHOTI HOSSAM    970-35028110    drghoti123@yahoo.com Less <<
NCT00995059 Multiple Myeloma ... More >> Refractory Multiple Myeloma Less << Phase 1 Phase 2 Withdrawn - -
NCT00670631 Multiple Myeloma Phase 2 Completed - -
NCT00871546 Lymphoma, Mantle-Cell ... More >> Leukemia, Lymphocytic, Chronic, B-Cell Less << Phase 2 Terminated - -
NCT01653418 Multiple Myeloma Phase 2 Terminated(Due to the high rat... More >>e of morbidity and mortality) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63122 Less <<
NCT01370434 Multiple Myeloma Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Asanbyeongwon-gil, songpa-gu, Korea, Republic of, 138-736 Less <<
NCT01215344 - Completed - -
NCT01556438 Multiple Myeloma Phase 1 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 467-0001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 811-1395 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 259-1193 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan, 602-0841 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 104-0045 Less <<
NCT03493737 - Not yet recruiting May 2019 -
NCT03759093 Multiple Myeloma Phase 2 Phase 3 Not yet recruiting January 1, 2021 Singapore ... More >> National University Hospital Not yet recruiting Singapore, Singapore, 119228 Contact: Wee Joo Chng, Prof    67795555    mdccwj@nus.edu.sg    Contact: Sanjay de Mel, Dr    67795555    sanjay_widanalage@nuhs.edu.sg    Principal Investigator: Wee Joo Chng, Prof          Sub-Investigator: Edward Chow, Dr          Sub-Investigator: Dean Ho, Prof          Sub-Investigator: Sanjay de Mel, Dr          Sub-Investigator: Melissa Ooi, Dr Less <<
NCT01653418 - Terminated(Due to the high rat... More >>e of morbidity and mortality) Less << - -
NCT00814541 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - Ireland ... More >> Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland, 24 Mater Misericordiae University Hospital Dublin, Ireland, 7 St. James's Hospital Dublin, Ireland, 8 University College Hospital Galway, Ireland Mid-Western Cancer Centre at Mid-Western Regional Hospital Limerick, Ireland, 0009 United Kingdom Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE University College Hospital London, England, United Kingdom, NW1 2BU Belfast City Hospital Trust Incorporating Belvoir Park Hospital Belfast, Northern Ireland, United Kingdom, BT9 7AB Less <<
NCT00283634 NSCLC Phase 2 Terminated(insufficient effica... More >>cy) Less << - United States, Tennessee ... More >> University of Tennesee Knoxville, Tennessee, United States, 37920 Less <<
NCT00461747 Multiple Myeloma Phase 3 Completed - -
NCT02086942 Multiple Myeloma Phase 2 Recruiting August 2017 China, Jiangsu ... More >> Jinling Hospital Recruiting Nanjing, Jiangsu, China, 210002 Contact: zhai yo ping, doctor    13951947646    ypzhai@medmail.com.cn Less <<
NCT00609817 Multiple Myeloma Phase 1 Terminated(Lack of funding) - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Wisconsin Froedtert & Medical College Clinics, Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00505700 Leukemia Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel/ Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01277016 AL Amyloidosis Phase 3 Completed - Italy ... More >> Amyloidosis Research and Treatment Center Pavia, Italy Less <<
NCT00313690 Lung Cancer Phase 1 Phase 2 Withdrawn(Recruitment difficul... More >>ties) Less << - -
NCT02481934 Multiple Myeloma Phase 1 Completed - Spain ... More >> Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Less <<
NCT02481934 - Completed - -
NCT00737529 Mantle Cell Lymphoma Phase 2 Completed - -
NCT01415882 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 2 Recruiting April 1, 2019 United States, Arizona ... More >> Mayo Clinic in Arizona Active, not recruiting Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Vivek Roy          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Shaji K. Kumar Less <<
NCT00737529 - Completed - -
NCT00095680 Multiple Myeloma Phase 2 Completed - -
NCT01484626 Multiple Myeloma Phase 1 Phase 2 Terminated(Celgene would no lo... More >>nger supply lenalidomide for the study) Less << - United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT00851552 - Terminated(Lack of sponsor sup... More >>port) Less << - -
NCT03173092 Multiple Myeloma Phase 4 Recruiting November 30, 2023 -
NCT00851552 Lymphoma Phase 2 Terminated(Lack of sponsor sup... More >>port) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00111748 Multiple Myeloma Phase 3 Completed - United States, Arkansas ... More >> University of Arkansas for Medical sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT01484626 - Terminated(Celgene would no lo... More >>nger supply lenalidomide for the study) Less << - -
NCT00702052 Lymphoma, Mantle- Cell Phase 2 Completed - -
NCT00023855 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT01460420 Hematologic Malignancies ... More >> Multiple Myeloma Less << Phase 1 Phase 2 Completed - Germany ... More >> Medizinische Klinik and Poliklinik II, University Hospital Würzburg,, Germany Italy S Giovanni Battista Hospital Torino, Italy Azienda Ospedaliera Universitaria di Udine Udine, Italy Spain Hospital Clinic i Provincial, Barcelona,, Spain Hospital Santa Creu I Sant Pau, Barcelona,, Spain Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital Gregorio Marañón, Madrid, Spain Hospital Clinico Universitario Salamanca, Salamanca,, Spain Hospital Universitario Virgen del Rocío, Sevilla, Spain Sweden Karolinska University Hospital, Huddinge Stockholm, Sweden Less <<
NCT02971982 Treatment Phase 1 Phase 2 Unknown December 2018 China, Jiangsu ... More >> First Affiliated Hospital, Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Fu chengcheng, Phd    13962191404    evergirl@sina.com Less <<
NCT00106262 Cervical Cancer Phase 2 Terminated(Lack of accrual) - United States, Rhode Island ... More >> Women & Infants' Hospital Providence, Rhode Island, United States, 02905 Less <<
NCT01134484 Multiple Myeloma Phase 3 Unknown December 2015 Italy ... More >> AOU di Bologna Policlinico S.Orsola-Malpighi, UO di Ematologia Bologna, Italy, 40138 Less <<
NCT02951819 Multiple Myeloma Phase 2 Active, not recruiting December 25, 2020 -
NCT01000285 Leukemia-Lymphoma, Adult T-Cel... More >>l Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> University of Miami Hospital/Sylvester Miami, Florida, United States, 33136 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21231 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Columbia University, College of Physicians and Surgeons New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00217503 Lymphoma Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT01000285 - Completed - -
NCT00963820 Multiple Myeloma Phase 1 Completed - United States, Arizona ... More >> Mayo Clinic- Scottsdale Scottsdale, Arizona, United States, 85259 United States, California James R. Berenson, MD, Inc West Hollywood, California, United States, 90069 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Weill-Cornell Medical College New York, New York, United States, 10011 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT01324947 Multiple Myeloma Phase 3 Completed - -
NCT01311687 - Completed - -
NCT01324947 - Completed - -
NCT01311687 Multiple Myeloma Phase 3 Completed - -
NCT00891618 Lymphoma Myel... More >>oma Peripheral Neuropathy Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00889798 - Active, not recruiting December 2019 -
NCT00963820 - Completed - -
NCT00891618 - Completed - -
NCT03056599 Soft Tissue Sarcoma Adult Phase 1 Recruiting December 31, 2019 United States, New York ... More >> Monter Cancer Center (Northwell Health) Recruiting Lake Success, New York, United States, 11042 Contact: Sharon Fox          Principal Investigator: Gary Deutsch, MPH, MD          Sub-Investigator: Robert Maki, MD, PHD          Sub-Investigator: Tony Philip, MD          Sub-Investigator: Mee-young Lee, NP          Sub-Investigator: Shamsah Lakhani, PA          Sub-Investigator: Priscila Goncalves, MD          Sub-Investigator: Eran Ben-Levi, MD          Sub-Investigator: Daniel Ramirez, MD          Sub-Investigator: Brian Burke, MD          Sub-Investigator: Howard Goodman, MD          United States, Oregon OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Sierra Bertolone-Smith          Principal Investigator: Kenneth Gundle, MD          United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Taylor Hain          Principal Investigator: Seth Pollack, MD          University of Washington Recruiting Seattle, Washington, United States, 98195 Contact: Taylor Hain          Sub-Investigator: Darin Davidson, MD          Sub-Investigator: Matthew Thompson, MD Less <<
NCT01553357 Primary Plasma Cell Leukemia Phase 2 Completed - Italy ... More >> IRCCS - CROB Ethic Committee Rionero in Vulture, Pz, Italy, 85028 Less <<
NCT00558896 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01270009 - Unknown November 2013 France ... More >> Service de Médecine interne et cancérologie - Hôpital de l'Archet Recruiting Nice, France, 06002 Contact: Jean-Gabriel Fuzibet, MD    04 92 03 58 24    fuzibet.jg@chu-nice.fr    Contact: Frederic Luciano, PhD    04 93 37 77 58    fluciano@unice.fr    Principal Investigator: Jean-Gabriel Fuzibet, MD Less <<
NCT00932698 Relapsed and Refractory Multip... More >>le Myeloma Less << Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33617 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00734877 Multiple Myeloma Phase 3 Recruiting September 2020 United States, Arkansas ... More >> University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan Petty    501-526-6990 ext 2435    pettynathanm@uams.edu    Sub-Investigator: Frits van Rhee, MD, PhD          Sub-Investigator: Michele Fox, MD          Sub-Investigator: Maurizio Zangari, MD          Sub-Investigator: Atul Kothari, MD          Sub-Investigator: Carolina Schinke, MD          Sub-Investigator: Faith Davies, MD          Sub-Investigator: Gareth Morgan, MD          Sub-Investigator: Juan Crescencio, MD          Sub-Investigator: Mary Burgess, MD          Sub-Investigator: Meera Mohan, MD          Sub-Investigator: Muthukumar Radhakrishnan, MD          Sub-Investigator: Pankaj Mathur, MD          Sub-Investigator: Sharmilan Thanendrajan, MD          Sub-Investigator: Shadiqul Hogue, MD          Sub-Investigator: Sandra Susanibar-Adaniya, MD Less <<
NCT00558896 - Completed - -
NCT01410981 - Completed - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02573935 Multiple Myeloma Phase 2 Terminated(Suspected side effe... More >>cts to the combination of clarithromycin and VCD (bortezomib, cyclophosphamide and dexamethasone)) Less << - Denmark ... More >> Department of Hematology, Aalborg University Hospital Aalborg, Denmark, 9000 Department of Hematology, Aarhus University Hospital Aarhus, Denmark, 8000 Department of Hematology, Rigshospitalet Copenhagen, Denmark, 2100 Department of Hematology, Herlev Hospital Herlev, Denmark, 2730 Department of Hematology, Odense University Hospital Odense, Denmark, 5000 Department of Hematology, Roskilde Hospital Roskilde, Denmark, 4000 Department of Hematology, Vejle Hospital Vejle, Denmark, 7100 Less <<
NCT02322320 Multiple Myeloma Phase 3 Active, not recruiting December 2018 -
NCT02811822 Multiple Myeloma Phase 1 Recruiting March 2021 Denmark ... More >> Vejle Hospital Recruiting Vejle, Denmark Contact: Lea Hahn    +45 7940 6757       Principal Investigator: Torben Plesner, MD, PHD          Germany Medizinische Klinik/Abt. Innere Medizin V Recruiting Heidelberg, Germany Contact: Klara Sarr    +496221/566588       Principal Investigator: Marc-Steffen Raab, MD, PhD          Ireland Cork University Hospital, Wilton Recruiting Cork, Ireland Contact: Debra O'Hare    +021 4920051       Principal Investigator: Mary E Cahill, MD          Beaumont Hospital Recruiting Dublin, Ireland Contact: Tara Kenny    +01 809 2080       Principal Investigator: John Quinn, MB PhD          National University Ireland - Galway Recruiting Galway, Ireland Contact: Jessica Walsh    +0915 44544       Principal Investigator: Michael O'Dwyer, MD          United Kingdom Sheffield Teaching Hospital Recruiting Sheffield, England, United Kingdom Contact: Marie Marshall    0114 2713339       Principal Investigator: Andrew Chantry, MD          Saint James's University Hospital Leeds Recruiting Leeds, United Kingdom, LS9 7TF Contact: Lindsay Taylor    011 3206 7420       Principal Investigator: Christopher Parrish, MD          University College London Hospitals Recruiting London, United Kingdom Contact: Anne Jennings    020 344 72930/12929       Principal Investigator: Rakesh Popat, MD Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02577783 Multiple Myeloma Phase 4 Recruiting December 2019 China, Jiangsu ... More >> the First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215006 Contact: Jia Chen, M.D.    +86 512 67781856    chenjiasuzhou@gmail.com Less <<
NCT00006184 Multiple Myeloma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00617591 Multiple Myeloma Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT03670173 Multiple Myeloma Phase 1 Phase 2 Not yet recruiting September 30, 2020 -
NCT00006184 - Completed - -
NCT03530683 Lymphoma Myel... More >>oma Less << Phase 1 Recruiting April 22, 2021 United States, Colorado ... More >> Colorado Blood Cancer Institute Recruiting Denver, Colorado, United States, 80218 Contact: Stacey Gates       Stacey.gates@healthonecares.com    United States, District of Columbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20057 Contact: Pari Ramzi, RN ,MSN    202-784-0038    ramzip1@georgetown.edu    United States, Michigan Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Silva Pregja    313-576-8673    pregjas@karmanos.org    United States, Ohio Gabrail Cancer Center Research, LLC Recruiting Canton, Ohio, United States, 44718 Contact: Kirstie Armstrong       karmstrong@gabrailcancercenter.com Less <<
NCT00617591 - Completed - -
NCT01264315 Multiple Myeloma Phase 2 Active, not recruiting December 2021 Italy ... More >> A.O.U. San Giovanni Battista Torino, Italy, 10126 Less <<
NCT03422874 Neoplasms Lym... More >>phoma Less << Phase 1 Withdrawn(Sponsor withdrew sup... More >>port) Less << August 4, 2017 United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT03619252 Multiple Myeloma ... More >> Pneumococcal Infection Febrile Neutropenia Pneumococcal Pneumonia Less << Phase 4 Enrolling by invitation November 1, 2019 Belarus ... More >> Minsk Scientific Practical Center of Surgery, Transplantation and Hematology, Belarus Minsk, Belarus, 220045 Less <<
NCT01501370 Multiple Myeloma Phase 2 Withdrawn - Italy ... More >> Clinica di Ematologia, A.O.U. Ospedali Riuniti, Ospedale Umberto I di Ancona Ancona, Italy, 60020 U.O.S. di Ematologia, Ospedale Mazzoni Ascoli Piceno, Italy, 63100 Dh ematologia, A.O.U. Careggi Firenze, Italy, 50139 Ematologia, Ospedale S. Maria della Misericordia Perugia, Italy, 06156 Ematologia e Immunoematologia, Azienda Ospedaliera Riuniti Marche Nord Pesaro, Italy, 61100 Dip. Ematologia-U.O di Ematologia Generale-Azienda USL di Pescara-P.O. dello Spirito Santo Pescara, Italy, 65100 Ematologia , A.O.U. Pisana Pisa, Italy, 56126 Universitaria di Ematologia, A.O.U. San Giovanni Battista di Torino, Torino, Italy, 10126 Less <<
NCT01998971 Multiple Myeloma Phase 1 Active, not recruiting June 12, 2020 United States, California ... More >> Duarte, California, United States United States, Georgia Atlanta, Georgia, United States United States, Illinois Chicago, Illinois, United States United States, Indiana Indianapolis, Indiana, United States United States, Massachusetts Boston, Massachusetts, United States United States, New York New York, New York, United States Rochester, New York, United States United States, North Carolina Charlotte, North Carolina, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas Dallas, Texas, United States France Lille Cedex, France Nantes, France Paris, France Pessac, France Toulouse Cedex 9, France Tours, France Spain Badalona, Spain Barcelona, Spain Madrid, Spain Pamplona, Spain Salamanca, Spain Valencia, Spain Less <<
NCT03515200 Acute Lymphoblastic Leukemia, ... More >>in Relapse Acute Lymphoblastic Leukemia With Failed Remission Less << Phase 1 Recruiting September 2022 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Tanja A. Gruber, MD, PhD Less <<
NCT03440411 Multiple Myeloma Phase 3 Recruiting February 18, 2023 Italy ... More >> FO.NE.SA.Onlus Recruiting Torino, Italy, 10126 Contact: Mario Boccadoro, MD    +390116336107    clinicaltrialoffice@fonesa.it Less <<
NCT03057340 Carcinoma, Non-Small-Cell Lung Phase 1 Not yet recruiting December 1, 2020 -
NCT02088996 Chemotherapy Induced Periphera... More >>l Neuropathy (CIPN) Less << Not Applicable Unknown December 2015 Sweden ... More >> Västmanlands sjukhus, Västerås, Onkologiska kliniken Västerås, Sweden, 72224 Less <<
NCT02265510 Solid Tumors ... More >>Advanced Malignancies Metastatic Cancer Less << Phase 1 Phase 2 Active, not recruiting June 2019 United States, Alabama ... More >> Birmingham, Alabama, United States United States, California West Hollywood, California, United States United States, Connecticut New Haven, Connecticut, United States United States, Georgia Atlanta, Georgia, United States United States, Indiana Indianapolis, Indiana, United States United States, North Carolina Greenville, North Carolina, United States United States, Oregon Portland, Oregon, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Dallas, Texas, United States Less <<
NCT02871284 Exercise Chem... More >>otherapy-induced Polyneuropathy Less << Phase 2 Phase 3 Recruiting December 2019 Germany ... More >> National Center for Tumor Diseases Recruiting Heidelberg, Germany, 69120 Contact: Joachim Wiskemann, Dr.       joachim.wiskemann@nct-heidelberg.de    Contact: Jana Müller       jana.mueller@nct-heidelberg.de Less <<
NCT03104270 Multiple Myeloma Phase 2 Recruiting May 2020 United States, California ... More >> California Cancer Associates for Research & Excellence (cCARE) Recruiting Encinitas, California, United States, 92024 Contact: Daniela Slavin, PhD    760-452-3909    dslavin@ccare.com    Principal Investigator: Alberto Bessudo, MD          Robert A. Moss, MD, FACP, Inc Recruiting Fountain Valley, California, United States, 92708 Contact: Helen Tam    714-641-1128    helen.tam@sbcglobal.net    Principal Investigator: Robert A Moss, MD          Pacific Cancer Care Recruiting Monterey, California, United States, 93940 Contact: Dorothy Tenney    831-375-4105    dtenney@pacificcancercare.com    Principal Investigator: Laura Stampleman, MD          James Berenson, MD, Inc Recruiting West Hollywood, California, United States, 90069 Contact: Regina Swift, RN    310-623-1227    rswift@berensononcology.com    Principal Investigator: James R Berenson, MD          United States, Florida Millennium Oncology Research Clinic Recruiting Pembroke Pines, Florida, United States, 33024 Contact: Maria Contreras, MD    954-266-7885    mcontreras@millenniumoncologyfl.com    Principal Investigator: Isaac Levy, MD Less <<
NCT02092922 Advanced Multiple Myeloma Phase 2 Completed - -
NCT02751255 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting May 1, 2020 Netherlands ... More >> VU University Medical Center Amsterdam, NH, Netherlands, 1081HV Less <<
NCT03616782 Mantle Cell Lymphoma Phase 2 Not yet recruiting December 31, 2022 Korea, Republic of ... More >> Kosin University Gospel Hospital Not yet recruiting Busan, Western, Korea, Republic of, 49267 Contact: Ho Sup Lee, MI    82-51-990-6363    hs3667@hanmail.net Less <<
NCT02525172 Pompe Disease Phase 4 Recruiting July 2020 Taiwan ... More >> Yin-Hsiu Chien Recruiting Taipei, Taiwan, 100 Contact: Yin-Hsiu Chien    +886223123456    chienyh@ntu.edu.tw    Principal Investigator: Yin-Hsiu Chien Less <<
NCT03143036 Relapse and / or Refractory My... More >>eloma Less << Phase 2 Recruiting July 1, 2022 Hong Kong ... More >> Queen Mary Hospital Not yet recruiting Hong Kong, Hong Kong Korea, Republic of Samsung Medical Center Not yet recruiting South Korea, Korea, Republic of Singapore National University Hospital Recruiting Singapore, Singapore Singapore General Hospital Recruiting Singapore, Singapore Taiwan National Taiwan University Not yet recruiting Taipei, Taiwan Less <<
NCT03515915 - Recruiting December 31, 2019 France ... More >> Uhmontpellier Recruiting Montpellier, France, 34295 Contact: JEROME MOREAUX, PhD    467337903 ext 33    j-moreaux@chu-montpellier.fr Less <<
NCT01655823 - Terminated(Interim analysis co... More >>mpleted and decided to terminate and proceed to Phase 3 trial.) Less << - -
NCT01655823 Pain Peripher... More >>al Neuropathy Neuropathic Pain Less << Phase 2 Terminated(Interim analysis co... More >>mpleted and decided to terminate and proceed to Phase 3 trial.) Less << - -
NCT03288974 - Recruiting June 8, 2023 Korea, Republic of ... More >> Korea University Ansan Hospital Recruiting Ansan, Korea, Republic of, 15355 Hallym University Sacred Heart Hospital Recruiting Anyang, Korea, Republic of, 14068 Soonchunhyang University Hospital Recruiting Bucheon, Korea, Republic of, 14584 Inje University Busan Paik Hospital Recruiting Busan, Korea, Republic of, 47932 Inje University Haeundae Paik Hospital Recruiting Busan, Korea, Republic of, 48108 Dong-A University Hospital Recruiting Busan, Korea, Republic of, 49201 Pusan National University Hospital Recruiting Busan, Korea, Republic of, 49241 Kosin University Gospel Hospital Recruiting Busan, Korea, Republic of, 49267 Keimyung University Dongsan Medical Recruiting Daegu, Korea, Republic of, 41931 Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of, 42415 Daegu Catholic University Medical Center Recruiting Daegu, Korea, Republic of, 42472 Chungnam National University Hospital Recruiting DaeJeon, Korea, Republic of, 35015 Chonnam National University Hwasun Hospital Recruiting Hwasun, Korea, Republic of, 58128 Inha University Hospital Recruiting Incheon, Korea, Republic of, 22332 Chonbuk National University Hospital Recruiting Jeonju, Korea, Republic of, 54907 Gyeongsang National University Hospital Recruiting JinJu, Korea, Republic of, 52727 Inje University Sanggye Paik Hospital Recruiting Seoul, Korea, Republic of, 01757 Korea University Anam Hospital Recruiting Seoul, Korea, Republic of, 02841 Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Severance Hospital Recruiting Seoul, Korea, Republic of, 03722 Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 The catholic University of Korea Seoul St. Maty's Recruiting Seoul, Korea, Republic of, 06591 Seoul Metropolitan Government Seoul National University Boramae Medical Center Recruiting Seoul, Korea, Republic of, 07061 Ewha Womans University Medical Recruiting Seoul, Korea, Republic of, 07985 Korea University Guro Hospital Recruiting Seoul, Korea, Republic of, 08308 Ajou Unversity Medical Center Recruiting Suwon, Korea, Republic of, 16499 Ulsan University Hospital Recruiting Ulsan, Korea, Republic of, 44033 Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of, 26426 Pusan National University Yangsan Recruiting Yangsan, Korea, Republic of, 50612 Less <<
NCT01276717 Lymphoma Phase 1 Completed - United States, New York ... More >> University of Rochester Rochester, New York, United States, 14642 United States, Virginia Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT02555839 - Recruiting September 30, 2019 Austria ... More >> LKH Feldkirch, Intern E, Hämatologie Recruiting Feldkirch, Austria, 6800: Medical University Graz Recruiting Graz, Austria, 8036: KH der Elisabethinen Linz , 1. Interne Hämato-Onkologie Recruiting Linz, Austria, 4020: SCRI-CCCIT gemeinnützige GmbH & Universitätsklinikum der PMU Salzburg Gemeinnützige Salzburger Landeskliniken BetriebsgmbH Recruiting Salzburg, Austria, 5020: LKH Steyr, Innere Medizin II Recruiting Steyr, Austria, 4400 AKH, Innere Medizin I, Klin. Abt. f. Hämatologie Recruiting Vienna, Austria, 1090: AKH, Universitätsklinik für Innere Medizin I /Klin. Abteilung für Onkologie Recruiting Vienna, Austria, 1090: St. Josef Krankenhaus Wien,1. Abteilung für Innere Medizin Zentrum für Onkologie Recruiting Vienna, Austria, 1130: Hanusch Krankenhaus Wien 3. Medizinische Abteilung Hämatolog Not yet recruiting Vienna, Austria, 1140: Wilhelminenspital, 1. Med.Abteilung, Zentrum für Onkologie Not yet recruiting Vienna, Austria, 1160: Less <<
NCT00781170 Multiple Myeloma ... More >> Stem Cell Transplantation Less << Phase 2 Completed - -
NCT01790737 Multiple Myeloma Phase 2 Active, not recruiting December 2018 Finland ... More >> Kuopio University Hospital Kuopio, North Savo, Finland, 70200 Tampere University Hospital Tampere, Pirkanmaa, Finland, 33100 Helsinki University Hospital Helsinki, Finland Kanta-Häme Central Hospital Hämeenlinna, Finland Jyväskylä Central Finland Central Hospital Jyväskylä, Finland Kainuu Kajaani Central Hospital Kajaani, Finland Länsi-Pohja Central Hospital Kemi, Finland Kymenlaakso Central Hospital Kotka, Finland Mikkeli Southern-Savo Central Hospital Mikkeli, Finland Oulu University Hospital Oulu, Finland Satakunta Central Hospital Pori, Finland Turku University Central Hospital Turku, Finland Less <<
NCT00445068 Multiple Myeloma Phase 2 Terminated - -
NCT03030261 Multiple Myeloma in Relapse Phase 2 Recruiting February 28, 2026 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ravi Vij, M.D.    314-454-8323    rvij@wustl.edu    Principal Investigator: Ravi Vij, M.D. Less <<
NCT03361306 Multiple Myeloma Phase 2 Recruiting December 31, 2020 United States, North Carolina ... More >> Levine Cancer Institute (Main) Recruiting Charlotte, North Carolina, United States, 28204 Contact: Mallory Tucker Less <<
NCT03607643 Cancer of Pancreas ... More >> Cancer of Liver Cancer of Rectum Cancer of Colon Cancer, Gall Bladder Myeloma Multiple Glioblastoma Multiforme Less << Phase 1 Phase 2 Not yet recruiting December 15, 2020 United States, Florida ... More >> Southwest Cancer Center Not yet recruiting Orlando, Florida, United States, 32806 Contact: Sarah Katta, DO    407-426-8660    sarahfk1978@yahoo.com    Contact: Philip Arlen, PhD    407-443-0656    parlen@leafvertical.com Less <<
NCT02439476 - Recruiting June 2020 France ... More >> Hématologie Clinique, Hôpital Saint Antoine Recruiting Paris, France, 75571 Contact: Mohamad Mohty, MD, PHD    +33 (0)149282624    mohamad.mohty@inserm.fr Less <<
NCT02412228 Multiple Myeloma Phase 2 Recruiting September 2019 United States, Rhode Island ... More >> Memorial Hospital of Rhode Island Withdrawn Pawtucket, Rhode Island, United States, 02860 Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Kayla Rosati    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: John Reagan, MD          The Miriam Hospital Recruiting Providence, Rhode Island, United States, 02906 Contact: Kayla Rosati    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: John Reagan, MD Less <<
NCT03733691 Newly Diagnosed Multiple Myelo... More >>ma Less << Phase 2 Not yet recruiting February 20, 2024 -
NCT02412878 - Active, not recruiting - -
NCT01555281 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting December 2019 Italy ... More >> Istituto Europeo di Oncologia IEO Milano, Italy, 20141 University of Torino Torino, Italy, 10127 Switzerland Kantonsspital Aarau Aarau, Switzerland, 5001 Kantonsspital Baden Baden, Switzerland, 5404 Istituto Oncologico Svizzera Italiana IOSI Bellinzona, Switzerland, 6500 Inselspital Bern Bern, Switzerland, 3010 Kantonsspital Graubünden Chur, Switzerland, 7000 Kantonsspital Olten Olten, Switzerland, 4600 Kantonsspital St. Gallen St. Gallen, Switzerland, 9007 Regionalspital Thun, Switzerland, 3600 UniversitätsSpital Zürich Zürich, Switzerland, 8091 Less <<
NCT00961467 Multiple Myeloma Phase 2 Completed - Italy ... More >> Azienda Ospedaliera S Giovanni Battista Torino, Italy/Torino, Italy, 10126 Less <<
NCT02412878 Multiple Myeloma Phase 3 Active, not recruiting January 4, 2019 -
NCT03140943 Relapsed and/or Refractory Mul... More >>tiple Myeloma Less << Phase 2 Recruiting June 1, 2022 Hong Kong ... More >> Queen Mary Hospital Not yet recruiting Hong Kong, Hong Kong Korea, Republic of Not yet recruiting South Korea, Korea, Republic of Singapore National University Hospital Recruiting Singapore, Singapore Taiwan National Taiwan University Not yet recruiting Taipei, Taiwan Less <<
NCT03143049 Relapse Multiple Myeloma Phase 3 Recruiting June 1, 2022 Hong Kong ... More >> Queen Mary Hospital Not yet recruiting Hong Kong, Hong Kong Japan Not yet recruiting Japan, Japan Korea, Republic of Not yet recruiting South Korea, Korea, Republic of Singapore National University Hospital Recruiting Singapore, Singapore Taiwan National Taiwan University Not yet recruiting Taipei, Taiwan Less <<
NCT02468687 Multiple Myeloma Phase 1 Recruiting February 2019 Australia, Victoria ... More >> Peter MacCallum Cancer Centre Recruiting Melbourne, Victoria, Australia, 3002 Contact: Anetta Matera, Masters    +61 03 9656 3661    anneta.matera@petermac.org Less <<
NCT03477643 - Recruiting December 13, 2019 Spain ... More >> Hospital de Sant Joan de Déu Not yet recruiting Barcelona, Spain Contact: Cristina Motllo, Dr    + 34 932 53 21 00    cristinamotllo@gmail.com    Hospital Donostia-Donostia Ospitalea Not yet recruiting Donostia, Spain Contact: Mailen Sirvent, Dr    + 34 943 00 70 00    MAIALEN.SIRVENTAUZMENDI@osakidetza.eus    Hospital Universitario Virgen de Las Nieves Not yet recruiting Granada, Spain Contact: Rafael Rios, Dr    + 34 958 02 00 00    rriost33@gmail.com    Hospital General San Jorge - Huesca Not yet recruiting Huesca, Spain Contact: Ilda Maria Murillo, Dr    + 34 974 24 70 00    immurillof@gmail.com    Hospital de Jaén Not yet recruiting Jaén, Spain Contact: Soledad Duran, Dr    + 34 902 50 50 61    soledadduran@hotmail.com    Hospital Lucus Augusti Not yet recruiting Lugo, Spain Contact: Esperanza la Villa, Dr    + 34 982 29 60 00    esperanza.lavilla.rubira@sergas.es    Hospital Clínico San Carlos Not yet recruiting Madrid, Spain Contact: Belen Iñigo, Dr    + 34 913 30 30 01    belen.inigo@gmail.com    Hospital Del Tajo Not yet recruiting Madrid, Spain Contact: Ana Lafuente, Dr    + 34 918 01 41 00    apaz.lafuenteguijosa@salud.madrid.org    Hospital General Universitario Gregorio Marañón Not yet recruiting Madrid, Spain Contact: Cristina Encinas, Dr    + 34 915 86 80 00    crisenro@hotmail.com    Hospital Ramón Y Cajal Not yet recruiting Madrid, Spain Contact: Mª Jesus Blanchard, Dr    + 34 913 36 80 00    mjesusblanchard@yahoo.es    Hospital Universitario 12 de Octubre Recruiting Madrid, Spain Contact: Juan José Lahuerta, Dr    + 34 913 90 80 00    jjlahuerta@telefonica.net    Hospital Universitario de La Princesa Not yet recruiting Madrid, Spain Contact: Adrián Alegre, Dr    + 34 915202200    adrian.alegre@telefonica.net    Hospital Universitario Virgen de La Arrixaca Not yet recruiting Murcia, Spain Contact: Valentin Cabañas, Dr    + 34 968 36 95 00    valentin.cabanas@gmail.com    Complejo Hospitalario de Especialidades Virgen de La Victoria Not yet recruiting Málaga, Spain Contact: Ricarda García, Dr    + 34 951 03 20 00    ricarda_g@yahoo.es    Hospital Central de Asturias Not yet recruiting Oviedo, Spain Contact: Ana Pilar Gonzalez, Dr    + 34 985 10 80 00    anapilargonzalez@gmail.com    Hospital Universitari Son Espases Not yet recruiting Palma De Mallorca, Spain Contact: Antonia Sampol, Dr    + 34 871 20 50 00    antonia.sampolm@ssib.es    Complejo Hospitalario de Navarra Not yet recruiting Pamplona, Spain Contact: Jose María Arguiñano Pérez, Dr    948 25 54 00    jm.arguinano.perez@cfnavarra.es    Hospital El Bierzo Not yet recruiting Ponferrada, Spain Contact: Erik de Cabo, Dr    + 34 987 45 52 00    erikbierzo@hotmail.com    Hospital Universitario de Salamanca Not yet recruiting Salamanca, Spain Contact: María Victoria Mateos, Dr    + 34 983 42 00 00    mvmateos@usal.es    Hospital Mutua Terrassa Recruiting Terrassa, Spain Contact: Josep Mª Tutusaus, Dr    + 34 93 736 50 50    jmarti@mutuaterrassa.es    Complejo Hospitalario de Toledo Not yet recruiting Toledo, Spain Contact: Luis Casado Montero, Dr    + 34 925 26 92 00    lfcasadom@telefonica.net    Hospital Universitario Dr. Peset Aleixandre Not yet recruiting Valence, Spain Contact: Paz Ribas    + 34 961622300    ribas_paz@gva.es    Hospital Arnau de Vilanova Not yet recruiting Valencia, Spain Contact: Aurelio Lopez, dr    + 34 973 705 246 ...    aureliolopmar@hotmail.com    Hospital Universitario La Fe Not yet recruiting Valencia, Spain Contact: Mario Arnao, Dr    +34 961 244 350    arnao_mar@gva.es    HOSPITAL CLíNICO UNIVERSITARIO DE VALLADOLID Recruiting Valladolid, Spain Contact: Alfonso García de Coca, Dr    +34 983 42 00 00    agarciadecoca@gmail.com    Hospital Txagorritxu Not yet recruiting Vitoria, Spain Contact: Ernesto Pérez, Dr    + 34 945007000    ernesto.perezpersona@osakidetza.net Less <<
NCT02244125 Multiple Myeloma ... More >> First Relapse Less << Phase 2 Active, not recruiting December 2020 France ... More >> CHRU Hopital Sud Amiens, France, 80054 Centre Hospitalier de la côte Basque Bayonne, France, 64109 Hôpital Avicenne Bobigny, France, 93009 ICH - Hôpital A. Morvan Brest, France, 29609 Institut d'Hématologie de Basse Normandie - IHBN Caen, France, 14033 Chu Estaing Clermont Ferrand, France, 63003 CHU Henri Mondor Creteil, France, 94010 CHRU Dijon Dijon, France, 21000 Centre Hospitalier Général Dunkerque, France, 59385 Chru Grenoble Grenoble, France, 38043 Centre Hospitalier départemental de Vendée La Roche sur Yon, France, 85925 Clinique Victor Hugo Le Mans, France, 72000 CHRU - Hôpital Claude Huriez Lille, France, 59037 CHU de Limoges Limoges, France, 87042 Institut Paoli Calmette Marseille, France, 13273 Hopital Emile Muller Mulhouse, France, 68100 CHU de Nantes Nantes, France, 44093 CHU Carémeau Nimes, France, 30029 Institut Curie Paris, France, 750005 CHRU Hopital Saint Antoine Paris, France, 75012 CHRU Hôpital Haut Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Centre Hospitalier Annecy Genevois Pringy, France, 74374 CHRU Hopital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Centre Hospitalier Yves Le Foll Saint Brieuc, France, 22027 Centre René Huguenin Saint Cloud, France, 92210 Institut Universitaire du Cancer Toulouse-Oncopôle (IUCT-O) Toulouse, France, 31059 CHRU Hopital Bretonneau Tours, France, 37044 CHRU Hopitaux de Brabois Vandoeuvre les Nancy, France, 54511 Less <<
NCT03601624 Multiple Myeloma in Relapse ... More >> Multiple Myeloma Progression Refractory Multiple Myeloma Less << Phase 2 Recruiting July 30, 2020 Mexico ... More >> ISSSTE Recruiting Ciudad de Mexico, Mexico, 03229 Contact: MARTHA A ALVARADO, MD    15525600960    normoblasto@gmail.com Less <<
NCT01619358 - Unknown - Singapore ... More >> Nationa University Hospital Recruiting Singapore, Singapore Contact: Wee Joo Chng, PhD    +65 6779 5555    Wee_Joo_Chng@nuhs.edu.sg    Principal Investigator: Wee Joo Chng, PhD Less <<
NCT01236391 Mantle Cell Lymphoma Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Cll Research and Treatment Program New Hyde Park, New York, United States, 11042 New York Presbyterian Hospital/Cornell Medical Center New York, New York, United States, 94305 United States, Ohio The Ohio Sate university Columbus, Ohio, United States, 43210 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia University of Virginia School of Medicine Hospital Charlottesville, Virginia, United States, 22908 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Germany Klinikum der Universitat Munchen - Campus Grosshadern Munchen, Germany, D - 81377 Universitatsklinikum Ulm, Klinik fur Innere Medizin II ULM, Germany, 89081 Poland Oddzail Kliniczny Onkologil Bydgoszcz, Poland, 85-796 Malopolskie Centrum Medyczne Krakow, Poland, 30-510 MTZ Clinical Research Sp. z o.o. Warsaw, Poland, 02-106 United Kingdom Centre for Experimental Cancer Medicine London, United Kingdom, EC1M6BQ Christie Hospital Manchester, United Kingdom, M20 4BX Derriford Hospital Plymouth, United Kingdom, PL6 8DH Southampton General Hospital Southampton, United Kingdom, SO16 6YD Less <<
NCT01236391 - Completed - -
NCT03393273 Multiple Myeloma Phase 2 Not yet recruiting May 2023 -
NCT00747877 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 3 Unknown - -
NCT00466674 Myeloma Phase 2 Completed - France ... More >> Mohamad Sobh Lyon, France, 69437 Less <<
NCT03651128 Multiple Myeloma Phase 3 Not yet recruiting June 9, 2025 United States, Tennessee ... More >> Sarah Cannon Research Institute Center for Blood Not yet recruiting Nashville, Tennessee, United States, 37203: Less <<
NCT01088048 Indolent Non-Hodgkin's Lymphom... More >>a Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Less << Phase 1 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, California UCLA Los Angeles, California, United States, 90024 Stanford Cancer Center Palo Alto, California, United States, 94304-5548 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Weill Medical College of Cornell New York, New York, United States, 10021 United States, Oregon Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States, 97477 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 United States, Washington North Star Lodge Cancer Center Yakima, Washington, United States, 98902 Less <<
NCT03004287 Multiple Myeloma Phase 2 Recruiting January 2021 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan Petty    501-526-6990 ext 2435    pettynathanm@uams.edu Less <<
NCT01283997 Myeloma Phase 2 Active, not recruiting January 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00092222 Lymphoproliferative Disorder ... More >> HHV-8 Malignancy HIV Less << Phase 2 Recruiting October 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT00871013 Myeloma Phase 2 Recruiting December 2020 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan Petty    501-526-6990 ext 2435    pettynathanm@uams.edu    Sub-Investigator: Frits van Rhee, M.D.,Ph.D.          Sub-Investigator: Maurizio Zangari, MD          Sub-Investigator: Atul Kothari, MD          Sub-Investigator: Carolina Schinke, MD          Sub-Investigator: Faith Davies, MD          Sub-Investigator: Gareth Morgan, MD          Sub-Investigator: Juan Crescencio, MD          Sub-Investigator: Mary Burgess, MD          Sub-Investigator: Meera Mohan, MD          Sub-Investigator: Muthukumar Radhakrishnan, MD          Sub-Investigator: Pankaj Mathur, MD          Sub-Investigator: Sharmilan Thanendrajan, MD Less <<
NCT02057380 Advanced Solid Tumors Phase 2 Completed - United States, California ... More >> Site US10004 La Jolla, California, United States, 92093-0987 United States, Florida Site US10006 Tampa, Florida, United States, 33612 United States, Maryland Site US10002 Baltimore, Maryland, United States, 21287 United States, Michigan Site US10008 Ann Arbor, Michigan, United States, 48109 United States, Oklahoma Site US10001 Oklahoma City, Oklahoma, United States, 73104 Brazil Site BR55005 Porto Alegre, Rio Grande Do Sul, Brazil, 90610-000 Czechia Site CZ42001 Ostrava-Poruba, Czechia, 70852 Germany Site DE49002 Berlin, Germany, 10117 Site DE49001 Wuerzburg, Germany, 97080 Poland Site PL48001 Szczecin, Zachodniopomorskie, Poland, 70-891 Singapore Site SG65002 Singapore, Singapore, 308433 Thailand Site TH66003 Khon Kaen, Thailand, 40002 Less <<
NCT01350232 Sickle Cell Anemia ... More >> Sickle Cell-hemoglobin C Disease Sickle Cell-β0-thalassemia Less << Not Applicable Terminated(Poor accrual) - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01350232 - Terminated(Poor accrual) - -
NCT01849783 Extramedullary Plasmacytoma ... More >> Isolated Plasmacytoma of Bone Light Chain Deposition Disease Primary Systemic Amyloidosis Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Active, not recruiting December 2020 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT01502267 End Stage Renal Disease Phase 2 Unknown January 2016 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-799 Less <<
NCT02719613 Multiple Myeloma Phase 2 Recruiting May 29, 2020 United States, Arizona ... More >> Arizona Clinical Research Center, Inc Active, not recruiting Tucson, Arizona, United States, 85715 United States, California Comprehensive Blood And Cancer Center Recruiting Bakersfield, California, United States, 93309 Contact: Alan Cartmell, Site 0017          James R. Berenson, MD, Inc. Recruiting Bakersfield, California, United States, 93309 Contact: James Berenson, Site 0016          Robert A. Moss, Md Facp, Inc. Recruiting Fountain Valley, California, United States, 92708 Contact: Robert Moss, Site 0022          United States, Colorado Rocky Mountain Cancer Centers (Williams) - USOR Recruiting Denver, Colorado, United States, 80218 Contact: Robert Rifkin, Site 0019          United States, Florida Cancer Specialists of North FL Recruiting Jacksonville, Florida, United States, 32256 Contact: Suprith Badarinath, Site 0021          United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Sagar Lonial, Site 0009    404-778-4176       United States, Indiana Investigative Clinical Research Of Indiana, Llc Recruiting Indianapolis, Indiana, United States, 46260 Contact: Robert Manges, Site 0003    317-297-2208       United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Paul Richardson, Site 0002          United States, Missouri Washington University School Of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ravi Vij, Site 0008    314-747-7813       United States, New York Icahn School Of Medicine At Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Sundar Jagannath, Site 0004    212-241-2592       United States, Pennsylvania St. Luke's University Health Network Recruiting Bethlehem, Pennsylvania, United States, 18015 Contact: Yacoub Faroun, Site 0001    484-503-4150       United States, Texas Texas Oncology Recruiting Dallas, Texas, United States, 75231 Contact: Kristi McIntyre, Site 0018          Canada, Ontario Local Institution Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Site 0011          Canada Local Institution Recruiting Halifax, Canada, B3H 2Y9 Contact: Site 0010          Italy Local Institution Recruiting Ancona, Italy, 60126 Contact: Site 0015          Local Institution Recruiting Firenze, Italy, 50134 Contact: Site 0012          Local Institution Recruiting Genova, Italy, 16132 Contact: Site 0013          Local Institution Recruiting Torino, Italy, 10126 Contact: Site 0014 Less <<
NCT00833833 Multiple Myeloma Phase 1 Phase 2 Completed - -
NCT00869232 Multiple Myeloma Phase 2 Active, not recruiting October 2019 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT02461888 Multiple Myeloma Phase 2 Recruiting May 2019 United Kingdom ... More >> Queen Elizabeth Medical Centre Recruiting Birmingham, United Kingdom, B15 2TH Heart of England NHS Foundation Trust Recruiting Birmingham, United Kingdom, B9 5ST Royal Bournemouth General Hospital Recruiting Bournemouth, United Kingdom, BH7 7DW University Hospital Bristol NHS Foundation Trust Recruiting Bristol, United Kingdom, BS1 3NU North Tees and Hartlepool NHS Foundation Trust Recruiting Hartlepool, United Kingdom, TS24 9AH Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom, LS9 7TF Royal Liverpool and Broadgreen University Hospital NHS Trust Recruiting Liverpool, United Kingdom, L7 8XP Barts and the London NHS Trust Recruiting London, United Kingdom, E1 1BB University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom, NW1 2PG Guy's and St Thomas's NHS Foundation Trust Recruiting London, United Kingdom, SE1 9RT Royal Marsden Hospital Recruiting London, United Kingdom, SW3 6JJ Imperial College Healthcare NHS Trust Recruiting London, United Kingdom, W2 1NY The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Nottingham University Hospital NHS Trust Recruiting Nottingham, United Kingdom, NG7 2UH Churchill Hospital Recruiting Oxford, United Kingdom, OX3 7LE Sheffield Teaching Hospitals NHS Foundation Trust Recruiting Sheffield, United Kingdom, S5 7AU Southampton University Hospital NHS Trust Recruiting Southampton, United Kingdom, SO16 6YD The Royal Wolverhampton Hospital NHS Trust Recruiting Wolverhampton, United Kingdom, WV10 0QP Less <<
NCT01457144 Mantle Cell Lymphoma Phase 2 Completed - France ... More >> Valerie ROLLAND NEYRET Grenoble, France, 38043 Less <<
NCT02559778 Neuroblastoma Phase 2 Recruiting September 2026 -
NCT03089411 - Active, not recruiting July 15, 2017 -
NCT03643276 Acute Lymphoblastic Leukemia, ... More >>Pediatric Less << Phase 3 Recruiting July 14, 2028 -
NCT01272466 Relapsed Multiple Myeloma Phase 1 Phase 2 Completed - Denmark ... More >> Department of Haematology, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT00833833 - Completed - -
NCT02164955 - Recruiting August 31, 2022 -
NCT00511238 - Completed - -
NCT03390387 Childhood Acute Lymphoblastic ... More >>Leukemia Less << Not Applicable Recruiting November 2025 -
NCT00511238 Multiple Myeloma Phase 2 Completed - -
NCT03416374 Relapsed and/or Refractory Mul... More >>tiple Myeloma Less << Phase 4 Recruiting May 31, 2021 Japan ... More >> Kameda Medical Center Recruiting Kamogawa, Chiba, Japan The Jikei University Kashiwa Hospital Recruiting Kashiwa, Chiba, Japan Ogaki Municipal Hospital Recruiting Ogaki, Gifu, Japan Gunma University Hospital Recruiting Maebashi, Gunma, Japan Shibukawa Medical Center Recruiting Shibukawa, Gunma, Japan Kobe city Medical Center General Hospital Recruiting Kobe, Hyogo, Japan Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan Iwate Medical University Recruiting Morioka, Iwate, Japan Yokohama Municipal Citizen's Hospital Recruiting Yokohama, Kanagawa, Japan Suwa Red Cross Hospital Recruiting Suwa, Nagano, Japan Dokkyo Medical University Recruiting Koshigaya, Saitama, Japan Juntendo University Hospital Recruiting Bunkyo-ku, Tokyo, Japan Nippon Medical School Hospital Recruiting Bunkyo-ku, Tokyo, Japan Nihon University Itabashi Hospital Recruiting Itabashi-ku, Tokyo, Japan The Cancer Institute Hospital of JFCR Recruiting Koto-ku, Tokyo, Japan The Jikei University Hospital Recruiting Minato-ku, Tokyo, Japan Kyorin University Hospital Recruiting Mitaka, Tokyo, Japan Japanese Red Cross Medical Center Recruiting Shibuya-ku, Tokyo, Japan Tokyo Disaster Medical Center Recruiting Tachikawa, Tokyo, Japan Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital Recruiting Hiroshima, Japan Kyoto Kuramaguchi Medical Center Recruiting Kyoto, Japan Niigata Cancer Center Hospital Recruiting Niigata, Japan Osaka Red Cross Hospital Recruiting Osaka, Japan Less <<
NCT02440464 Multiple Myeloma Phase 2 Active, not recruiting March 2023 United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 BMT Northside Atlanta, Georgia, United States, 30342 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Ohio Ohio State/Arthur G. James Cancer Hospital Columbus, Ohio, United States, 43210 United States, Texas University of Texas /MD Anderson CRC Houston, Texas, United States, 77030 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506 United States, Wisconsin University of Wisconsin Hospital & Clinics Madison, Wisconsin, United States, 53792 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53211 Less <<
NCT02178579 - Active, not recruiting August 2018 United States, Alabama ... More >> University of Alabama Medical Center at Birmingham Birmingham, Alabama, United States, 35294 United States, Pennsylvania University of Pennsylvania/Smilow Center for Translational Research Philadelphia, Pennsylvania, United States, 19104-5159 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00956033 - Completed - Netherlands ... More >> Erasmus MC, Centrumlocatie en Daniel den Hoed Rotterdam, Zuid-Holland, Netherlands, 3000CA Less <<
NCT02188368 Multiple Myeloma Phase 2 Recruiting December 2018 United States, California ... More >> California Cancer Associates for Research & Excellence (cCARE) Recruiting Encinitas, California, United States, 92024 Contact: Alberto Bessudo, MD          Contact: Beth Kimball, RN    (760) 452-3909    BKimball@ccare.com    Compassionate Care Research Group Recruiting Fountain Valley, California, United States, 92708 Contact: Haresh Jhangiani, MD          Contact: Barbara Lepthien    (714) 698-0300    barbaral@compcareresearch.com    Comprehensive Cancer Center at Desert Regional Medical Center Completed Palm Springs, California, United States, 92262 Inland Hematology Oncology Medical Group, Inc Recruiting San Bernardino, California, United States, 92404 Contact: Samir Kubba, MD          Contact: Emmarin Saribut    (909) 886-6806    es.ihomg@gmail.com    Wellness Oncology and Hematology Recruiting West Hills, California, United States, 91307 Contact: Ashkan Lashkari, MD          Contact: Mary Mau    (818) 346-1773    mary@wellnessoncology.com    James R. Berenson, MD, Inc. Recruiting West Hollywood, California, United States, 90069 Contact: Regina Swift, RN    310-623-1222    rswift@berensononcology.com    Contact: James R. Berenson, MD    310-623-1214    jberenenson@imbcr.org    Principal Investigator: James Berenson, MD          United States, Nevada VA Sierra Nevada Completed Reno, Nevada, United States, 89502 United States, New Mexico San Juan Oncology Associates Recruiting Farmington, New Mexico, United States, 87401 Contact: Jeffrey Neidhart, MD          Contact: Rosemarie Mestas    (505) 564-6874    rosemarie@sjonc.com    United States, Ohio Gabrail Cancer Center Recruiting Canton, Ohio, United States, 44718 Contact: Nashat Gabrail, MD          Contact: Kirstie Armstrong    (330) 492-3345    karmstrong@gabrailcancercenter.com    United States, South Dakota Rapid City Regional Hospital Completed Rapid City, South Dakota, United States, 57701 United States, Tennessee Wellmont Medical Associates Oncology and Hematology Recruiting Kingsport, Tennessee, United States, 37660 Contact: Ibrahim Nakhoul, MD          Contact: Justin Reynolds    (423) 578-8553    Justin.Reynolds@wellmont.org    United States, Washington Vista Oncology Completed Olympia, Washington, United States, 98502 Less <<
NCT03117751 Acute Lymphoblastic Leukemia ... More >> Acute Lymphoblastic Lymphoma Less << Phase 2 Phase 3 Recruiting March 31, 2028 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Hiroto Inaba, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Hiroto Inaba, MD, PhD Less <<
NCT01510613 Primary Amyloidosis of Light C... More >>hain Type Less << Phase 2 Completed - Italy ... More >> Centro per lo Studio e la Cura delle Amiloidosi Sistemiche - Fondazione IRCCS Policlinico S.Matteo Pavia, Italy, 27100 Less <<
NCT02336815 Multiple Myeloma Phase 2 Active, not recruiting October 2019 -
NCT02981199 Microtransplantation ... More >> Autologous Stem Cell Transplantation Multiple Myeloma in Relapse Less << Not Applicable Recruiting December 2019 China, Beijing ... More >> Beijing Chaoyang Hospital Recruiting Beijing, Beijing, China, 100020 Contact: Guorong Wang, doctor    +861085231572    blunlake@163.com    Contact: Wenming Chen, doctor    +861085231581    wenming_chen@yahoo.com Less <<
NCT00771875 Graft Rejection Phase 2 Completed - United States, Ohio ... More >> The Christ Hospital Cincinnati, Ohio, United States, 45202 University of Cincinnati Medical Center Cincinnati, Ohio, United States, 45267 Less <<
NCT00771875 - Completed - -
NCT02666209 - - - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02208037 Acute Leukemia ... More >> Chronic Myelogenous Leukemia Myelodysplasia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Hodgkin's Lymphoma Less << Phase 2 Completed - -
NCT02645149 Melanoma Phase 4 Not yet recruiting August 2021 Australia, New South Wales ... More >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez    612 9911 7200    maria.gonzalez@melanoma.org.au    Principal Investigator: John Thompson          Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez    +612 9911 7200    maria.gonzalez@melanoma.org.au    Contact: Alex Menzies    +612 9911 7200    info@melanoma.org.au    Sub-Investigator: Georgina Long          Principal Investigator: Alex Menzies Less <<
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT01959698 CD20 Positive ... More >> Recurrent Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Stage I Diffuse Large B-Cell Lymphoma Stage II Diffuse Large B-Cell Lymphoma Stage III Diffuse Large B-Cell Lymphoma Stage IV Diffuse Large B-Cell Lymphoma Less << Phase 1 Phase 2 Recruiting July 15, 2023 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park    877-275-7724    ASKRPCI@RoswellPark.org    Principal Investigator: Francisco J. Hernandez-ILizaliturri Less <<
NCT03490084 - Not yet recruiting September 2021 France ... More >> HAD Not yet recruiting Paris, Île-de-France, France, 75005 Less <<
NCT02220049 Advanced or Metastatic Solid T... More >>umors Less << PHASE1 COMPLETED 2025-11-13 Gustave Roussy, Villejuif, Val... More >> de Marne, 94805, France Less <<
NCT05163405 Multiple Myeloma COMPLETED 2022-06-01 Odense University Hospital, Od... More >>ense, 5000, Denmark Less <<
NCT05137860 Acute Lymphoblastic Leukemia, ... More >>in Relapse|Chemotherapeutic Toxicity|Minimal Residual Disease Less << PHASE4 UNKNOWN 2023-06-23 Hospital General de México "Dr... More >>. Eduardo Liceaga", Mexico City, 06720, Mexico Less <<
NCT00437086 Chronic Myeloproliferative Dis... More >>orders|Leukemia Less << EARLY_PHASE1 COMPLETED 2025-11-08 Mayo Clinic in Florida, Jackso... More >>nville, Florida, 32224, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|M. D. Anderson Cancer Center at University of Texas, Houston, Texas, 77030-4009, United States Less <<
NCT04678089 Multiple Myeloma|Bortezomib UNKNOWN 2025-12-23 Beijng Chao Yang Hospital, Bei... More >>jing, 100020, China Less <<
NCT03344328 Chemotherapy Induced Periphera... More >>l Neuropathy|Multiple Myeloma Less << COMPLETED 2020-01-31 CHU Clermont-Ferrand, Clermont... More >>-Ferrand, 63003, France Less <<
NCT06029998 Metastatic Castration-resistan... More >>t Prostate Cancer Less << PHASE2 RECRUITING 2025-12-28 Huntsman Cancer Institute/Univ... More >>ersity of Utah, Salt Lake City, Utah, 84112, United States Less <<
NCT00504634 Multiple Myeloma PHASE2 COMPLETED 2025-05-10 UT MD Anderson Cancer Center, ... More >>Houston, Texas, 77030, United States Less <<
NCT00104871 Insular Thyroid Cancer|Recurre... More >>nt Thyroid Cancer|Stage II Follicular Thyroid Cancer|Stage II Papillary Thyroid Cancer|Stage IV Follicular Thyroid Cancer|Stage IV Papillary Thyroid Cancer Less << PHASE2 COMPLETED 2025-04-14 University of Colorado at Denv... More >>er Health Sciences Center, Aurora, Colorado, 80045, United States|Lombardi Comprehensive Cancer Center at Georgetown University, Washington, District of Columbia, 20057, United States|Emory University, Atlanta, Georgia, 30322, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02114, United States|Dana-Farber Harvard Cancer Center, Boston, Massachusetts, 02115, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, 44195, United States|Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, 43210, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States Less <<
NCT06215638 Rheumatoid Arthritis ACTIVE_NOT_RECRUITING 2024-12-30 Peking Union Medical Cllege Ho... More >>spital, Beijing, Beijing, 100005, China Less <<
NCT06284395 Response, Acute Phase|Survivor... More >>ship Less << RECRUITING 2024-10-30 Hospital General de Mexico Dr.... More >> Eduardo Liceaga, Mexico City, Cdmx, 06720, Mexico Less <<
NCT06012383 Multiple Myeloma, Refractory COMPLETED 2025-12-22 -
NCT02797041 Multiple Myeloma UNKNOWN 2025-06-16 -
NCT06034561 Acute Lymphoblastic Leukemia, ... More >>in Relapse|Acute Lymphoblastic Leukemia With Failed Remission Less << PHASE2 RECRUITING 2025-08-29 Instituto do Cancer do Estado ... More >>de Sao Paulo, S?o Paulo, SP, 01246000, Brazil Less <<
NCT06203145 Multiple Myeloma|Renal Injury RECRUITING 2025-11-30 Peking University First Hospit... More >>al, Beijing, Beijing, 100034, China Less <<
NCT05599880 Relapsed/Refractory Immune Thr... More >>ombocytopenia Less << PHASE2 RECRUITING 2027-12-31 Seoul National University Bund... More >>ang Hospital, Guri-si, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of Less <<
NCT05383547 Bortezomib|Glomerulonephritis|... More >>MN|MPGN|FSGS|IgA Nephropathy Less << UNKNOWN 2023-12-31 Ruijin Hospital, Shanghai Jiao... More >> Tong University School of Medicine, Shanghai, Shanghai, 200025, China Less <<
NCT00570180 Multiple Myeloma PHASE2 COMPLETED 2015-09-15 Cross Cancer Institute 11560 U... More >>niversity Ave, Edmonton, Alberta, T6G-1Z2, Canada|CancerCare Manitoba 675 McDermot Ave., Winnipeg, Manitoba, R3E 0V9, Canada|Queen Elizabeth II Health Sciences Centre., Halifax, Nova Scotia, B3H 2Y9, Canada|London Regional Cancer Program 790 Commissioners Road East, London, Ontario, N6A 4L6, Canada|The Ottawa Hospital, Ottawa, Ontario, K1H 8L6, Canada|Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada|Saskatoon Cancer Centre 20 Campus Drive, Saskatoon, Saskatchewan, S7N 4H4, Canada Less <<
NCT03850366 Hematological Malignancy PHASE2 RECRUITING 2026-01-01 Henry Ford hospital, Detroit, ... More >>Michigan, 48202, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.60mL

0.52mL

0.26mL

13.01mL

2.60mL

1.30mL

26.03mL

5.21mL

2.60mL

References

 

Historical Records

Categories